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ABSTRACT 
 Although the rendering process serves as invaluable means for the disposal of 
inedible animal by-products, the finished products often harbor pathogenic and 
opportunistic microorganisms such as Salmonella and enterococci, respectively. The 
temperatures used during the rendering process far exceed the heat tolerance threshold of 
most bacterial species, so cross-contamination from the environment and/or from the 
incoming raw material is the proposed source of the contamination. Research has 
demonstrated that the raw material coming into the rendering facility is highly 
contaminated with pathogenic bacteria including Salmonella. While not in a rendering 
facility, studies have also demonstrated that bacteria such as Salmonella can persist on 
food processing equipment and be transferred into the product upon contact. The 
objectives of this study were to: 1) isolate and characterize Salmonella and enterococci 
from finished animal by-products, 2) produce and optimize a bacteriophage cocktail 
against Salmonella, 3) apply the bacteriophages to reduce Salmonella levels on 
environmental surfaces found in a rendering facility and in raw offal, and 4) use the 
bacteriophage as a feed additive to reduce or prevent Salmonella infection in mice. 
 To determine the prevalence of Salmonella and enterococci, two hundred finished 
meals provided by various rendering facilities across the U.S. were analyzed. While the 
animal meals were shown to not be a suitable environment for bacterial growth (moisture 
content 1.9 to 11.5%), these products did contain enterococci and Salmonella. 
Enterococci were detected in 83% of the samples and accounted for up to 54% of the 
total bacterial count, which ranged from 1.7 to 6.8 log CFU/g. Characterization of the 
iii 
 
enterococci isolates revealed that only 3 isolates were resistant to vancomycin (32 
µg/ml). PCR analysis revealed that none of these 3 VRE isolates were E. faecalis or E. 
faecium. In addition, no VRE isolates were of the VanA or VanB-type, which confer the 
highest levels of resistance to vancomycin. Salmonella (n = ? ) was isolated from 8.7% of 
the finished meal samples. There were 13 Salmonella serotypes identified among the 
isolates with 16 pulse field gel electrophoresis (PFGE) patterns. Thermal tolerance 
studies revealed that these Salmonella isolates had D-values of 9.27-9.99, 2.07-2.28, and 
0.35-0.40 min at 55°C, 60°C, and 65°C, respectively. 
 As a means to prevent or reduce Salmonella contamination, bacteriophages were 
isolated from raw chicken offal that would be used for rendering. Bacteriophages were 
isolated by using the Salmonella spp. isolated previously from the finished meals as the 
host bacteria. For further study, five of the isolated bacteriophages (n =  ?  ) were selected 
to produce a cocktail for bacteriophage treatment studies. The selection was based on 
which bacteriophage had the highest lytic activity against 5 pre-determined Salmonella 
serotypes, i.e., Enteritidis, Idikan, Johannesburg, Mbandaka, and Typhimurium. Prior to 
bacteriophage treatment studies, the optimal bacteriophage cocktail concentration was 
determined by multiplicity of infection (MOI) optimization. Initial results indicated that 
an actively growing culture is needed for lytic activity of bacteriophages. When using an 
actively growing Salmonella cocktail, the effectiveness of the bacteriophage cocktail was 
shown to increase by raising the MOI from 1 to 10, whereas MOI of 50 didn’t enhance 
the lytic activity further. MOI optimization also revealed that resistance strains of the 
Salmonella spp. are selected for quickly (12 h), but that the lytic activity of the 
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bacteriophage treatment is easily extended through the addition of a different 
bacteriophage cocktail at the 12 h mark. 
 The optimized bacteriophage cocktail was able to successfully reduce Salmonella 
levels on all tested environmental surfaces (HDPE plastic, cement, rubber, stainless 
steel). Treatment of Salmonella cells attached to the environmental surfaces resulted in a 
2 log CFU/cm2 reduction at 40° and 30°C, and ca. 1 log CFU/cm2 reduction at 20°C on 
all surface materials. The presence of an organic layer on the surface had identical levels 
of reduction, indicating the organic material does not interfere with the bacteriophage’s 
lytic activity. Treatment of the single species biofilm resulted in ca. 1-2, 2-3, and 1 log 
CFU/cm2 reduction in S. Enteritidis H4717 populations on all surface materials at 20, 30, 
and 40°C, respectively, as compared with ca. 0.5, 1.5-2, and 0.5 log CFU/cm2 reduction 
in S. Enteritidis populations of the double species biofilm under the same experimental 
condition. 
 In addition to the surface materials, the bacteriophage cocktail was shown to 
reduce Salmonella levels in raw chicken offal. When treating irradiated raw offal that was 
artificially contaminated with the Salmonella cocktail (105 CFU/g), the bacteriophage 
cocktail reduced Salmonella levels by ca. 2.0, 2.7, and 2.5 log CFU/g at 20°, 30°, and 
40°C, respectively. The bacteriophage was also capable of reducing Salmonella levels to 
the same degree, i.e., ca. 2.0, 2.2, and 2.2 log CFU/g at 20°, 30°, and 40°C, respectively, 
in the non-sterile raw chicken offal at the presence of background microorganisms.   
 The bacteriophage cocktail was also evaluated as a feed additive.  The 
bacteriophage cocktail was lyophilized and added into the animal meals (blood, feather, 
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and poultry), which were artificially contaminated with a five-strain Salmonella cocktail 
at initial level of ca. 105 CFU/g. A series of dehydration studies revealed that the addition 
of dehydrated bacteriophages to finished meals does not reduce the level of Salmonella 
present upon rehydration; however, there was an observable difference between those 
samples containing the bacteriophages and those that did not after 12 h of rehydration, 
with those containing the bacteriophages having lower levels of Salmonella (ca. 2 log 
CFU/g difference ??).  Our results also revealed that the bacteriophage cocktail’s stability 
was reduced quickly when applied in a dehydrated form. The concentration of the 
dehydrated bacteriophage decreased by 1.5 log PFU/g within the rendered meal over a 4 
week period at 30°C.  However, the stability of the bacteriophage was maintained well 
when the bacteriophage was added to the animal feed in liquid form and stored under 
refrigeration conditions (4°C). Under these conditions, the bacteriophage cocktail’s 
concentration decreased by 0.23 log PFU/g over a 4 week period.  
 The liquid bacteriophage was then supplemented into animal feed and given to 
mice during an animal trial. The mice that had been given a diet containing the 
bacteriophage for a period of a week prior to Salmonella inoculation were not infected as 
evidenced through fecal sampling. These mice shed no Salmonella in their feces over a 4 
week period. Mice that had not been given the diet supplemented with the bacteriophage 
shed Salmonella in their feces for a period of 2.5 weeks. Histological analysis of the liver 
and intestine also indicated no observable signs of inflammation in those mice given the 
bacteriophages. In mice not receiving the bacteriophage treatment, venous dilation, 
cholangiohepatitis, and monocytes in the portal areas were observed in the liver. 
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 Our results indicate that the Salmonella contamination of finished rendered meals 
is likely the source of cross-contamination between the environment or the incoming raw 
material and the finished products. The risk for cross-contamination may be reduced 
through the use of bacteriophage treatment which was found to reduce ca. 99 to 99.9% of 
Salmonella levels on both the environmental surfaces and raw material. The 
bacteriophage cocktail was also found to have the potential to be used as  a feed additive 
to reduce pathogen levels within an animal host when added to the feed in liquid form 
just prior to consumption. 
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CHAPTER ONE 
LITERATURE REVIEW 
The Rendering Industry: An Overview 
In the U.S. alone, approximately 100 million hogs, 35 million cattle, and eight billion 
chickens are slaughtered for consumption annually (Meeker and Hamilton, 2006). This leads to a 
large amount of by-products which include, skin, hair, hides, hoofs, horns, feet, heads, bones, toe 
nails, blood organs, glands, intestines, muscle and fat tissue, feathers, shells, and in some 
instances an entire carcass. On average, approximately 50% of an animal used for food 
production (meat, milk, and eggs) is not consumed by humans. To break it down further, 
“approximately 49% of the live weight of cattle, 44% of the live weight of pigs, 37% of the live 
weight of broilers, and 57% of the live weight of most fish species are materials not consumed 
by humans” (Ockerman and Hansen, 1988; Meeker and Hamilton, 2006). The increasing use of 
pre-packaged and ready-to-eat (RTE) meat products has further increased the amount of material 
intake for rendering over the past few years. Currently, the U.S. has an approximate raw material 
intake of 54 billion pounds per year as compared with ca. 5 billion pounds of raw material in 
Canada. The composition of these raw materials is reported to be 60% water, 20% protein and 
mineral, and 20% fat (Meeker and Hamilton, 2006). These materials spoil quickly and are highly 
contaminated with microorganism including those that are pathogenic to humans; therefore, 
rendering is a fast and efficient way of disposing of these materials and eliminating the 
microorganisms from the finished product (Meeker and Hamilton, 2006; Aird and Spragg, 2005). 
The rendering process breaks down these animal by-products (those not suitable for 
human consumption) by physical and chemical manipulation. In general there are four categories 
of rendering systems: wet rendering, batch rendering, dry continuous, and continuous low- 
temperature rendering (Ockerman and Hansen, 1988). All rendering methods use heat to 
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thoroughly cook the material followed by moisture removal and fat extraction. The temperature 
used and the length of application are crucial to the quality of the finished product. Although 
both factors vary depending on the raw material being processed, the rendering process involves 
a set of general steps regardless of the raw material. Initially all raw material is transported to an 
area in the facility where it is ground and fed onto a conveyer that transports it into the cooker. 
The cooking process typically lasts for 40-90 minutes at 115° to 145°C (Meeker and Hamilton, 
2006).  Once the material has been thoroughly cooked, the melted fat is separated and the 
majority of the moisture is removed. This separation of fat is performed in a closed vessel using 
a screw press. The remaining material, “cracklings”, is ground further and has additional 
moisture removed (Ockerman and Hansen, 1988). When the “cracklings” have been ground to 
sufficient size particles, both the processed protein meal and fat are either transferred to a storage 
facility or shipped out to a consumer (Meeker and Hamilton, 2006). 
 There are approximately 300 rendering facilities in North America. The rendering facility 
processes the inedible animal by-products into many valuable products, the largest of which is 
meals used as supplements in animal feed. The type of meal is dependent on the raw material it 
is produced from. There is a wide range of meal types which includes meat and bone meal, meat 
meal, poultry meal, hydrolyzed feather meal, blood meal, and fish meal (Meeker and Hamilton, 
2006). A breakdown on the application of two meal types (meat and bone meal and blood meal) 
is presented in Table 1.1. 
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Table 1.1 Domestic use of animal proteins by various animal species1 
  Meat and Bone Meal Blood Meal 
Species fed Million pounds Percentage Million pounds Percentage 
Ruminants 567.4 10 158.55 70 
Swine 737.6 13 45.3 20 
Poultry 2439.6 43 22.65 10 
Pet food 1304.9 23 - - 
Other 624.1 11 - - 
Total 5673.5 100 226.5 100 
1 (Sparks, 2001)
 
Rendering Processes 
 Modern rendering facilities have made vast improvements in the technology and 
processes used over the past several years. Current facilities are constructed so as to separate the 
incoming raw material from other areas of the facility such as the processing and storage areas. 
The rendering process is controlled by a computer system that regulates the temperature, time, 
and in some cases pressure during processing. The technology ensures that the raw material 
receives sufficient treatment to achieve thermal kill time requirements for the pathogenic 
microorganisms. In the mean time, it prevents overheating of the material which will lead to a 
decrease in the nutritional value and digestibility of the finished product (Meeker and Hamilton, 
2006). 
 Essentially there are two major types of rendered processing, wet and dry rendering. In a 
wet rendering system, there is high moisture content in the finished product, which may or may 
not be dried. This form of rendering is primarily used for the production of edible fats and oils. 
Early wet rendering systems were of simple design and involved cooking the fat in an open kettle 
heated over a wood fire or hot coal. The fat would rise to the top and was skimmed off 
(Anderson, 2006). Current methods for wet rendering include loading the raw material into a 
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vertical digestor where steam is injected into the material through the perforated plates in the 
digestor. This method of rendering is being gradually phased out due to several disadvantages 
including: long cooking times, labor intensive, and up to 25% of the meal can be lost during 
processing (Ockerman and Hansen, 1988). 
 Dry rendering systems are the most common form of rendering used today. Dry rendering 
is accomplished through one of two system designs, batch rendering or continuous rendering. 
The use of batch cooking rendering systems began to be universally used during the later part of 
the twentieth century. A batch system is designed to be “loaded, processed to a percentage dry, 
and then discharged for fat separation” (Anderson, 2006). In a batch system, a batch cooker can 
be used to cook, dry, hydrolyze, or process raw material. Originally, large pieces of animal meat 
or offal would be pressure cooked in a batch system prior to drying, which would make the 
bones softer and easier to handle. Modern particle reduction technology has eliminated the need 
for pressure cooking, but it is still used in Europe as means to further reduce bovine spongiform 
encephalopathy (BSE) causing prions. Pressure cooking is being used in the processing of hair 
and feathers to make the associated proteins more digestible. For example, the pressure is needed 
to break down the bonds in the keratin proteins found in feathers. While chemicals could break 
the bonds post-processing by 100%, the chemicals also destroy the amino acids produced from 
protein degradation (Anderson, 2006). While batch systems do offer the major advantage of 
being able to cook, pressurize, and sterilize within the same vesicle, it has more disadvantages 
than continuous rendering systems. These disadvantages include: the meat based by-products 
must be cut and washed which adds ca. 35% to the moisture content, problems processing 
gelatinous material, the material is not contained in enclosed vesicles making it susceptible to 
contamination, labor intensive, and inefficient drying (Ockerman and Hansen, 1988). 
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 Continuous rendering has undergone many structural changes over time. One of the 
earliest continuous systems developed was the Anco Strata-Flow system. This system was 
composed of batch cookers that had been modified and linked together to form a continuous 
processing system with each batch cooker responsible for a specific aspect of the rendering 
process. Since then, several adaptations have been made to the design including the DUKE, 
Carvo-Greenfield, Atlas, and the Stord-Bartz systems (Anderson, 2006). Regardless of the 
design, the flow of raw material through a continuous rendering system is the same. Initially, raw 
material is transferred into a grinder where the material is ground into small uniform particles. 
The particles are then transferred into a continuous cooker where they are heated to 115°-145°C 
with steam. Once the material has been adequately cooked, the liquid fat and solid material are 
separated using a drainer conveyor. The solid material is fed into a screw press to reduce the fat 
content to ca. 10-12%. The solid material is then combined to form the finished meal.(Ockerman 
and Hansen, 1988; Anderson, 2006). The continuous rendering system is outlined in Figure 1.1 
(Anderson, 2006). 
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Figure 1.1. Continuous Rendering System Outline1 
1 Available at: http://nationalrenderers.org/assets/flow_charts.pdf 
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Finished Rendered Products 
 Annually, the U.S. rendering industry produces ca. 11.2 billion pounds of protein and 
10.9 billion pounds of fats. About 85% of these products are then used in the production of 
animal feed ingredients (Meeker and Hamilton, 2006). The composition of these feed ingredients 
is defined by the National Research Council (NRC) or the Association of American Feed Control 
Officials (AAFCO), which puts out and updated manual annually with feed ingredient guidelines 
(Aird and Spragg., 2005). Table 1.2 outlines the nutrient composition of commonly used 
rendered products. As of 2006, the AAFCO manual referenced ca. 125 individual animal by-
products produced in the U.S. (Meeker and Hamilton, 2006). Some major meal types are 
discussed in detail in the following paragraphs. 
According to AAFCO, meat and bone meal (MBM) is made from mammalian tissues 
including the bone but excluding blood, hide, horn, hooves, stomach or rumen contents, or hair. 
MBM must also have a phosphorus content of at least 4% and a calcium level less than 2.2 times 
the phosphorus level. If the phosphorus content is less than 4%, the meal is defined as meat meal 
(Meeker and Hamilton, 2006). In addition, the meal cannot contain more than 12% and 9% 
indigestible pepsin residue and crude protein, respectively; however, in other countries such as 
Australia the amount of indigestible pepsin is slightly higher at ca. 15% (Meeker and Hamilton, 
2006; Aird and Spragg., 2005). MBM of poultry origin is used for all species of livestock; 
however, ruminants cannot be fed meals that have been made from ruminant animals as outlined 
by the feed law passed by the FDA in 1997 (title 21, Code of Federal Regulations, Part 
589.2000) to prevent the transference of BSE (Meeker and Hamilton, 2006). 
Poultry bone meal (PBM) by definition is composed from the cleaned carcass of poultry 
including the neck, feet, undeveloped eggs, and intestines. Some feathers are unavoidably 
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incorporated into the raw material, but in general the product is free of feathers. Like MBM, the 
calcium level in PBM must not exceed the phosphorus level by more than 2.2 times the amount 
(Meeker and Hamilton, 20006). The NRC has the calcium content listed at ca. 10.3% and the 
phosphorus content at 5.1% (Aird and Spragg., 2005). PBM is usually of high quality with 
essential amino acids, vitamins, minerals, and fatty acids, so it has been commonly used to 
produce pet grade feed (Meeker and Hamilton, 2006; Aird and Spragg., 2005).  
The feathers not used to produce poultry meal can be used to produce feather meal 
(FeM). The largest market for unused feathers is in meal production (Ockerman and Hansen, 
1988). A minimum of 75% of the meal’s crude protein must be digestible by pepsin. The 
undecomposed feathers are cooked under pressure to break the keratin protein bonds, which 
results in a feather meal that is free-flowing and easily digestible by all species of livestock 
(Meeker and Hamilton, 2006). Typically the finished feather meal far exceeds the digestibility 
guidelines set by AAFCO, but digestibility in ruminant animals has been shown to increase 
through the addition of urea to the meal (Ockerman and Hansen, 1988). A unique aspect of this 
meal type is that it is an excellent source for sulfur containing amino acids, particularly cystine 
(Meeker and Hamilton, 2006); however, it is deficient in lysine, methionine, histidine, and 
tryptophan (Ockerman and Hansen, 1988). 
In addition to inedible animal parts and feathers, clean (free of hair, urine, and stomach 
contents) blood from slaughtered animals can also be used to produce finished, rendered by-
products. Initially, blood is treated by removing a large amount of the moisture by mechanical 
dewatering or turning the blood into a semi-solid state by coagulating it with steam. In this 
instance, the semi-solid masses are flash dried to rapidly remove the remaining moisture content. 
According to AAFCO guidelines, the minimum biological activity of lysine within the finished 
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meal must be at least 80% (Meeker and Hamilton, 2006; Ockerman and Hansen 1988). During 
the 1960s and 1970s, blood meal production was limited due to the vat-drying procedures which 
significantly lowered the bioactivity of lysine. With newer methods of drying (ring or flash-
drying), blood meal not only has the highest amount of lysine but is the richest source of protein 
for animal feed as well (Meeker and Hamilton, 2006). The ring drying system has been shown to 
increase the amount of biologically active lysine by ca. 34% and the amount of protein by 7.5% 
in blood meal (Ockerman and Hansen, 1988). 
Table 1.2 Nutrient composition of animal proteins1 
Item 
Meat and Bone 
Meal 
Blood 
Meal2 
Feather 
Meal 
Poultry 
Meal 
Crude Protein % 50.40 88.90 81.00 60.00 
Fat % 10.00 1.00 7.00 13.00 
Calcium % 10.30 0.40 0.30 3.00 
Phosphorus % 5.10 0.30 0.50 1.70 
TMEN3 kcal/kg 2666 3625 3276 3120 
Methionine % 0.70 0.60 0.60 1.00 
Cystine % 0.70 0.50 4.30 1.00 
Lysine % 2.60 7.10 2.30 3.10 
Threonin % 1.70 3.20 3.80 2.20 
Isoleucine % 1.50 1.00 3.90 2.20 
Valine % 2.40 7.30 5.90 2.90 
Tryptophan % 0.30 1.30 0.60 0.40 
Arginine % 3.30 3.60 5.60 3.90 
Histidine % 1.00 3.50 0.90 1.10 
Leucine % 3.30 10.50 6.90 4.00 
Phenylalanine % 1.80 5.70 3.90 2.30 
Tyrosine % 1.20 2.10 2.50 1.70 
Glycine % 6.70 4.60 6.10 6.20 
Serine % 2.20 4.30 8.50 2.70 
1 (National Research Council 2004)
 
   
2 Ring or flash dried 
3 TME
N
= true metabolizable energy nitrogen corrected (Dale, 1997)
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Microbiological Safety of the Rendering Process 
 In addition to producing a profitable end product, the rendering industry also plays a 
major role in removing pathogenic microorganisms from the food chain. The effective treatment 
of pathogenic microorganisms in the incoming animal by-products has been documented by 
some research (Troutt et al., 2001).  
The incoming raw material serves as a reservoir for many pathogenic bacteria. Cattle 
have been reported with a 23% contamination rate with E. coli O157:H7 (Smith et al., 2001), a 
50% contamination rate with Salmonella (Troutt et al., 2001), and a 39% contamination rate with 
Cryptosporidium parvum (Huetink, 2001). Poultry has been reported with up to a 100% 
contamination rate by Salmonella (Council of Agricultural Science and Technology, 1994). 
Swine have been reported to be contaminated with Salmonella (46%) and Yersina enterocolitica 
(49%) (Swanenburg et al., 2001; Council of Agricultural Science and Technology, 1994). 
One of the major microbial contaminants in finished feed is Salmonella. As mentioned 
previously, the rendering process should effectively eliminate Salmonella, but one of the major 
issues facing the rendering industry is cross-contamination from the incoming raw material 
(Ockerman and Hansen, 1988). Once the meal is contaminated with Salmonella, it is 
incorporated into the finished feed given to livestock. This allows Salmonella to continuosly 
enter the food chain. Several studies have been able to link cases of Salmonella infection in 
humans to contaminated animal feed. Boyer et al. (1958) established a link between serotypes of 
Salmonella recovered from humans and animals to feed ingredients and animal feed. A year 
later, Watkins et al. (1959) was able to recover 28 different serotypes of Salmonella from 18.5% 
of animal by-products sampled. Pomeroy et al. (1961) expanded on Watkins work by collecting 
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samples from 22 states across the United States. In total, Salmonella was identified in 170 of the 
980 samples tested with 43 serotypes identified.  
The problem with Salmonella was further illustrated by a Salmonella agona outbreak. 
From 1969 to 1970, S. agona was identified as a public health concern in the United States, 
United Kingdom, Netherlands, and Israel. In each country, initial detection of S. agona in fish 
meal was followed by the detection of the pathogen in domestic animals and humans (Clark et al. 
1973). By 1972, S. agona was the 8th most commonly isolated serotype in the United States. 
During a period from March to May of that year, an outbreak of S. agona occurred in Paragould, 
Arkansas. In total, seventeen people were infected. The source was traced back to a local 
restaurant which had received poultry products from a Mississippi farm that had used fish meal 
contaminated with S. agona (Franco, 2006). 
From 1965 to 1970, the animal health division of the United States Department of 
Agriculture (USDA) collaborated with the Federal Drug Administration (FDA) to sample animal 
by-products and finished meals to determine levels of Salmonella contamination. In response to 
some of the initial findings, Commissioner Goddard made the decision within the FDA to 
include food produced for animal consumption as part of Section 201 (f) of the Federal Food, 
Drug and Cosmetic Act in 1967. This meant that Salmonella contamination in animal feed was 
now considered an adulterant by definition of the Act (Franco, 1999). 
While studies have indicated that Salmonella can be detected in finished animal by-
products, the amount present after processing declines rapidly. Sutton et al. (1992) demonstrated 
that in a sample of MBM stored at 28.8°C, Salmonella levels decrease from 30 CFU/g to below 
the detection limit within 2 days of storage. Even when Salmonella is present, animal by-
products still pose less of a risk for Salmonella contamination when compared to meals 
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composed of vegetable proteins. Hamilton (2002) determined the incidence rate of Salmonella in 
animal by-product meals was higher in the Netherlands, Canada, and the U.S., while the levels 
were higher in the vegetable proteins in Germany and the UK. The highest incidence rates for 
both proteins were observed in products produced in the U.S. While the animal proteins had a 
higher range of incident rates, the risk factor associated with vegetable proteins is higher due to 
the fact that makes up a larger percentage of the finished feed. The animal proteins have a risk 
factor of 0.9-1.68 and vegetable proteins have a risk factor of 1.743-8.964 for Salmonella 
(Hamilton, 2002) 
The establishment of linkages between human disease and contaminated animal by-
products along with the FDA’s incorporation of animal feed into the definition of food led to the 
rendering industry began placing a higher emphasis on the biological safety of the products they 
produce. In 1984, the rendering industry founded the Animal Protein Producers Industry (APPI) 
to regulate biosecurity within the industry, such as Salmonella screening or developing protocols 
such as hazard analysis and critical control plans (HACCP) to ensure the safety of the product, 
and to continuously educate the industry on new issues that may impact their products (Franco, 
2006). 
Since the formation of APPI, vast improvements have been made to the rendering process 
and more recent studies have provided data that indicates finished meals are free of pathogenic 
bacteria including Salmonella as it leaves the cooker. Troutt et al. (2001) tested raw products 
used in production at 17 rendering facilities in the mid-western United States. The results 
showed there were high levels of Salmonella spp., Listeria monocytogenes, Campylobacter 
jejuni, and Clostridium perfringens contamination. When the processed meals were tested, none 
of these pathogens were detected (Table 1.3). In addition to bacteria, viruses are also effectively 
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eliminated during the rendering process. The time and temperature used by the rendering 
industry was always thought to be sufficient to kill viruses within the by-products. Pirtle (1999) 
demonstrated this using pseudorabies virus (PRV, a common viral disease in pigs) as a model 
microorganism. To determine the effectiveness of the rendering process, raw materials with 
varying degrees of viral contamination were processed and the resulting MBM was analyzed for 
the presence of the virus. The results indicated that the virus was unable to survive the rendering 
process (Pirtle, 1999). 
Table 1.3 Pathogen elimination from finished rendered products 
Pathogen 
Raw Tissue  
(% positive) 
Finished Product 
 (% positive) 
Clostridium perfringens 71.4 0 
Listeria spp. 76.2 0 
Listeria monocytogenes 8.3 0 
Campylobacter spp. 29.8 0 
Campylobacter jejuni 20.0 0 
Salmonella spp. 84.5 0 
Troutt et al. (2001)
 
 Two years after the establishment of the APPI (1986) BSE was confirmed in the United 
Kingdom and believed to have originated from MBM produced from sheep by-products 
(Kimberlin, 1990). This led to the USDA conducting an 8 year study in an attempt to 
demonstrate that the rendering process kills the prions responsible for BSE and they are not 
transmitted orally to cattle via consumption of finished MBM. Neonatal calves were fed a diet of 
raw brain or finished MBM from sheep infected with scrapie. During the eight year period, the 
calves were checked for signs of disease, lesions, or prion protein deposits associated with 
scrapie or BSE (Cutlip et al., 2001). The results showed that experimental calves given the MBM 
diet did not exhibit any clinical signs or develop lesions associated with BSE. In addition, 
examination of spinal cord and brain samples did not indicate the presence of any prions (Cutlip 
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et al., 2001). Howevere, a disease found in humans, Creutzfeldt-Jakob disease, linked to the 
consumption of cattle suffering from BSE was identified a decade after the intial discovery of 
BSE. This led to the FDA’s decision to ban the use of feed produced from ruminants as a feed 
ingredient for ruminant animals (Franco, 2006).  
 While there are some risks associated with finished animal by-products, the rendering 
process is still the best means for the disposal of the raw by-products and mortalities. The 
rendering industry provides numerous advantages including: infrastructure, volume reduction, 
controlled processing, established regulations, and timely processing (Hamilton et al., 2006). To 
validate this claim, the United Kingdom Department of Health (2001) conducted a study 
evaluating the risks involved with various methods of disposal for animal by-products. Their 
study determined biological hazards were negligible if the material was treated by rendering, 
incineration, or funeral pyre. While biological hazards were eliminated, incineration and pyres 
create chemical hazards associated with burning. The rendering process was the only means of 
disposal that successfully eliminated the biological and chemical hazards. The only exception 
was BSE, which was found to be a negligible risk to humans if the solid material was incinerated 
(Hamilton et al., 2006). A summary of the study can be seen in Table 1.4. 
 
 
 
 
 
 
 
 15 
 
 
Table 1.4 Potential health risks of various methods of animal by-products disposal1 
  Disposal Options 
Disease/Hazardous 
Agent Rendering Incineration Landfill Pyre Burial 
Campylobacter, E. coli,  
Listeria, Salmonella,  
Bacillus anthracis,  
C. botulinum,  
Leptospira, 
Mycobacterium 
tuberculosis var bovis,  
Yersinia 
very small 
 
 
 
very small 
 
 
 
moderate 
 
 
 
very small 
 
 
 
high 
 
 
 
 
Cryptosporidium, 
Giardia 
very small 
 
very small 
 
moderate 
 
very small 
 
high 
 
 
Clostridium tetani very small very small moderate very small high 
 
Prions for BSE, scrapie moderate very small moderate moderate high 
Methane, CO2 very small very small moderate very small high 
Fuel-specific chemicals, 
metal salts 
very small 
 
very small 
 
very small 
 
High 
 
very small 
 
 
Particulates, SO2, NO2, 
nitrous particles 
very small 
 
moderate 
 
very small 
 
high 
 
very small 
 
 
PAHs, dioxins very small moderate very small high very small 
 
Disinfectants, detergents very small very small moderate moderate high 
 
Hydrogen sulfide very small very small moderate very small high 
 
Radiation very small moderate very small moderate moderate 
1 (U.K. Department of Health 2001)
 
    
 In addition to potential biological and/or chemical hazards, the other mean of disposal 
can simply not handle the volume of raw materials. When the by-products are disposed of in 
landfills, an additive such as saw dust is mixed in to reduce high moisture content in raw 
materials. The addition of saw dust can raise the volume of material by 25% to a point that 
disposing of all the animal by-product and mortalities generated in 1 year would consume of 
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25% of the total landfill space in the United States (Sparks, 2001). Another alternative for 
disposal of animal by- products is composting, but composting is limited to small scale 
production due to the amount of material need to balance the carbon and nitrogen ratio and 
moisture content in the raw by-products and mortalities (Hamilton et al., 2006). Based on the 
pork industry alone, a space of ca. one trillion cubic feet would be needed to compost the amount 
of material rendered each year (Glanville, 2001). While effective at eliminating biological 
hazards, incineration is also limited by the volume of raw by-products produced each year. The 
volume of raw material would require large amounts of fossil fuel which is also cost prohibitive. 
In addition, the ash produced from the raw by-products would have to be disposed of as well 
(Hamilton et al., 2006). 
 This literature review will focus mainly on the microbiological safety of the rendered 
products. Two microbial species, Enterococcus and Salmonella, will be discussed in detail in the 
following sections. 
Enterococci: General Overview 
 Enterococci are ubiquitous and found in most environments, but most commonly they 
can be isolated from an animal’s alimentary tract, the soil, water, and food. They have acquired 
many attributes that ensures their survival in such diverse environments including heat tolerance 
up to 45°C (higher in certain species), tolerance of high salt concentrations and a broad range of 
pH levels. In addition to these characteristics, the enterococci are commonly multi-drug resistant 
which has allowed them to persist with in an animal host (Facklam et al., 2002). The common 
presence within the alimentary tract of livestock and its ability to survive in various 
environments makes enterococci a concern for finished rendered meals. Like Salmonella, there is 
an opportunity for enterococci contamination of rendered animal meals due to cross-
 17 
 
contamination with the incoming raw material (Ockerman and Hansen, 1988). Once in the feed, 
enterococci can enter the food chain. While most strains of enterococci lead to treatable or self-
limiting diseases, there is a major concern for vancomycin resistant enterococi (VRE), which 
will be discussed in more detail later. 
 Thiercelin (1899) first reported what is now thought to be enterococci in human fecal 
samples. He described the bacterium as appearing in pairs or short chains. Andrews and Horder 
(1906) identified a bacterium of fecal origin, Streptococcus faecalis, which would clot milk. 
Thirteen years later. Orla-Jensen (1919) identified an organism with different fermentation 
patterns, which was Streptococcus faecium. A third bacterium, Streptococcus durans, of fecal 
origin was discovered by Sherman and Wing (1935, 1937) with less fermentation activity. In 
1967, a new species Streptococcus avium was added to the group by Nowlan and Deibel (1967). 
Kalina (1970) proposed a new genus name, Enterococcus, should be established. Genetic 
evidence provided by Schleiter and Kilpper-Balz (1984) showed that S. faecalis and S. faecium 
were significantly different from other member of the Streptococcus genus resulting in the 
formation of the new genus, Enterococcus. 
Disease, Virulence, and Antibiotic Resistance of Enterococci 
 While enterococci do inhabit the gastrointestinal tract of the majority of humans, they are 
still responsible for a wide variety of diseases. Enterococci have been linked to endocarditis 
(MacCallum et al., 1899; Rantz and Kirby, 1943; Megran, 1992), respiratory tract infections 
(Rantz and Kirby, 1943), and urinary tract infections (Braude, 1973; Gross et al., 1976; Richards 
et al., 2000; Rantz and Kirby, 1943; Rantz, 1942). The most common species associated with 
human illnesses are E. faecalis and E. faecium; however, the following species have also been 
linked to human disease: E. avium, E. casseliflavus, E. durans, E. gallinarum, and E. raffinosus 
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(Murray, 1990). Recently, enterococci have been identified as the leading cause of surgical site 
infections (17.1%), second leading cause of blood stream infections (11.5%), and the third 
leading cause of nosocomial urinary tract infections (14.3%) (Richards, 2000). In particular, E. 
faecalis accounts for up to 80% of the nosocomial infections resulting from enterococci (Huycke 
et al., 1998; Sahm, 2000). 
  The high incidence of enterococci infections can be partially attributed to a large set of 
virulence factors. For example, E. faecalis is capable of producing the enzymes cytolysin, 
gelatinase, and serine protease which play a role in host tissue degradation  (Hancock and 
Gilmore, 2000; Dupont et al., 1998; Burns et al., 1996; Okamoto et al., 1997; Plaut, 1983; 
Prokesova et al., 1992; Schultz and Miller, 1974; Sundqvist et al., 1985; Lantz et al., 1991; 
Travis et al., 1994). The Enterococcus genus is also capable of producing an aggregation 
substance (Clewell, 1993) and Enterococcal surface protein (Esp) (Shankar et al., 2001) which 
aid in conjugation and adherence to epithelial cells, respectively. Enterococci may also be 
surrounded by a capsule allowing them to evade phagocytosis (Gilmore, 2002). Enterococcci 
also produce large amounts of superoxide. The superoxide fragments the chromosome of 
epithelial cells in the colon granting the enterococci entrance into the bloodstream (Huycke et al., 
1996; Huycke et al., 2001). 
 In addition to the treatment of human infections, antibiotics have other applications such 
as animal growth promoters. There are four primary applications for antibiotics in food animals. 
The first is the therapeutic treatment of infections within the animal. The second use is for the 
treatment of a healthy animal living in a flock where at least one animal is infected in an effort to 
prevent infection. A third use is as a prophylactic way to treat animals to prevent the occurrence 
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of disease. The final means is as a growth promoter, which prevents the animal from having to 
fight off infection and the growth of the animal will improve (Aarestrup, 2002). 
 The Union of Concerned Scientists estimated that in the United States 24.6 million 
pounds of antimicrobial agents are used on feed animals every year compared to the 3 million 
pounds used for human treatment (Mellon et al., 2001). Similarly, the European Agency for 
Evaluation of Medical products reported that in 1997 that ca. 10 million pounds of antimicrobial 
agents were used for feed animals across Europe (EMEA, 1999). 
 While enterococcal infections are rarely treated in animals, enterococci are persistently 
present within the animal’s intestinal tract. These enterococci are then constantly exposed to an 
antimicrobial agent when it is being used as a growth promoter or prophylactic, which could lead 
to the selection of strains resistant to the antimicrobial agent used (Aarestrup, 2002). Starr and 
Reynolds (1951) demonstrated this possibility with coliforms in the intestinal tracts of turkeys 
being continually fed feed supplemented with streptomycin. Their results indicated the presence 
of streptomycin resistant coliforms. Two other studies also demonstrated that the use of 
tetracycline as a growth promoter selected for resistant strains of group D streptococci, 
enterococci, within chickens (Barnes, 1958; Elliot and Barnes, 1959). 
 Due to the overuse of antibiotics as growth promoters, enterococci have developed high 
levels of resistance to various classes of antibiotics including aminoglycosides, chloramphenicol, 
glycopeptides, macrolides, streptogramin, and tetracycline. Several studies have idenitified 
enterococci resistant to one or more of these classes (Table 1.5). 
The antimicrobial agents used for therapy and growth promotion in these feed animals 
are essentially identical to the classes of antibiotics used for human treatment (Aarestrup, 2002). 
This causes concern that the antimicrobial agents used in growth promotion can results in a 
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decrease in efficiency of those used for human treatment. This concern was first acted upon in 
1969 by the Swann committee (Swann, 1969). The committee developed a report recommending 
that any antibiotic used as a method of treatment not be used for growth promotion. This 
recommendation was partially adopted by the European Union, but the United States continued 
using antibiotics such as penicillin in large amounts (Aarestrup, 2002). The antibiotic avoparcin, 
which is in the glycopeptide class, was banned from use as a growth promoter in Denmark in 
1995 due to concerns that it would select for enterococci resistant to vancomycin and that these 
resistant strains could then spread to the human population. This led to a complete ban of 
avoparcin in all countries within the European Union in 1997. A year later, virginiamycin was 
banned due to cross resistance with quinupristin/dalfopristin. The antibiotics bacitracin, 
spiramycin, and tylosin were also banned as growth promoters in 1998 by the European Union 
(Aarestrup, 2002). 
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Table 1.5 Reported cases of antibiotic resistant enterococci  in food animals1 
Class Antibiotic Enterococcus spp. Summary Ref. 
Aminoglycosides 
 
 
 
 
 
Gentamicin faecalis  22% chicken meat samples Thal et al., 1995 
Gentamicin faecalis 11.5% broiler Yoshimura et al., 2000 
Kanamycin faecalis and faecium 30% bovine mastitis Jayorao and Oliver, 1992 
Kanamycin faecalis 62% chickens and 36% swine Rollins et al., 1985 
Streptomycin faecalis and faecium 80% bovine mastitis Jayorao and Oliver, 1992 
Streptomycin faecalis 64% chickens and 57% swine Rollins et al., 1985 
Streptomycin faecium and faecalis 14.4% and 67.9% broilers Yoshimura et al., 2000 
Chloramphenicol 
 
 
 
Chloramphenicol faecium 1% broilers and 7% swine Aarestrup et al., 2000a 
Chloramphenicol faecalis 2% broilers and 4% swine Aarestrup et al., 2000a 
Chloramphenicol faecium and faecalis 40% raw meat samples Pavia et al., 2000 
Chloramphenicol faecalis 2.6% broilers Yoshimura et al., 2000 
Macrolide 
 
 
 
 
 
Erythromycin faecium 12.7% broilers and 46.7% swine Aarestrup et al., 2001 
Erythromycin faecalis 28.1% swine Aarestrup et al., 2001 
Erythromycin faecium and faecalis 65.3% and 89.7% broilers Yoshimura et al., 2000 
Tylosin faecalis 50% poultry Dutta and Devriese, 1982 
Tylosin faecium 67% poultry Dutta and Devriese, 1982 
Tylosin faecium and faecalis 65.4% and 89.7% broilers Yoshimura et al., 2000 
Tylosin faecium 75.4% broilers and 81.8% swine Aarestrup et al., 2000b 
Tylosin faecium 82% broilers and swine Butaye et al., 2001 
Tylosin faecalis 54% broilers and 86% swine Butaye et al., 2001 
Streptogramin 
 
 
 
 
Quinupristin/dalfopristin faecium 79% broilers and 60% swine Aarestrup et al., 2000a 
Quinupristin/dalfopristin faecalis 90% broilers and 98% swine Aarestrup et al., 2000a 
Quinupristin/dalfopristin faecium 51.2% poultry cloacal swabs Hayes et al., 2001 
Quinupristin/dalfopristin faecium 93% poultry carcass McDonald et al., 2001 
Quinupristin/dalfopristin faecium 23% 24 day old turkey Welton et al., 1998 
Quinupristin/dalfopristin faecium 100% 130 day old turkey  Welton et al., 1998 
Virginiamycin faecium 33.9% broilers and 22.5% swine Aarestrup et al., 2001 
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Virginiamycin faecium 75% broilers and 85% swine Aarestrup et al., 2000a 
Virginiamycin faecalis 95% broilers and 99% swine Aarestrup et al., 2000a 
Tetracycline 
 
 
 
Tetracycline faecium 20% broilers and 70% swine Aarestrup et al., 1998 
Tetracycline faecium 32% broilers and 63% swine Aarestrup et al., 2000a 
Tetracycline faecalis 59% broilers and 68% swine Aarestrup et al., 2000a 
Tetracycline faecium and faecalis 94.8% and 93.6% broilers Yoshimura et al., 2000 
Oxytetracycline faecium 92% broilers and 97% swine Butaye et al., 2001 
Oxytetracycline faecalis 79% broilers and 100% swine Butaye et al, 2001 
1 (Gilmore, 2002)
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Vancomycin Resistant Enterococci 
 Enterococci have also developed high levels of resistance to the glycopeptides. 
Resistance was first detected in E. faecium clinical isolates from France in 1986 (Leclerq et al., 
1988) and the United Kingdom (Utley et al., 1989). The first detection of glycopeptide resistant 
enterococci (GRE) outside of a clinical setting was the occurrence of the vanA phenotype of 
vancomycin resistance in the sewage and among chickens in the United Kingdom (Bates et al., 
1993). As mentioned previously the use of the growth promoter avoparcin was identified as the 
cause of the spread of GRE. Fecal samples collected from farms using avoparcin as a growth 
promoter contained high levels of GRE; whereas, samples from farms not using avoparcin were 
only rarely contaminated with GRE (Aarestrup, 1995; Bayer et al., 1997; Klare et al., 1995). The 
presence of GRE in food animals has become widespread in Europe (Gilmore, 2002). Aarestrup 
(1998a) detected glycopetide resistance in 70% and 20% of the E. faecium isolates collected 
from broilers and pigs, respectively, in Denmark. Reports from the Netherlands have indicated 
that 34% and 80% of the enterococci isolated from the feces of pigs and broilers, respectively, 
are GRE (Van den Bogaard et al., 1997). While the presence of GRE in Europe has been well 
documented, there have been no reports of GRE in the US, where avoparcin is not used (Coque 
et al., 1996). 
Vancomycin is a glycopeptide antibiotic that is used to treat infections resulting from 
antibiotic resistant gram positive bacteria. The first reported cases of vancomycin resistant 
enterococci (VRE) were in E. faecium isolates collected from patients with leukemia in France 
and Patients in England suffering from renal failure (Leclerq et al., 1988; Uttley et al., 1988). 
The occurrence of VRE is not limited to Europe. Fridkin and Gaynes (1999) reported that over 
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20% of enterococci isolates collected in 1998 in the US were VRE. In some hospitals, E. faecium 
has been reported as resistant to vancomycin over 90% of the time (Kak and Chow, 2002). 
 The emergence of VRE has been attributed to the widespread use of the antibiotic in 
clinical settings and the use of glycopeptides as growth promoters in animal feed. The variety in 
VRE genotypes and their sequence variability implies that they did not emerge as a single point 
mutation (Kak and Chow, 2002). The guanine (G) & cytosine (C) content exhibited in vanA and 
vanB type VRE exceeds that typically found in either E. faecalis or E. faecium, implying that 
VRE probably acquired gene cluster from other microorganisms (Patel,1999). The proposed 
theory of evolution is that the gene cluster responsible for resistance was transferred from 
vancomycin producing organisms to a specific organism with a similar G & C content. These 
organisms then transferred the gene clusters to enterococci. Once enterococci had gained 
resistance, the occurence of resistance grew due to the abundant use of glycopeptides. In the US, 
the problem is more concentrated in clinical settings. The occurrence of VRE in Europe is mostly 
concentrated in non-human hosts and within healthy humans. The reasons for these patterns can 
be contributed to the difference in primary use of glycopeptides between the two regions. In the 
US, glycopeptides have primarily been used as human therapy while in Europe they have been 
largely used as growth promoters in feed animals (Kak and Chow, 2002). 
Vancomycin works by inhibiting the synthesis of the cell wall within gram positive 
bacteria. Specifically, the glycopeptides binds to the D-alanine-D-alanine terminus of the 
pentapeptide side chains within the cell wall. Once bound, the drug prevents the formation of 
hydrogen bonds that bind the peptide side chains to each other. This prevents the cross-linking of 
the peptidoglycan chains leading to a loss in the structural integrity of the cell wall resulting in 
cell death (Arthur and Courvalin, 1993; Reynolds, 1989; Walsh et al., 1996). 
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 Resistance to vancomycin in enterococci results from a modification in the composition 
of the pentapeptide side chains. The D-alanine-D-alanine terminus is replaced by a terminus 
composed of either D-alanine-D-lactate or D-alanine-D-serine. The substitution with D-lactate 
decreases the results in a 1000x decrease in the affinity for vancomycin due to the loss of a 
hydrogen bond (Bugg et al., 1991). In contrast, the substitution with D-serine only results in a 7x 
decrease in affinity for vancomycin (Billot-Klein et al., 1994). 
 Six  gene clusters have been identified as mediators of vancomycin resistance in 
enterococci (Table 1.6). Five have been identified as acquired traits, while one gene (vanC) is 
intrinsic. The mechanisms for resistance are genotypically and phenotypically distinct for each 
gene cluster involving a complex group of enzymes. These enzymes are responsible for detecting 
the presence of vancomycin, initiating the change in peptidoglycan side chain production to a 
resistant state, and to eliminate the normal (sensitive) peptide-side chain precursors (Kak and 
Chow, 2002). 
Table 1.6 VRE Genotypes1 
Genotype 
Vancomycin 
MIC (µg/ml) 
Teicoplanin 
MIC Expression Precursor Species 
vanA 
 
 
64-1000 
 
 
16-512 
 
 
inducible 
 
 
D-Ala-D-Lac 
 
 
E. faecalis, E. 
faecium, 
and 7 others 
vanB 
 
4-1000 
 
≤1 
 
inducible 
 
D-Ala-D-Lac 
 
E. faecalis and 
E. faecium 
vanC 
 
 
2-32 
 
 
≤1 
 
 
constitutive 
inducible 
 
D-Ala-D-Ser 
 
 
E. casseliflavus, 
E. gallinarum, 
and E. flavescens 
 
vanD 64-128 4-64 constitutive D-Ala-D-Lac E. faecium 
 
vanE 16 0.5 inducible D-Ala-D-Ser E. faecalis 
 
vanG <16 <0.5 ? ? E. faecalis 
1 (Gholizadeh and Courvalin 2000)
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 The vanA cluster is characterized by high levels of induced resistance to vancomycin 
(≥64 µg/ml) and teicoplanin (≥16 µg/ml). Typically, enterococci acquire this gene cluster 
through the incorporation of the Tn1546 transposon or from a Tn3 transposon (Arthur, 1993a; 
Brisson-Noel et al., 1990). Like the vanA cluster, the vanB cluster also confers high levels of 
resistance to vancomycin, but vanB does not confer resistance to teicoplanin (Evers et al., 1994; 
Evers et al., 1993; Quintilions et al., 1993; Williamson et al., 1989). While vanB is typically 
present within the chromosome, it can also be carried on plasmids (Rice et al., 1998). Studies by 
Quintilioni et al. (1996; 1994) have demonstrated that the vanB gene cluster can be transferred 
between enterococci via the Tn1547 transposon. In addition, Carlos et al. (1998) demonstrated 
that the vanB gene cluster was transmitted simultaneously as induced ampicillin resistance via 
the Tn5382 transposon. The vanC gene cluster is only found within the motile species of 
enterococci and confers low levels of resistance to vancomycin. The specific genes encoding 
vanC type resistance are dependent upon the bacterial species. It is encoded for by the vanC-1 
gene in E. gallinarum, vanC-2 in E. casseliflavus, and vanC-3 in E. flavescens (Clark et al., 
1998; Dutka-Malen et al., 1992; Leclerq et al., 1992; Navarro and Courvalin, 1994). The vanD 
gene cluster confers intermediate levels of resistance to both vancomycin and teicoplanin. Unlike 
the previous gene clusters, vanD is located on the chromosome and is non-transferable 
(Casadewell and Courvalin, 1999; Perichon et al., 1997). Both the vanE and vanG confer low 
levels of vancomycin resistance, can be transmitted, and are inducible (Fines et al., 1999; 
McKessar et al., 2000). 
 The vanA operon is composed of seven genes (Table 1.7). The first set of genes (vanH, 
vanA, and vanX) is directly involved in glycopeptides resistance. The second set (vanR and vanS) 
regulate resistance, while the vanY gene is responsible for the removal of normal cell wall 
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precursors. The function of the seventh gene, vanZ, is still unclear (Kak and Chow, 2002). 
Resistance is initiated by the transmembrane segment of vanS (protein kinase) which is 
responsible for sensing the presence of glycopeptides. After sensing the glycopeptides, vanS 
undergoes autophosphorylation which results in the transfer of a phosphoryl group to vanR, the 
response regulator. The activated vanR then activates vanH by binding to its promoter region. It 
also bind to its own promoter region leading to further transcription of both the vanR and vanS 
genes (Arthur, 1992b). The vanH protein then begins the process of D-Ala-D-Lac production by 
reducing pyruvate to D-Lac (Arthur, 1992a). The ligase, vanA, then bind the D-Lac to a D-Ala. 
The newly formed D-Ala-D-Lac are then bound to UDP-N-acetyl muramide to be incorporated 
into the peptidoglycan layer. The D-Ala-D-Ala components of the tetrapeptide side chains are 
then removed by vanX, a dipeptidase (Reynolds et al., 1994). VanY finishes the process by 
removing any remaining D-Ala-D-Ala precursors that were missed by vanX (Arthur et al., 1998).  
The vanB operon has similar components that function the same way as in vanA. The 
exceptions is that vanB contains a vanW gene instead of a vanZ gene, but like vanZ its function is 
unknown (Quintiliani et al., 1993). The vanD operon differs in the fact that the vanY 
carboxypeptidase is sensitive to penicillin and the vanX dipeptidase has little function (Kak and 
Chow, 2002). VanE operons produce D-Ala-D-Ser subunits rather than D-Ala-D-Lac like vanA 
(Fines et al., 1999; Aries et al., 1999). The less studied vanG operon is composed of 7 open 
reading frames which are believed to lead to the production of D-Ala-D-Ser subunits in a matter 
similar to vanC and vanE (McKessor et al., 2000) 
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Table 1.7 vanA Operon Genes and their Functions1 
Gene Protein Function 
vanH dehydrogenase converts pyruvate to lactate 
vanA Ligase ligates alanine to lactate to form D-Ala-D-Lac 
vanX Dipeptidase breaks the D-Ala-D-Ala dipeptide that may have formed 
vanY carboxypeptidase hydrolysis of any D-Ala-D-Ala pentapeptide precursor 
vanR response regulator activates transcription of the resistance pathway 
vanS protein kinase senses presence of glycopeptides and phosphorylates VanR 
1 (Gholizadeh and Courvalin 2000)
 
 
 Enterococci Non-Human Reservoirs and Occurrence in Rendered Products 
 Although, enterococci are found in numerous environments, patterns in the distribution of 
a particular species do exist (Aarestrup, 2002). Winslow and Palmer (1910) studied the 
distribution of streptococci, including enterococci, in humans, horses, and cows in an effort to 
determine the source of fecal contamination in public water supply. While there were certain 
species found within all three hosts, the most commonly isolated species from the farm animals 
were E. faecalis, E. faecium, E. hirae, and E. durans. Other less common enterococcal species 
are typically found in a distinct host species, e.g. Enterococcus columbae from pigeons. The 
colonization of Enterococcus within chickens has a distinct age dependent pattern. Younger 
chicks are mostly colonized by E. faecalis, but as the chicks age the E. faecalis is rapidly 
replaced by E. faecium, E. hirae, E. cecorum, and E. durans (Devriese et al., 1987, 1991; Kaukus 
et sl., 1987). Similar colonization patterns by species have been reported in cattle as well. Pre 
ruminant calves typically contain E. faecalis, E. faecium, and E. avium, which are gradually 
replaced by E. cecorum. The overall Enterococcus population level diminishes as the cattle age, 
and typically, the feces of adult cattle show little to no presence of enterococcal species 
(Devriese et al., 1992). 
 Enterococci are a common contaminant of animals used to produce rendered animal 
meals (beef, poultry, and pork) (Franz et al., 2003). For example, Knudtson and Hartman (1993) 
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detected levels of 4-8 log CFU/cm3 on pig carcasses, with E.faecalis and E. faecium as the 
dominant species. While there has been little work in the detection of enterococci in finished 
rendered animal meal, the common occurrence in the animals used as raw material and 
enterococci’s elevated heat tolerance could potentially result in contamanitation of the finished 
meal. Cullen et al. (2003) and Schwalbe et al. (1999) both demonstrated that enterococi can be 
isolated from finished rendered meals. In 2003. The FDA conducted a national survey, and 
enterococci was identified in 84% of the meal samples collected with the highest level of 
incidence in MBM and E. faecium being the dominant species (Cullen et al., 2003). 
Salmonella: Overview 
 Salmonella spp. are gram-negative, bacillus shaped, facultative anaerobic, and motile 
members of the Enterobacteriaceae family. A list of other biochemical characteristics can be seen 
in Table 1.8. Typically, Salmonella are identified by the fermentation of glucose into gas and 
acid on triple sugar iron (TSI) medium and will not utilize sucrose or lactose in differential 
media (Andrews et al., 1994; D’Aoust and Purvis, 1998). While typical Salmonella do not utilize 
sucrose or lactose, Le Minor et al. (1974; 1973) have demonstrated in some cases sucrose and 
lactose fermentation can be mediated by plasmids. 
The nomenclature has changed several times during the 20th century due to biochemical 
and serological characteristics as well as DNA homology. Advances in the detection of the 
somatic (O) and flagellar (H) antigens allowed the genus to be split into different “groups” (Le 
Minor, 1981). This antigenic means of classification was first proposed by White in 1926. 
White’s system of classification was further expanded upon by Kauffman in 1941 giving the 
modern day Kauffman-White classification system which currently includes over 2,541 different 
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serovars of Salmonella (Popoff et al., 2004). A complete detailing of the changes in 
nomenclature can be seen in Table 1.9. 
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Table 1.8 Biochemical characteristics of Salmonella spp.1 
Biochemical Test 
Glucose Lactose Sucrose Oxidase Catalase Citrate H2S Lysine Ornithine Urea 
Result + - - - + + + + + - 
1 (D'Aoust and Maurer, 2007)
 
        
Table1.9 Taxonomy of Salmonella1 
Diagnostic basis Features Serovar Nomenclature Reference 
Biochemical Five subgenera (1-V) S. typhimurium (Kauffman, 1966) 
 
Biochemical 
 
Three species (S. typhi, S. choleraesuis, 
S. enteritidis) Arizona is separate genus 
S. enteritidis serovar 
Typhimurium 
(Ewing, 1972) 
 
 
DNA homology 
 
 
Single species (S. choleraesuis) 
Seven subspecies (choleraesuis, salamae, 
arizonae, diarizonae, houtenae, 
bongori,indica) 
S. choleraesuis subsp. 
Choleraesuis 
serovar Typhimurium 
 
(Le Minor et al., 1986) 
 
 
 
DNA homology 
 
 
 
Single species (S. enterica) 
Seven subspecies (choleraesuis, salamae, 
arizonae, diarizonae, houtenae, 
bongori,indica) 
 
S. enterica subsp. Enterica 
serovar  
Typhmurium or Salmonella 
serovar 
Typhimurium 
(Le Minor and Popoff, 1987) 
 
 
 
 
 
Multilocus enzyme 
electrophoresis 
Two species (S. enterica [six subspecies] and 
S. bongori) 
S. enterica subsp. Enterica (I) 
 
(Reeves et al., 1989) 
 
1 (D'Aoust and Maurer, 2007)
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Salmonella Occurrence and Presence in Rendered Products 
Salmonella continues to be a prominent foodborne pathogen in the human food chain due 
to its widespread distribution in the natural environment, within the meat (beef, poultry, fish, and 
shellfish) industry, and the recycling of inedible animal parts (offal) into animal feed (D’Aoust, 
1989; D’Aoust 1994). To address this issue, the Food Safety Inspection Service (FSIS) with the 
USDA published the “Final Rule on Pathogen Reduction and Hazard Analysis and Critical 
Control Point (HAACP) Systems” in 1996. This document required the meat industries to 
implement HAACP plans and to take regular samplings to detect the indicator organism 
Escherichia coli biotype I, while the FSIS collected regular samples to determine if the 
implemented HAACP plans were sufficiently reducing Salmonella levels. Prior to the release of 
the “Final Rule”, data indicated that broiler chickens were contaminated with Salmonella ca. 
24% of the time. In 1999, broiler Salmonella contamination levels had been reduced to ca. 11%; 
however, the rate has gradually increased since 1999 reaching ca. 16% in 2005 (D’Aoust and 
Maurer, 2007). 
Aside from the raw materials, it is possible for the environmental surfaces to contaminate 
the final products upon contact. Stainless steel, cement, rubber, and high density polyethylene 
plastic are materials found inside a rendering facility. Kusumaningrum et al. (2003) has 
demonstrated that Salmonella is capable of adhering to stainless steel. While low inoculum levels 
of S. Enteritidis (10 CFU/cm2) were undetectable on the steel after 1 h. A high inoculum of 
Enteritidis (105 CFU/cm2) was detected after 96 h. that the presence of Salmonella on rubber 
conveyor belts was documented on a Danish pig farm. A rubber conveyor belt was used to 
transport the manure from the piggery to an on-site manure dump. S. Typhimurium isolates 
collected from this conveyor belt were identical to Typhimurium isolates that were detected 20 
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months earlier during the first isolation (Sandvang et al., 2000). It is possible that this strain has 
been persistent on the conveyor belt and is continuously passed between the manure dump and 
piggery. The presence of food residues increased the survival time of the bacteria. S. Enteritidis 
can be transferred from the steel to food (Kusumaningrum et al., 2003).  The study tested the 
bacterial transfer to cucumber slices and chicken filets by steel immediately after contamination 
or 15 minutes after contamination. Directly after contamination, contamination rates were as 
high as 105 ± 28% for cucumber slices and 94 ± 42% for chicken filets. When the contamination 
was allowed to sit for 15 minutes, the transfer rates were reduced to 90 ± 27% for cucumber 
slices and 55 ± 21% for the chicken filets. 
Salmonella spp. are capable of producing biofilm on environmental surfaces (Jones and 
Bradshaw, 1996). Salmonella Weltevreden formed biofilms on high density polyethylene plastic, 
cement, and stainless steel with the following cell densities: 3.4 x 107, 1.57 x 106,  and 3 x 105 
CFU/cm2, respectively (Joseph et al., 2001). The same environmental materials can be found in a 
rendering facility; therefore, Salmonella biofilms can act as a continuous source for cross-
contamination between contact surfaces and products.  
A study conducted by Weigel et al. (1999) revealed some potential sources of the 
Salmonella contamination in animal feed on an Illinois swine farm. During the study, one 
hundred samples of feed were collected and only 2% were contaminated with Salmonella. In 
addition to the feed, samples were collected from the worker’s boots, water, the floor, cats in the 
area, mice on the farm, and flies. The boots of the workers had the highest rate (17.2%, n=93) of 
Salmonella contamination, while the flies and the flooring had the lowest levels of contamination 
at 7.4% (n=95) and 7.9% (n=471), respectively. All of these mentioned factors could the 
potentially serve as a source for cross-contamination. 
 34 
 
Salmonella has been identified as a common contaminant of rendered animal products. 
This has been reported in meat (81%) and feather meal (40%) by Hacking et al. (1977), Loken et 
al. (1968), and Beumer (1997) reported Salmonella contamination in sampled rendered products 
with incidence rates of 17% and 3.2-7.6%, respectively. The FDA conducted two separate 
studies in 1993 and 1994 to test for the presence of S. enterica, with Salmonella positive rates of 
56% and 25%, respectively (McChesney et al., 1995; Crump et al., 2002). The Animal Protein 
Producers Industry (APPI) has collected weekly samples from the rendering processing plant and 
tested for the presence of Salmonella. The average incidence rate was reported as 25% (Franco, 
2005). During one particular testing year, four serotypes commonly associated with food borne 
illness (Typhimurium, Enteritidis, Agona, and Infantis) were isolated with the prevalence rates of 
0.5, 0.5, 3.0, and 3.5% of the samples, respectively. In addition, human Salmonella infection has 
been linked to the contaminated animal feed (Crump et al., 2002). Knox et al. (1963) established 
a connection to a S. Heidelberg outbreak from contaminated milk to meat and bone meal used in 
the feed supplied to the milk-producing cattle. 
Salmonella: Survival Adaptations 
 Salmonella spp. are capable of adapting to numerous environmental stresses including 
extreme temperatures (high and low), a wide range of pH values, and low water activity (aw) 
levels. Some strains of Salmonella have been able to grow in environments as high as 54°C and 
as low as 2°C (D’Aoust et al., 1975). Angelotti et al. (1961) detected Salmonella in custard and 
chicken a la king that had been heated to 45.6°C. Droffner and Yamamoto (1992) determined 
that a strain of S. Typhimurium was capable of mutating to survive at 54°C after prolonged 
exposure to thermal stress. The mechanism behind this resistance has not been determined, but 
the mutation has been determined to occur in the ttl gene or the mth gene which gives resistance 
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up to 48° and 54°C, respectively. In addition to these genes, other environmental factors play a 
role in the level of heat resistance. For example, heat resistance has been shown to increase as a 
result of a decrease in the aw of the substance (D’Aoust, 1989). Goepfert demonstrated that when 
the substrate’s aw was reduced to a level of 0.90 by sucrose or glycerol, the S. Typhimurium had 
D-values at 57.2°C of 40-55 minutes and 1.8-8.3 minutes, respectively. Other factors that 
determine the level of heat resistance acquired include the nutrients available in the growth 
environment, the phase of growth the cells are in, and the moisture level of the environment it 
was isolated from (Goepfert et al., 1970; Kirby and Davies, 1990; Ng et al., 1969). Salmonella 
can also become heat resistance through continuous exposure to higher sub-lethal temperatures, a 
heat shock phenomenon. Exposing Salmonella cells to temperatures ≤50°C for 15-30 minutes 
results in the production of heat shock proteins that confer higher levels of heat resistance 
(Humphrey et al., 1993; Mackey and Derrick, 1990; Mackey and Derrick, 1986). The fate of 
Salmonella under freezing temperatures is dependent on the matrix it is suspended in, the 
kinetics of the freezing process, the physiological state of the bacterial cells before freezing, and 
the particular serotype involved (Corry, 1971).  
 In addition to growing or surviving under temperature extremes, Salmonella can adapt to 
a wide range of pH levels from 4.5 to 9.5 with an optimal range of 6.5 to 7.5. S. Typhimurium 
has been shown to acquire high levels of acid tolerance through repeated exposure to mildly 
acidic environments (ph 5.5-6.0). These exposed cells could then be transferred to a more acidic 
environments (pH ≤4.5) resulting in a complex acid tolerance reaction involving the production 
of acid shock proteins, new outer membrane proteins, reduced growth rate, and pH homeostasis 
which allows the cells to grow in environments with a pH of 3.0-4.0 (Foster and Hall, 1991; 
Hickey and Hirshfield, 1990). Three systems have been described that confer increased acid 
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tolerance to Salmonella spp. including: pH dependent and rpoS independent log phase acid 
tolerance response (ATR), the pH dependent and rpoS independent stationary phase ATR, and 
the pH independent and rpoS dependent stationary phase ATR. 
 Salmonella Infection and Disease 
 Salmonella infections have a wide array of symptoms depending on the serotype involved 
including enteric fever, enterocolitis, and potential systemic infections. Enteric fever results from 
infection with the typhoid or paratyphoid strains with symptoms including diarrhea, fever, 
headache, and prostration (D’Aoust, 1991). Those infections caused by non-typhoid strains 
typically results in enterocolitis which appears from 8 to 72 hours after infection. These 
infections are usually self-limiting resulting in diarrhea and abdominal pain that can last for up to 
5 days (D’Aoust, 1989). In certain cases Salmonella can result in the following chronic 
conditions: aseptic reactive arthritis, Reiter’s Syndrome, and ankylosing spondylitis. 
 McCullough and Eisele (1951) observed that a high level of Salmonella contamination 
(104-107 CFU/ml) was needed in egg nog to comprise an infectious dose; however, D’Aoust et 
al. (1985) and Kapperud (1990) have both demonstrated that 1 to 10 cells can be an infectious 
dose in food with a high solid fat content. A lower infectious dose is required in a food substrate 
with a high fat content due to the potential protection offered against the acidic environment of 
the stomach. Once inside the duodenum, the lipids compromising the fat would disperse and the 
Salmonella would be free to attach to the small intestine. 
 The first step of infection begins when Salmonella cells attach and then enter the 
epithelial cells (enterocytes) lining the intestinal tract and the M cells that overly the Peyer’s 
patches. Attachment is brought on by the interaction between type 1 (mannose-sensitive) or type 
3 (mannose resistant) fimbriae adhered to host receptors which are located on the microvilli or to 
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the glycocalyx surrounding the surface of the intestinal cells (D’Aoust, 1991, Polotsky et al., 
1994). Upon contact with the epithelial cells, proteinaceous appendages form on the surface of 
the Salmonella cells (Galan and Ginnochio, 1994; Ginnochio et al., 1994). The production of 
these appendages is energy dependent and they are shed once membrane ruffles are formed on 
the attached epithelial cell (Ginnochio, 1994; Collazo et al., 1995). The attachment by the 
Salmonella cells initiates a series of chemical signals between the invading Salmonella cell and 
the host enterocyte or M cell (Garcia-del Portillo and Finlay, 1994; Ginnochio et al., 1994). The 
invasion (inv) locus stimulates a calcium influx which results in a rearrangement of the 
cytoskeleton within the host enterocytes and M cells (Finlay, 1994; Polotsky et al., 1994). The 
influx of calcium ions is responsible for actin polymerization (Ruschkowski et al., 1992). In 
addition to the calcium influx, the Salmonella cells also deliver the following invasion proteins 
to the host cells: SipA, SipB, SipC, SptP, SopE2, and SopB (Collazo and Galan, 1997; Collazo et 
al., 1995). Like calcium, these proteins stimulate the polymerization of actin into microfilaments 
in the vicinity of the invading Salmonella cell (Galan and Zhou, 2000; Ginnochio et al., 1992). 
Specifically, SipA and SipC act as catalyst for the polymerization of F-actin into microfilaments 
(Hayward and Koronakis, 1999.; Zhou et al., 1999; Zhou et al., 1999a). SopE2 activates the 
process of cytoskeleton rearrangement (Stender et al., 2000). The epithelial cell membranes 
undergo “ruffling” by which the membrane stretches to surround and engulf the attached 
Salmonella cell resulting in the bacterial cell entering the host epithelial cell via pinocytosis 
(Jones et al., 1993). Once the Salmonella cell has invaded the host cell, SptP results in the 
disruption of the host cell cytoskeleton returning into to its original state (Fu and Galan, 1998).  
 Once inside the cell, the Salmonella cell is initially confined inside a vacuole where it 
will initiate its replication (Garcia-del-Partillo and Finlay, 1994). The vacuole then is transported 
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through the cell, where it will eventually release the Salmonella cells into the lamina propria 
(Isberg and Nhieu, 1994; Polotsky et al., 1994). The fimbriae surrounding the Salmonella’s 
surface allows the cells to attach to host plasminogen which could greatly enhance the 
invasiveness of that strain. Once attached, the plasminogen (zymogen) would likely be converted 
to its active proteolytic form where it would allow the bacterial cell to easily breach through host 
tissue barriers and penetrate into the deep tissues of the host (Sjobring et al., 1994).  
 Within the host cells, these Salmonella cells are capable of evading the host immune 
system by preventing phagosome acidification (Alpuche-Aranda et al., 1994; Alpuche-Aranda et 
al., 1992), avoiding lysosome fusion (Buchmeier and Heffron, 1991; Uchiya et al., 1999), or 
preventing the maturation of phagolysosomes (Rathman et al., 1997). Evidence has also 
demonstrated that Salmonella is capable of not only surviving inside phagolysomes but are 
capable of replication inside them as well (Oh et al., 1996; Rathman et al., 1996). For example, 
Salmonella produce several enzymes such as superoxide dismutase, peroxidase, and catalase that 
protect them from the toxic oxygen products formed during the metabolic burst of phagocytes. In 
total, there are 30 proteins produced in response to these toxic oxygen by-products (Popoff and 
Noral, 1992). Salmonella cells may also have an additional system that protects them from 
phagocytic cells referred to as the phoP/phoQ regulon (Miller, 1991; Popoff and Noral, 1992). It 
is believed that these genes are responsible for producing chemical signals which alter the core 
antigen component of the lipopolysaccharide (LPS) on the cell’s outer membrane (Vaara et al., 
1981) and provide resistance to antimicrobial peptides produced by neutrophils (Shafer et al., 
1984). The phoP/phoQ gene set is also responsible for the production of a cell surface protease 
that degrades the defensins released by phagocytic cells (Guina et al., 2000). 
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Salmonella: Traditional Chemical Control Methods 
 Since Salmonella is a continuous problem for the food industry, methods of sanitation 
have been developed to reduced the risk of contamination in food products. Traditionally these 
methods of sanitation have employed the use of chemical disinfectants to clean surfaces the 
processed food may come in contact with. These chemicals have included chlorine based 
compounds, iodine containing compounds, and quaternary ammonium compounds (Cramer, 
2006; Hui et al., 2003; Marriot,1994; Guthrie, 1992). 
 Chlorine based compounds are used as either a liquid chlorine, hypochlorites, chlorine 
dioxide, or inorganic and organic chloramines. The exact mechanism behind chlorine’s activity 
is not clear but the following mechanism have been suggested: disruption of protein synthesis, 
oxidative decarboxylation of amino acids, reactions with the nucleic acids, disruption of 
metabolism by degrading enzymes, disruption of DNA, formation of toxic derivatives of 
cytosine, and creation of chromosomal aberrations (Marriot, 1994). These chlorine based 
compounds are corrosive and result in bleaching, so they must be used carefully around metals 
and material susceptible to bleaching. The biggest drawback to chlorine based compounds in the 
food industry is their affinity to bind to organic material. Once bound to this organic material the 
compounds are inactivated, so higher concentrations in the range of 100 to 150 ppm are required 
(Guthrie, 1992). The FSIS has required that animal slaughtering houses spray down their 
equipment with a solution containing at least 200 ppm chlorine (Swacina, 1988). 
 There are three forms of iodine primarily used in food processing sanitation i.e., 
iodophors, alcohol-iodine solutions, and aqueous iodine solutions. The bactericidal activity has 
not been studied in great detail but in general the iodine compounds release triciodide ions which 
mix with acid to produce hypoiodous acid and diatomic iodine, which are the active 
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antimicrobial forms (Marriott, 1994). Iodine containing compounds have drawbacks similar to 
those of chlorine. They are corrosive to metal and have a high affinity for organic material, 
which results in their inactivation. A positive aspect of these iodine-containing compounds is that 
they react with microorganisms rapidly and are effective against a wide range of organisms. 
These compounds are always mixed with detergents within an acid medium. The final solution 
should contain between 25 to 50 ppm active iodine (Guthrie, 1992). 
 The major form of quaternary ammonium compounds is cationic detergents which inhibit 
cell metabolic processes by inhibiting enzyme activity and cause the bacterial cells to leak 
resulting in lysis. It is also known that when these compounds are added to a surface they form a 
bacteriostatic film that is selective for particular microbes (Marriott, 1994). The quaternary 
ammonium compounds have the advantage that they are not corrosive, but unlike the previous 
two compounds, these quaternary ammonium compounds do not sufficiently work against gram 
negative bacteria. These compounds also have some additional limitations including: they tend to 
adhere to surfaces requiring excessive rinsing, they react with calcium and magnesium (cannot 
be used in hard water), and they are incompatible with most soaps and detergents (Guthrie, 
1992). 
 Another class of sanitizer is acids.  Acids used most frequently for food processing 
sanitation are the organic acids, such as acetic, peroxyacetic, lactic, propionic, and formic acids. 
These acids destroy the microbial cells by penetrating their cell envelope and acidify the cell’s 
interior. The efficiency of these sanitizers are dose dependent and have great potential on 
surfaces where they may persist for long periods of time such as stainless steel (Marriott, 1994). 
The major disadvantage to the use of acid sanitizers is that they are highly corrosive (Guthrie, 
1992). 
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Bacteriophages: Overview and Discovery 
Bacteriophages have been used as a biological control method for various applications. 
Bacteriophages are viruses which use bacteria as a host for undergoing replication. The 
bacteriophages attach to specific bacterial cells and releases endolysins which degrade the 
bacterial cell wall. This allows the bacteriophage DNA to enter the cell where it hijacks the 
host’s metabolic machinery to produce phage particles. The particles then self assemble and 
newly formed bacteriophages escape the host through cell lysis. These newly produced 
bacteriophages can then repeat this process with additional bacterial host cells (Doyle 2007). 
Bacteriophages can be divided into five groups: tailed bacteriophages, polyhedral DNA 
bacteriophages, polyhedral RNA bacteriophages, filamentous bacteriophages, and pleomorphic 
bacteriophages (Ackermann, 2005). Of these the tailed bacteriophages account for the majority 
with ca. 4,950 different strains being identified (Ackermann, 2001). The tailed bacteriophages 
are all within the order Caudoviridae and are divided into three families based on their tail 
structure. These families include Myoviridae (contractile tail), Siphoviridae (long, non-
contractile tail), and Podoviridae (short, non-contractile tail) (Ackermann, 2001).  
The tailless bacteriophages only account for 4% of the identified bacterial viruses 
(Ackermann, 2001). The first type of tailless bacteriophage is the polyhedral bacteriophages, 
which contain an icosahedral head and have cubic symmetry (Ackermann, 1999). The polyhedral 
bacteriophages include Microviridae (ssDNA), Corticoviridae (dsDNA), Tectiviridae (dsDNA), 
Leviviridae (ssRNA), and Cystoviridae (dsRNA) (Ackermann, 2005). The second group of 
tailless bacteriophages is the filamentous bacteriophages, which include the families Inoviridae 
(ssDNA), Lipothrixviridae (dsDNA), and Rudiviridae (dsDNA) (Ackermann, 2005). The final 
type of tailess bacteriophage is the pleomorphic bacteriophages, which includes the families 
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Plasmoviridae (dsDNA) and Fuselloviridae (dsDNA) (Ackermann, 2005). Common 
characteristics of the different bacteriophages are summarized in Table 1.10. 
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Table 1.10 Characteristics of identified bacteriophage groups1         
Shape Family 
Nucleic 
Acid Adsorption Site 
Infection 
by 
Host-Virus 
Relationship Example Members 
Tailed Myoviridae dsDNA  cell wall, capsule, pili, flagella DNA lytic or temperate T4 1243 
Siphoviridae dsDNA  cell wall, capsule, pili, flagella DNA lytic or temperate Lambda 3011 
Podoviridae dsDNA  cell wall, capsule, pili, flagella DNA lytic or temperate T7 696 
Polyhedral Microviridae ssDNA cell wall DNA lytic ØX174 40 
Corticoviridae dsDNA  cell wall ? lytic PM2 3 
Tectiviridae dsDNA  pili, cell wall DNA lytic PRD1 18 
Leviviridae SSRNA pili RNA lytic MS2 39 
Cystoviridae dsRNA pili, cell wall capsid lytic Ø6 1 
Filamentous Inoviridae ssDNA pili virion temperate fd 57 
Lipothrixviridae dsDNA  pili ? temperate TTV1 6 
Rudiviridae dsDNA  cell wall ? carrier state SIRV-1 2 
Pleomorphic Plasmaviridae dsDNA  plasma membrane DNA temperate L2 7 
  Fusseloviridae dsDNA  ? ? temperate SSV1 7 
1(Ackermann, 2005)
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The idea of using phage as a form of treatment has gained significant interest as 
an alternative to antibiotics. The majority of antibiotics (50-70%) used in the United 
States are given to farm animals as a prophylactic, to treat livestock, or as a growth 
promoter (Gustafson, 1991). The overuse of these antibiotics may have contributed to the 
decline in efficiency of the antibiotics in humans, but banning their use completely may 
have a negative effect on the health of the animals they have been administered to (Kutter 
and Sulakvelidze, 2005). An alternative method of treatment, such as bacteriophage 
therapy, is necessary. The use of phage offers multiple advantages: the host specificity is 
not likely to select for phage resistant bacterial strains, resistance against phage does not 
affect the effectiveness of antibiotics given to humans, and phage mixtures can be easily 
modified and rapidly developed against resistant bacteria (Kutter and Sulakvelidze, 
2005). 
The use of bacteriophage as a therapeutic agent was first realized by Felix 
d’Herelle in 1919. D’Herelle was conducting research to determine if phage could be 
used to prevent the natural infection of chickens by Bacillus gallinarum. The phage 
appeared to prevent development of avian typhosis, the disease caused by B. gallinarum. 
The treatment was then performed in large scale in rural areas of France where the 
disease had developed into an epidemic. The flocks of chickens that received the phage 
treatment “had fewer deaths, the duration of the epidemic was shorter, and second rounds 
of infection were prevented” (d’Herelle, 1921;  Kutter and Sulakvelidze, 2005). 
D’Herelle also demonstrated that the administration of phage to water buffalo in 
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Indochina could prevent infection with Pasteurella multocida, the causative agent of 
bovine hemorrhagic septicemia (d’Herelle, 1926).  The use of bacteriophages as a form 
of therapy has been investigated well before the introduction of antibiotics. In the 1930s, 
such therapy was being marketed by American pharmaceutical companies. During World 
War II, the Germans and Soviets were using phage therapy to treat dysentery; however, 
the advent of antibiotics in the 1940s caused a decline in the need for research with phage 
therapy. Today with the prevalence of antibiotic resistant bacteria on the rise, 
bacteriophage research is on the rise as well especially in terms of biopreservation of 
food products. Bacteriophages naturally found in the food microbiota are safely 
consumed as part of the human diet. It is possible then that bacteriophages can be used to 
reduce or eliminate contamination by foodborne pathogens such as Salmonella (Doyle 
2007). 
Life Cycle of Bacteriophages 
 Bacteriophages have two alternative life cycles, lysogenic or lytic. In both cycles, 
the virus will adhere to specific receptors on the bacterial cell’s surface, where it will 
penetrate the surface and inject its nucleic acid into the host cell. Once the genetic 
material is inside the cell, the bacteriophage will enter one of two life cycles. At this point 
the bacteriophage may enter the lysogenic phase by inserting the nuleic acid into the 
chromosome of the bacterial host. This state is referred to as a prophage. The prophage is 
replicated along with host cell replication so that all progeny will contain the 
bacteriophages genetic material as well. The bacteriophage will remain in this prophage 
form until it is induced to leave the host chromosome, replicate, and lyse the cell. The 
  46 
second route for the bacteriophage is the lytic cycle, which is the focus of this study and 
discussed in more detail in the following paragraphs (Cowan and Talaro, 2009). 
Bacteriophage infection begins with the attachment of the bacteriophage virus to 
the bacteria’s surface receptors. Attachment is initiated when the tail fibers or spikes of 
the virus recognize and bind to specific surface receptors of its bacterial host. In gram-
negative bacteria numerous components can serve as a surface receptor including any of 
the outer membrane proteins, the lipopolysaccharides, and the oligosaccharides. While 
some bacteriophages only require a single attachment type of receptor, others such as T4-
like phages go through a two-part attachment process involving two types of receptors. In 
the case of the T4-like bacteriophages, at least three of the six tail fibers have to bind to 
their surface receptors which trigger the rearrangement of the baseplate proteins in the 
phage allowing the spike to irreversibly bind to the host’s surface (Guttman et al., 2005). 
 Following attachment, the bacteriophage penetrates the surface of the host cell 
and injects its genetic material into the cell. The “injection” process actually involves a 
series of mechanisms for the transfer of DNA that is specific for each bacteriophage. The 
general process initiates when the tail pins release enzyme that allow them to break 
through the cell wall and inner membrane. Once this opening has been made the 
bacteriophage’s genetic material is released into the cell. The bacteriophage also has 
mechanisms that prevent the genome from leaving the capsid prematurely. The process of 
how the DNA enters into the host cell is poorly understood and is dependent on the 
bacteriophage involved. For example, DNA enters the host cell from T7 phages as a 
result of its transcription. Once inside the cell, the bacteriophage genome is susceptible to 
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degradation by host cell enzymes, so bacteriophages have evolved mechanisms to protect 
their genetic material. One way in which they do this is by circularizing their DNA 
through the use of terminal redundancies (“sticky ends”). Some have incorporated an 
irregular nucleotide that is not commonly found in DNA or RNA such as 
hydroxymethyldeoxyuridine or hydroxymethyldeoxycytidine which are found in SP01 
and T4 bacteriophages, respectively. As another mechanism, some phages such as the 
Streptococci phage SD-1 and the coliphage N4 have evolved so they no longer contain 
sites that are commonly recognized by enzymes of their natural host bacterial species 
(Guttman et al., 2005). 
 Inside the host cells, the bacteriophage genome is recognized by the host RNA 
polymerase leading to the initial transcription and translation of “early genes”. The 
products of these genes are responsible for blocking host proteases and restriction 
enzymes, terminate host cell metabolism, and denature host proteins. After this is 
complete, a second set of “middle genes” is transcribed and translated to produce the 
products needed for replication of the bacteriophage genome. Following replication, a 
final set of “late genes” is transcribed and translated to produce the protein components 
of the bacteriophage particles. In all of these processes, the bacteriophages either produce 
sigma factors or DNA binding proteins to reprogram the host cell RNA polymerase or 
they contain a gene set that is transcribed and translated early that codes for its own RNA 
polymerase. Additional adaptations include the degradation of the host DNA and 
preventing protein synthesis (Guttman et al., 2005). 
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 Following replication and the production of components of the bacteriophage 
particles, the bacteriophages have to be assembled and the genetic material needs to be 
packaged within the capsid head. The packaging of the capsid protein involves 
interactions between scaffolding proteins and structural proteins. At one vertex of the 
icosahedral head there is a portal complex which is the origin site for head assembly, 
docking site for packaging enzymes, and the site at which the genome enters the capsid. 
At some point during the packaging process, the head expands in order to accommodate 
the bacteriophage DNA or RNA (Guttman et al., 2005). 
 Once the bacteriophages have completely assembled, they must exit the cell 
through lysis. The process of lysis is dependent on the bacteriophage type and its timing 
is crucial (Guttman et al., 2005). If the cell is lysed too soon, there is not enough 
bacteriophages to continue the lytic cycle, but prolonging lysis too long results in the loss 
of opportunities for infection (Abedon, 1990). Tailed phages use a two enzyme system 
for lysis. They produce pores in the inner cytoplasmic membrane by an enzyme. The 
second enzyme, lysin, passes through the pores formed by holin and begins breaking 
down the bonds between the layers of peptidoglycan. The tail-less phages produce 
individual enzymes that inhibit the host cell enzymes responsible for peptidoglycan 
formation (Guttman et al., 2005). The lytic process is illustrated in Figure 1.2 
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Figure 1.2 Bacteriophage lytic cycle (Cowan and Talero, 2009) 
Bacteriophage Treatment of Raw Meats and Surfaces 
While there is a lack of studies investigating phage usage as a treatment method in 
animal by-products, several researchers have demonstrated the possibility of creating 
bacteriophage mixtures capable of reducing Salmonella levels significantly in the raw 
animal meats. One group of researchers found that phage treatment can significantly 
reduce S. Enteritidis (SE) levels in poultry products (Higgens et al., 2005). The study 
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found that the phage PHL4 (108 and 1010 PFU/ml) was capable of reducing SE on the 
carcass by 85-93% and in the rinse water by 50-100%. In addition, a 72 phage cocktail 
(107-108 PFU/ml) used to treat SE on commercially processed turkey carcasses resulted 
in a 50-60% reduction in SE. Another study demonstrated that SE (106 CFU/ml) 
contamination on chicken skin was significantly reduced by washing the skin with 109 
PFU/ml of three wild-type bacteriophage cocktail (Fiorentin et al., 2005). During storage 
at 5°C, a significant difference between the means of Salmonella populations on the 
control and experimental skin was observed on days 3, 6, and 9 with Salmonella 
reduction at 2.27, 4.56, and 4.49 x 108  (CFU / cut), respectively. 
Studies have shown bacteriophages to be effective against Salmonella serovars 
other than Enteritidis as well. Atterbury et al. (2007) recovered 232 phages from poultry 
farms, abattoirs, and wastewater from 2004-2005. Among those collected phages, the 
three with the broadest range against Enteritidis, Hadar, and Typhimurium were selected 
for further study. The phage cocktail resulted in ≥ 4.2 and  ≥2.19 log10 CFU reduction in 
Enteritidis and Typhimurium cecal colonization, respectively (Atterbury et al., 2007). 
There are also studies demonstrating the ability of bacteriophage to reduce the 
population of bacterial cells attached to an inert surface.  Roy et al. (1993) studied the 
effectiveness of phage treatment against L. monocytogenes. In their study, a three phage 
mixture (H387, H387-A, and 2671) was used to treat stainless steel templates that had 
been contaminated with the pathogen. Phage treatment resulted in a 3 log decrease in L. 
monocytogenes populations. The elimination of L. monocytogenes from stainless steel 
was also investigated by Hibma et al. (1997).  
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Bacteriophage Treatment of Biofilms 
Often bacteria are not simply attached to environmental surfaces but are rather 
components of a large microbial network known as a biofilm. A biofilm can be composed 
of one or various species of bacteria and their excreted products. The concern for phage 
treatment is to ensure that the phage can actually come in direct contact with the bacterial 
cells within the biofilm matrix. It has been shown that many biofilms actually contain 
water filled pathways that can transport the phage into the biofilm’s interior and provide 
access to the bacteria cells. In addition, a large number of phages are capable of 
producing polysaccharases or polysaccharide lyases. These enzymes are host specific so 
they are only effective against a range of related polysaccharide structures. Phages 
capable of degrading the exopolysaccharide (EPS) of various gram-negative bacteria, 
including species that are capable of producing a biofilm, have been isolated (Sutherland, 
2004). 
Studies on the effect of phage on biofilm produced by Enterobacter agglomerans 
revealed that the biofilm can be degraded if two conditions were met (Hughes, 1998a; 
Hughes, 1998b). First the bacterium being investigated has to be susceptible to the phage 
being used. Second the polysaccharide lyases produced by the phage has to be able to 
degrade the biofilm’s EPS. Even when only one of these conditions were met, the phage 
still cause a significant amount of biofilm degradation.  
The effects of phage treatment on single species biofilms have been well 
documented.  Doolittle et al. (1996a) discovered that the matrix produced by an E. coli 
biofilm was ineffective in preventing phage T4 from infecting the bacterial cells. To 
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confirm their findings, the T4 phage was labeled with fluorescent and chromagenic 
probes and introduced to the E. coli biofilm. Microscopic observations revealed that the 
T4 was infecting the E. coli cells and were not inhibited by any of the extracellular 
components within the biofilm (Doolittle et al., 1996b). Karunasagar et al. (2007) 
demonstrated that phage can be used to reduce Vibrio harveyi levels in biofilm formed on 
high density polyethylene. When using a phage concentration of 105 PFU/ml, V. harveyi 
counts were reduced nearly 1 log CFU/cm2 after 18 h. A higher phage concentration (108 
PFU/ml) reduced the V. harveyi counts by 1 log every 6 h from 2.19 x 106 to 9.40 x 103 
CFU/cm2 in 18 h. Another study determined the effectiveness of phage KH1 against E. 
coli O157:H7 biofilm (Sharma et al., 2005). The phage was able to significantly reduce 
(P<0.05) bacterial counts in biofilms produced from strain FRIK 816-3 from an initial 
concentration of 4.0 log CFU per coupon to 2.8 log CFU per coupon and  2.7 log CFU 
per coupon after 24 and 48 h of phage treatment, respectively.  
 Research on the use of phage for biofilms composed of multiple bacterial species 
has not been thoroughly investigated, and some reported less promising results 
(Sutherland 2004).  Storey and Ashbolt (2001) attempted to treat biofilm composed of 
Bacteroides fragilis and E. coli in an urban water distribution system with phages. The 
phages were initially taken in by the biofilm that had formed on stainless steel and 
polythene surfaces; however, following the initial treatment, phage numbers began to 
decrease rapidly, suggesting that the phages were not infecting the host cells. Their study 
has shown that biofilms composed of multiple bacterial species may contain additional 
barriers such as bacterial cell co-aggregation (Rickard et al., 2003) that phage treatment 
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must overcome to be successful. Therefore, additional research into developing phage 
treatments against biofilms composed of more than one species of bacteria is needed. 
Examples of Salmonella Reduction via Bacteriophage Treatment 
Several studies have demonstrated that phage treatment can be very effective 
against Salmonella contamination. For example, a study conducted by Modi et al. (2001) 
investigated whether the addition of phage SJ2 to the starter culture used in cheddar 
cheese production would reduce the survival of Salmonella. A strain of Salmonella 
Enteritidis that had been associated with an outbreak due to contaminated cheese was 
inoculated into the milk post pasteurization at 104 CFU/ml. The results showed that the 
experimental cheese made with pasteurized milk was negative for Salmonella 
contamination after 88 days. The experimental cheese produced with raw milk treated 
with bacteriophage had very low Salmonella contamination levels of 50 CFU/g. In 
contrast, all cheeses produced without bacteriophage had Salmonella counts of 103 
CFU/g after 99 days. Whichard et al. (2003) demonstrated that both the wild-type and a 
large plaque variant of the Felix 01 phage can be used to control S. Typhimurium 
contamination on chicken frankfurters. The results indicated both phage strains were 
capable of reducing S. Typhimurium levels by 102 CFU/g. A study by Leverentz et al. 
(2001) demonstrated the potential use of phages for reducing Salmonella contamination 
on fresh produce. Their results demonstrated that the phage was capable of reducing 
Salmonella levels on fresh cut honey-dew melon by 3.5 logs at 5°C and 10°C, and a 2.5 
log reduction at 20°C. There was no significant reduction of Salmonella on apple slices at 
any temperature. Titers of the phage were stable on the honey-dew melon but were non-
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detectable on the apples after 48h, this is possibly due to the more acidic pH (4.2) of the 
apples as opposed to that of the melon (5.8). Pao et al. (2004) studied the effect of two 
different phages simultaneously against three serotypes of Salmonella. One phage was 
effective against S. Typhimurium and S. Enteritidis. The other phage was effective 
against S. Montevideo.  Phage treatment was shown to significantly suppress growth of S. 
Typhimurium and S. Enteritidis in both broccoli and mustard seeds for 24 h. A 
combination of the two bacteriophages suppressed the growth of the three serotypes by 
0.57 ± 0.04 log (P<0.001) in the broccoli seeds. One desirable aspect of phage treatment 
is the host specificity of bacteriophages. In terms of Salmonella treatment, this host 
specificity is a hurdle for reducing contamination levels. There is not a single phage 
capable of lysing all known serovars of Salmonella. In fact, a particular phage may not 
even be capable of lysing all members of a particular serovar. To overcome this 
shortcoming, a “cocktail” of phages must be designed capable of lysing all Salmonella 
strains of interest (Joerger 2003). The production of an effective phage cocktail for 
Salmonella has been reported previously. For example, Chighladze et al.(2001) reported 
to have developed a phage cocktail capable of lysing 232 of 245 Salmonella isolates 
composed of 21 serovars with 78 pulse field gel electrophoresis (PFGE) pattern types 
(Joerger 2003). 
Bacteriophage Therapy in Animals 
As previously mentioned, the use of bacteriophages as a therapeutic agent dates 
back 1919 with the work of Felix d’Herelle (Sulakvelidze and Barrow, 2005). 
Salmonellosis in mice served as one of the earliest models for bacteriophage therapy. For 
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example, Topley et al. (1925) tested the effectiveness of bacteriophage therapy in mice 
infected with S. Typhimurium. The results indicated that the therapy did not reduce the 
mortality rate or shedding of the bacteria in the feces. The ineffectiveness during this 
study was contributed to the lack of optimization of the bacteriophage. The bacteriophage 
used was found not to completely lyse the bacterial strain (Topley and Wilson, 1925). 
Fisk’s study (1938) concluded that Salmonella infection could be prevented through the 
use of bacteriophage therapy. 
The interest in bacteriophage as a therapeutic agent was renewed by the work of 
Smith and Huggins (1982). Their initial studies investigated the effectiveness of 
bacteriophages specific to the K1 capsule antigen found on E. coli O18:K1:H7 ColV. 
Their results indicated that a single injection of the bacteriophage (3 x 108) was more 
effective than several antibiotics in protecting mice against infection by that E. coli strain. 
In a subsequent study, Smith and Huggins (1983) tested the ability of a bacteriophage to 
prevent infection in calves, piglets, and lamb by E. coli O9:K30.99. The mortality rates 
for calves, piglets, and lambs infected with E. coli and left untreated were 100, 57, and 
25%, respectively; whereas, the mortality rate for those animals treated with the 
bacteriophage was 17, 0, and 0%, respectively. 
The success of the in vivo studies by Smith and Huggins renewed the interest in 
bacteriophage therapy. More recently, Huff et al. (2002) conducted three experiments to 
determine the effect of bacteriophages on respiratory infections by E. coli in broiler 
chickens. During all three trials, E.coli was administered by air-sac inoculation while the 
bacteriophage was administered by either air-sac inoculation or in the drinking water. 
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The results showed that bacteriophage treatment by air-sac inoculation reduced the 
mortality rate from 80% to 0% or 30% depending on the concentration of bacteriophage 
used. Treatment with the bacteriophage in the drinking water demonstrated the 
bacteriophage was only effective when given prior to infection. When given prior to 
infection, the bacteriophage was able to reduce the mortality rate from 85% to 0% or 35% 
depending on the concentration of the bacteriophage. Biswas et al. (2002) demonstrated 
that other bacteria, such as VRE, can be treated with bacteriophage therapy as well. The 
bacteriophage was shown to prevent bacteremia caused by VRE infections in mice. 
Recent studies have also tested the effectiveness of bacteriophage as a therapeutic 
agent against Salmonella as well. Berchieri et al. (1991) were able to isolate several 
phages with activity against S. Typhimurium. The isolated phages were then orally 
administered to chickens infected with S. Typhimurium. The addition of the 
bacteriophages was shown to significantly reduce the mortality rate. Phage 2.2 was one 
of the most effective isolates during their study. It decreased the viable numbers of the 
pathogen within the host’s alimentary tract. The Salmonella population was decreased by 
1 log in the crop, intestine, and caeca of the chickens within 12 h of phage administration. 
Salmonella counts in the liver were reduced by 0.9 log within 24 h of phage 
administration. The results also demonstrated that administering the bacteriophage close 
to the time of infection was significantly more efficient than delaying bacteriophage 
administration. This was believed to be due to the nature of Salmonella which is an 
intracellular pathogen. In theory, it is more effective to expose the Salmonella to the 
bacteriophage before it is able to enter the epithelial cells in the intestinal tract. This study 
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demonstrated that oral administration of bacteriophage to animals can reduce Salmonella 
contamination levels. 
Advantages of Bacteriophage Treatment/Therapy 
 The use of antibiotics as feed additives has become a major concern for national 
health organizations and the livestock industry due to the increase in antibiotic resistant 
pathogens in human health that have been linked to those antibiotics used in livestock 
feed (Smith et al., 2002). This has led to the banning of many traditional antibiotics as 
feed additives. For example, the European Union has banned the use of virginiamycin, 
bacitracin zinc, spiromycin, and tylosin phosphate (Ferber, 2003). While the bans may 
have decreased the amount of antibiotic use, it also poses health concerns to the livestock 
which will lead to safety concerns in food products. An alternative treatment that is both 
effective and safe to the animal host and environment is needed to replace the antibiotics 
in the feed. 
 Bacteriophages may be the most environmentally safe alternatives available 
considering they are naturally found in the environment and animal hosts. In addition, 
they have several advantages over antibiotics. Typically the antibiotics used as feed 
additives are broad spectrum so as to target as many bacterial species as possible. The 
issue is when resistance arises it can occur in several different bacterial species. 
Bacteriophages have a high specificity for their host, typically only infecting one 
bacterial species or even a few serotypes within a species. An advantage with the use of 
bacteriophages is that if there is bacteriophages resistance it would only arise in the 
bacterial species that is their host and would have little to no effect on other species in the 
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environment. The resistance mechanism for bacteriophages is not related to the 
mechanisms developed in antibiotic resistance, so resistance to a bacteriophage will not 
influence the efficiency of antibiotics that are used for pathogen treatment. When 
resistance does occur, bacteriophages can be rapidly modified through natural selection to 
produce a new treatment; whereas, antibiotics may require several years of research and 
development to produce (Pirisi, 2000). In application, it has been demonstrated that 
bacteriophages may be transferred between animal hosts. This transfer provides a large 
advantage as a prophylactic due to the fact one animal could be administered the 
bacteriophage and it would transmit throughout the population on its own (Smith et al., 
1987). A final advantage is that they are self-replicating, so a single dose would last 
throughout the course of infection. This advantage would also mean a relatively low 
initial dose could be used (Barrow and Soothill, 1997). 
Summary 
 It is well established that finished rendered by-products can be contaminated with 
pathogenic bacteria including Salmonella spp. and Enterococcus spp. The reason behind 
this contamination is debatable and is one of the focuses of our study. Although the 
material may be contaminated, the rendering process is still the best alternative available 
for handling animal by-products, and it provides a valuable source of nutrients needed for 
the finished animal feed. Although the benefits of the feed may outweigh the biological 
risks, there is still concern that the feed serves as a continuous vehicle for introducing 
pathogenic bacteria into the food chain. In this particular study, the focus is on 
enterococci and Salmonella. Enterococci typically only cause mild treatable disease, so 
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the concern is with VRE which has the capability of transferring the vancomycin 
resistance genes to more pathogenic bacteria via conjugation.  
 Salmonella is one of the leading causes of human food-borne illness; therefore, its 
presence in finished meals is of major concern. The heat used during the rendering 
process is sufficient to kill pathogenic bacteria, which leads to the theory that the 
contamination was resulting from cross-contamination within the rendering facility.  
There are several potential sources for cross contamination including the incoming raw 
material and the environmental surfaces found within the facility. 
 Due the potential for cross-contamination, it is important to develop a method for 
reducing bacterial levels that is biologically safe and cost efficient. Bacteriophages could 
potentially serve this need to the fact that they are self-producing and only affect their 
determined bacterial host. Numerous studies have demonstrated the ability of 
bacteriophages as a treatment method for both raw meat and hard surfaces such as steel. 
Bacteriophages have also been show to be an effective means of preventing or reducing 
infection within an animal host. 
The objectives of this study were as follows:  
• Determining contamination levels of Salmonella spp. and Enterococcus spp. 
within the finished rendered products provided by U.S. rendering facilities. 
• Characterizing and determining heat resistance of Salmonella and Enterococcus 
isolated from the animal by-products. 
• Screening enterococci isolates for VRE and determining the level of resistance. 
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• Developing a bacteriophage cocktail capable of lysing Salmonella that had been 
recovered from finished by-products 
• Using the produced bacteriophage cocktail to reduce Salmonella levels on 
environemental surfaces (steel, rubber, HDPE plastic, and concrete) in the form of 
attached cells and within a biofilm. 
• Using the bacteriophage cocktail to reduce Salmonella levels in the raw material 
used to produce the rendered by-products. 
• Conducting an animal study to use the bacteriophage cocktail as a feed additive 
for therapeutic purposes against Salmonella infection in mice. 
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ANALYSIS OF SALMONELLA AND ENTEROCOCCI ISOLATED FROM 
RENDERED ANIMAL PRODUCTS 
 
Abstract 
 The objectives of this study were to determine the current status of bacterial 
contamination in rendered animal products and analyze Salmonella and enterococci 
isolates from the samples. One hundred and fifty samples were provided by various 
rendering companies across the U.S., including the following meal types: feather, meat, 
meat and bone, meat and bone from poultry, poultry, and blood meals. The average pH of 
the meals ranged from 6.16 to 7.36, and the moisture content ranged from 1.9 to 11.5%. 
The total bacterial counts were in the range of 1.7 to 6.68 log CFU/g with the highest in 
blood meal and the lowest in meat meal. Enterococcus species were detected in 81.3% of 
the samples and accounted for up to 54% of the total bacterial counts in some samples. 
Both blood meal and feather meal were more contaminated (P < 0.05) with enterococci 
than other meal types, although all blood meals were from a single company.  Salmonella 
was detected in 8.7% of the samples.  E. coli was not detected in any of the samples, but 
coliforms were detected in four samples. Among enterococci isolates, three were 
vancomycin resistant. Thirteen serotypes of Salmonella displayed 16 pulse field gel 
electrophoresis (PFGE) patterns. PFGE analysis has indicated that Salmonella 
contamination was not persistent in the plant environment over time. D-values for the 
Salmonella isolates at 55°C, 60°C, and 65°C were in the ranges of 9.27-9.99, 2.07-2.28, 
and 0.35-0.40 min, respectively. These results suggest that the presence of Salmonella in 
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the finished products may be due to post-processing contamination. This study has also 
revealed that the rendering industry has microbiologically improved their products as 
compared to earlier studies. 
Introduction 
Each year, the U.S. meat industry generates over 2.3 x 1013 kg of animal parts not 
typically included in the food supply such as fat and bone trimmings, meat scraps, blood, 
offal, and feathers (Franco and Swanson 1996). Annually, the U.S. produces ca. 11.2 
billion pounds of protein and 10.9 billion pounds of fats. Approximately 85% of these 
products, are then used in the production of animal feed ingredients (Meeker and 
Hamilton, 2006).  A large portion of these U.S. products are then exported. In 2005, the 
amount of exported finished products worldwide was ca. 1.7 million metric tons with 0.8 
million metric tons being exported by the U.S. (Swisher, 2006).  These by-products are 
often contaminated with high numbers of microorganisms and will spoil rapidly 
becoming a public health hazard if left untreated.  Meat, meat and bone, feather, poultry 
and blood meals are produced by the rendering industry from these by-products of meat 
processing plants.  Therefore, the rendering industry has played a significant role in 
recycling inedible parts of food animals into a variety of value-added products (Franco 
and Swanson 1996).  Most importantly, the rendering industry contributes to maintaining 
a healthy environment by using processing conditions capable of eliminating pathogenic 
microorganisms including bacteria and viruses.  
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 While adding rendered animal meals to feed provides many needed nutrients and 
minerals essential for animal growth, animal feed is a source of foodborne pathogens 
contributing to human foodborne illnesses (Crump et al. 2002).  Although the rendering 
process involves high levels of heat treatment, there is still potential for the finished meal 
to become contaminated with bacteria.  When these contaminated products are used as 
ingredients of animal feed, inoculation of other animals in the food chain can occur and 
lead to potential human exposure.  A previous study on rendered products revealed 
poultry meal containing bacterial populations ranging from 1.6 to 4.02 log CFU/g 
(Hofacre et al. 2001). About 85% of the poultry and meat and bone meal samples 
contained bacteria resistant to amoxicillin, ampicillin, clavulanic acid and cephalothin.  
Some of the most commonly isolated bacteria were Acinetobacter colcoaceticus, 
Citrobacter freundii, and Enterobacter cloacae. Salmonella was also isolated from 14% 
of the meat and bone samples (Hofacre et al. 2001). 
 Enterococci have often been used as probiotics in food production, but also 
account for 12% of the nosocomial infections in the U.S. causing bacteremia, 
endocartitis, and infections, with Enterococcus faecalis and Enterococcus faecium 
causing the majority of these infections (Franz et al. 2003).  Enterococci are resistant to 
various stresses including mild heat treatment and are intrinsically resistant to a wide 
variety of antibiotics.  More specifically, resistance to vancomycin is of major concern 
since vancomycin is considered to be the last resort for enterococci treatment (Manero et 
al. 2006, Wegener 2003).  Therefore, it is important to identify potential reservoirs for 
enterococci in an effort to control the possible contamination with this microorganism.   
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The purpose of this study is two-fold. First it is necessary to determine if the 
rendered meals may serve as a vehicle for bacteria, specifically Enterococcus spp. and 
Salmonella spp.  Although early studies have demonstrated that rendered products are 
frequently contaminated with bacteria including Enterococcus spp. and Salmonella spp., 
the technological improvements of the rendering process have been made, and an updated 
study is needed to assess the microbiological quality of these products by taking rendered 
products directly from the production line to reduce the potential for post-processing 
contamination. The study then determined whether the contamination is likely to be a 
result of insufficient sterilization methods or through post-processing contamination. 
Materials and Methods 
 Analysis of moisture content, pH, and water activity.  To determine the 
moisture content, approximately 1g of each sample was weighed and dried in a 
mechanical convection oven (Blue M Electric Co., Blue Island, IL.) at 105°C for 24 h. 
For pH testing, one gram of each sample was mixed with 50 ml of distilled water and 
analyzed using a pH meter (Orion perpHect Log R meter model 310, Boston, MA.). The 
water activity (aw) values were determined using a Rotronic-Hygroskop DT (Rotronic 
Instrument Corp., Huntington, NY.). 
Bacterial enumeration. One hundred and fifty different rendered samples were 
provided by twelve rendering companies throughout the U.S from August, 2004 to 
February, 2005.  The products were separated into six meal types: feather meal (n=30), 
meat meal (n=14), meat and bone meal (MBM) (n=37), meat and bone meal from poultry 
  87 
(MBM-P) (n=6), poultry meal (n=51), and blood meal (n=12). Samples were stored at 
4°C prior to analysis.   
 Samples in duplicate were serially diluted using 0.1% sterile peptone water. 
Aliquots of each dilution were spread-plated onto Tryptic Soy Agar (TSA, Becton-
Dickinson and company, Sparks, MD.) for total bacterial counts (TBC) and Bile Esculin 
Agar (BEA, Becton-Dickinson and company) for enterococci counts, separately. Plates 
were incubated at 37°C for 24 h. Bacterial counts were reported as CFU/g, and the 
detection limit for both TBC and enterococci was 100 CFU/g. 
 Detection of E. coli/coliforms and Salmonella. Ten grams of each sample in 
duplicate were mixed with 90 ml of universal pre-enrichment broth (UPB, Becton-
Dickinson and company) and incubated at 37°C for 24 h. For E. coli/coliforms testing, 1 
ml of each enriched sample was placed on a Petrifilm™ E.coli/coliforms count plate (3M 
Microbiology Products, St. Paul, MN.) and incubated at 37°C for 48 h. For Salmonella 
detection, the enriched sample was inoculated into Tetrathionate Broth (TTB, Becton-
Dickinson and company) and incubated at 37°C for 24 h, followed by plating onto xylose 
lysine tergitol-4 (XLT-4, Becton-Dickinson and company). Presumptive Salmonella 
isolates were then confirmed with a Salmonella identification latex test (Oxoid®, 
Basingstoke, Hants, UK). The above procedure deviated some from FDA 
recommendations due to the quantity of samples received. Standard procedures require a 
25 g sample, but some samples were not large enough to do so. 
 Bacterial isolation. Purified isolates from both BEA (Enterococcus, n=200) and 
XLT-4 (Salmonella, n=30) plates were streaked onto TSA, preserved in TSB containing 
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20% glycerol, and stored at -80°C. These isolates were used for further testing including 
antibiotic and heat resistance determination. 
 Enterococci spp. confirmation. The prospective enterococci isolates were gram-
stained and then tested for growth at 45°C in TSB, growth in TSB containing 6.5% NaCl, 
catalase activity, and pyrrolidonyl arylamidase activity using PYR disks (Remel, Lenexa, 
KS.). All isolates that tested positive as an Enterococcus spp. were screened for 
vancomycin resistance by plating onto BEA supplemented with 6 µg/ml of vancomycin 
(Sigma-Aldrich, St. Louis, MO.) and incubating at 37°C for up to 48 h. 
Determination of minimum inhibitory concentration (MIC) of vancomycin. 
The agar dilution assay was used as described by CLSI protocol (CLSI, 1997) using 
Mueller Hinton agar (MHA, Becton-Dickinson and company). Plates were prepared 
using the following concentrations of vancomycin: 4, 8, 16, 32, 64, and 128µg/ml. 
Enterococci isolates were inoculated onto the MHA plates using a replica plater device 
(Sigma). Plates were incubated at 37°C for up to 48 h. 
PCR identification of genus and species for potential vancomycin resistance 
enterococci (VRE) isolates: The DNA of potential VRE isolates (n=16) were extracted 
by boiling method and used for genus confirmation and identifaction of the species E. 
faecium and E. faecalis. The primers, reaction mixtures, and reaction protocol were 
performed according to Shank et al. (2008), Sedgley et al. (2005), and Jackson et al. 
(2005), respectively. The PCR reaction was conducted in a Bio-RadiCycler iQTm (Bio-
Rad Laboratories, Hercules, CA), and the resulting products underwent electrophoresis in 
a 1.5% agarose gel at 70 v, and stained in ethidium bromide. Images of the gels were 
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captured using a GelDoc 2000 (Bio-Rad Laboratories).  E. faecalis ATCC 29212, E. 
faecium ATCC 51229, and E. coli G5244 were used as controls. 
Detection of vanA and vanB genes through PCR analysis. The DNA of 
potential VRE isolates (n=16) were extracted by boiling method and used to detect the 
presence of the vanA or vanB genes. The primers, reaction mixtures, and reaction 
protocol were performed according to Dutka-Malen et al. (1995). The PCR reaction was 
conducted in a Bio-RadiCycler iQTm (Bio-Rad Laboratories, Hercules, CA), and the 
resulting products underwent electrophoresis in a 1.5% agarose gel at 70 v, and stained in 
ethidium bromide. Images of the gels were captured using a GelDoc 2000 (Bio-Rad 
Laboratories).  E. faecium ATCC 51559 (vanA), E. faecium ATCC 51229 (vanB) and E. 
coli G5244 were used as controls. 
Thermal resistance screening. Bacterial isolates (Salmonella, enterococci, and 
VRE) were screened for thermal resistance. All cultures were grown on TSA at 37°C for 
24 h, and each culture was resuspended in saline and inoculated into TSB at a final 
concentration of 5 x 106 CFU/ml.  The inoculated TSB tubes were incubated at 60° and 
70°C in a Haake V26 circulating water bath (Thermo Haake GmbH, Karlsruhe, 
Germany) for Salmonella and enterococci, respectively. Three tubes were removed 
simultaneously at pre-determined time intervals and placed immediately into an ice bath. 
After the tubes had cooled, each tube was incubated at 37°C for 24 h and observed for the 
presence of growth. 
D-value and z-value determination. The six most heat resistant Salmonella 
isolates were inoculated into TSB and incubated at 37°C for 24 h. After incubation, all 
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samples were diluted in saline and inoculated into TSB at a final concentration of ca. 5 x 
106 CFU/ml. The inoculated tubes were then incubated separately at 55° (n=6), 60° 
(n=10), and 65°C (n=10) in a circulating water bath. The internal temperature of the broth 
was monitored by J-type thermocouples (DCC Corporation, Pennsauken, NJ) attached to 
a Hotmux data logger (DCC Corporation) and tubes were removed at pre-determined 
time intervals. After cooling in an ice bath, the inoculated tubes were then spiral plated 
onto TSA with a Autoplate 4000 (Spiral Biotech Norwood, MA) and incubated at 37°C 
for 24 h. The log CFU/ml values were plotted against heating time to determine the line 
of best fit. The formula for D-value calculation was D= t / (log No – log Nf), where t is 
total time, No is the intitial bacterial concentration, Nf is the final bacterial concentration, 
and D is the D-value. D-values were determined for each isolate at the three tested 
temperatures. Z-values were determined by plotting log D-values (y-axis) vs. heating 
temperatures (x-axis). The z-value is the temperature change required to change the D-
value by 1 log. 
Serotyping and PFGE analysis of Salmonella isolates. Twenty-nine Salmonella 
isolates were serotyped by the FDA lab using the Kauffman-White Classification system, 
and the PFGE patterns of these isolates were analyzed following PulseNet’s standard 
PFGE protocol for Salmonella (Ribot 2006). Briefly, plugs were prepared by mixing 
SeaKem Gold agarose and 1% sodium dodecyl sulfate (SDS) with Salmonella (108 
CFU/ml) and proteinase K. Once cell lysis was complete, the plugs underwent restriction 
digestion by XbaI. The plugs were then washed, cast into an agarose gel, and underwent 
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electrophoresis using a CHEF Pulse-Field system (Bio-rad). The gel was stained with 
ethidium bromide and imaged using a Gel Doc system (Bio-Rad).  
Statistical analysis.  All plate count data were converted into log10 values.  The 
mean counts and standard deviations were determined for the samples according to meal 
type as well as by the commercial renderer. The data were subjected to analysis of 
variance with a test criterion (F statistic) and type I error controlled at P = 0.05.  The 
Tukey’s multiple comparison procedure of the Statistical Analysis System (SAS 2001, 
Cary, NC.) was used to compare all pairs of means when the test criterion for the analysis 
of variance was significant.  
Results 
 In this study, 150 fresh samples of feather, meat, MBM, MBM-P, and blood 
meals were analyzed. Feather, meat, MBM, and poultry meals were provided by at least 4 
companies whereas blood and MBM-P were produced by a single company. 
The average pH of the meal types ranged from 6.16 to 7.36 (Table 2.1).  The pH 
of blood meal was higher (P < 0.05) than those of all other meal types.  Feather meal 
contained the highest amount of moisture (5.99%); whereas, meat meal contained the 
lowest amount of moisture (2.5%) (Table 2.1).  Both feather and blood meals were higher 
(P < 0.05) in moisture content than meat and MBM meal.  The water activity of different 
types of meal was analyzed; however, the aw values in the range of 0.41 to 0.49 were 
consistent among the meal types (data not shown). 
Total bacterial counts (TBCs) ranged from 1.70 to 6.68 log CFU/g, and 
enterococci counts ranged from less than 1.40 to 5.70 log CFU/g. The mean TBCs for 
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each meal type ranged from 3.70 to 5.88 log CFU/g; whereas, mean enterococci counts 
were in the range of 1.60 to 3.85 log CFU/g (Figure 2.1).  Total bacterial counts were 
found to be the highest in blood meal and the lowest in meat meal.  Enterococci counts 
were also the highest in blood meal but the lowest in the MBM-P.  Blood meal was more 
contaminated (P < 0.05) with total bacteria than other meal types, and both blood and 
feather meals contained higher levels (P < 0.05) of enterococci.  
 Comparisons between meal type and company for TBCs and enterococci counts 
are presented in Tables 2.2 & 2.3, respectively.  Since 38 out of 150 samples were 
received without the company information, those samples were excluded in both Tables.  
There were differences (P < 0.05) in TBCs for feather, meat, MBM, and poultry meal 
types among companies.  The feather and poultry meal produced by company F were 
contaminated with the highest (P<0.05) levels of total bacteria for that meal type. There 
were also differences (P < 0.05) in enterococci counts in MBM and poultry meal among 
companies.  All meals (feather, meat, or poultry) produced by company A and F had the 
highest levels (P < 0.05) of enterococci contamination.  For company H, blood meals 
contained higher TBC and higher enterococi counts than the other four meal types they 
produce. Enterococcus spp. was detected in 122 of 150 samples (81.3%), and accounted 
for up to 54% of the total bacterial counts in some samples (Table 2.4).  Over 90% of the 
blood or feather meals were positive for enterococci. 
 E. coli was not detected in any of the samples tested, but coliforms were detected 
in a few samples (4 out of 150) of the feather, MBM, and poultry meals (Table 2.4).  
Salmonella was detected in 13 of the 150 samples (8.7%) including feather, meat, MBM, 
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and poultry meals.  In general, the poultry meal samples had the highest contamination 
rate (13.7%) for Salmonella (Table 2.4).  
 Approximately 76% of the 200 isolates collected were confirmed enterococcus by 
traditional confirmational tests. Vancomycin resistance screening revelaed that of the 152 
enterococcus isolates only 16 (10.5%) are potentially resistant. These 16 isolates were 
confirmed as enterococcus by PCR assay. PCR analysis also indicated none of the 16 
isolates were E. faecalis or E. faecium (data not shown). The results of the agar dilution 
test revealed that the MIC of 13 enterococci isolates was 16 µg/ml or less; whereas, only 
three isolate were able to grow at 32 µg/ml. Since the breakpoint for VRE is 32 µg/ml, 
three (2%) enterococci isolates were considered VRE in this study (Willey 1992). PCR 
analysis of the 16 isolates further revealed that none of the isolates contained the vanA or 
vanB that are traditionally associated with higher levels of vancomycin resistance. 
 After initial thermal resistance screening, six Salmonella isolates were tested 
further for D- and z-vlaue determinations. Of those six isolates, five were isolated from 
the rendered products consisting of  different serotypes as well as an additional isolate 
provided by SC DHEC from a SC boiled peanut outbreak were used to determine D- and 
z-values (Table 2.5). There was no difference (P < 0.05) between all determined D-values 
at each temperature with a maximum range of 0.85 minutes between them. All z-values 
were approximately 7°C. 
 A total 13 distinguishable serotypes including Senftenberg, Oranienburg, Idikan, 
Johannesburg, IIIa. 42: z4,z23, Banana, Demerara, Putten, Molade, Montevideo, 
Mbandaka, Livingstone, and Amsterdam were identified. PFGE analysis was able to 
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further classify all distinguishable serotypes except those that were S. Banana. There 
were 16 PFGE patterns for 12 serotypes, including three types of S. Senftenberg, two 
types of S. Mbandaka, and two types of S. Demarara. 
Discussion 
To ensure the microbiological safety of rendering end products, rendering 
companies use various forms of heat treatment depending on the meal type.  Three forms 
of heat treatment were analyzed in this study.  The first method of treatment is for meat, 
MBM, MBM-P and poultry meal.  This process uses a continuous rendering process, 
which heats the raw material in a horizontal, steam-jacketed cylindrical vessel to a final 
temperature ranging from 121 to 135°C (Franco and Swanson 1996).  After the fat is 
removed, the meal is dried and packaged (National 2005).   In the continuous process of 
blood meal, the whole blood is passed through a system of tubes where steam is injected 
to coagulate blood solids.  After separation, the blood solids are fed into a gas-fired 
drying system, direct-contact ring dryer, a steam tube, or rotary dryer (Franco and 
Swanson 1996). As for feather meal production, the keratin of poultry feathers is first 
converted into short chain amino acids by chemical hydrolysis in a batch cooker at 
temperatures ranging from 138 to 149oC under pressure.  The feather meal is then dried 
in a manner similar to the way blood meal is (McGovern 2000).  In this study, total 
bacterial and enterococci counts based on meal type from the highest to lowest were: 
blood meal > feather meal > meat meal.  This would suggest that the continuous 
rendering system for meat, MBM, and poultry meal is more effective than the methods 
used for feather and blood meal in eliminating bacteria.  Although blood meal samples 
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were from a single company (H), both total bacterial and enterococci counts in blood 
meal were higher (P<0.05) than those in MBM, poultry, and meat meal produced by this 
company. In addition, the microbial contamination levels of raw materials can also affect 
the bacterial levels and contents in the finished meal products. A 2001 study indicated 
that raw material used for rendered by-product production contains the following levels 
of pathogens: Salmonella spp. 84.5%, Clostridium perfringens 71.4%,  Listeria 
monocytogenes 8.3%, Listeria spp. 76.2%, Campylobacter jejuni 20.0%, and 
Campylobacter spp. 29.8% (Troutt et al. 2001). 
Moisture is one of the key control points for preventing microbial growth of the 
rendered product.  In both blood and feather meal processing, the moist meals with ca. 50 
to 55% moisture are subjected to drying  If these meals are not properly dried, the 
moisture content will remain high and microbial levels may increase as evidenced in our 
study for both blood and feather meals. Although the moisture levels in animal meals 
analyzed in this study were much lower than the minimal moisture level for bacteria 
growth, some bacteria esp. Salmonella, if present, may persist for extended period of time 
during storage (Doyle et al., 2001;Meat 1997).   
 The machinery, plant environment and workers can all serve as possible sources 
of contamination as well.  It is possible for bacteria to form biofilm on the machinery, 
conveying belts, containers, and floor of the processing plant.  Foodborne pathogens such 
as E. coli O157:H7, Listeria monocytogenes, Yersinia enterocolitica, and Campylobacter 
jejuni form biofilms on food surfaces and food contact equipment (Chae and Schraft 
2000, Doyle et al. 2001, Kumar et al. 1998).  Recontamination can also occur in finished 
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meals during storage within the plant. Therefore, it is important to analyze the effect that 
the practices of various companies had on the contamination levels of the samples.  
Tables 2.2 and 2.3 revealed that all meals produced by company A and F contained 
higher (P < 0.05) levels of enterococci and total bacteria. Although there were some 
significant differences among the companies, it is not possible to discern if one company 
was any less contaminated than the others due to unequal numbers of meal types 
provided by each company. 
 Rendered animal products are frequently contaminated with Salmonella. 
Epidemiological studies also have linked human Salmonella spp. to contaminated animal 
feed (Crump et al. 2002).  For example, a S. enterica serotype Heidelberg outbreak in 
1963 led to 77 infections from milk consumption (Knox et al. 1963).  This outbreak was 
linked to bovine mastitis caused by the same Salmonella serotype, which was found in 
the meat and bone meal fed to the cows.  Over a four month period, Salmonella was 
detected in 81% of the meat meal, 40% of the feather meal, and 84.2% of the broiler 
premix (meat meal as a filler) produced in Ontario feed mills (Hacking et al. 1977).  
Loken et al. (1968) tested 1,395 rendered products from seven different plants and 
detected the presence of Salmonella in 241 (17%) of the samples. The study also tested 
the plant with environmental swabs, and Salmonella was isolated from 359/1901 (19%) 
of the swabs.  In 1993, a FDA study of feed samples from 78 protein-based rendering 
plants detected Salmonella enterica in 56% of the 101 samples collected (McChesney et 
al. 1995).  A year later a FDA test of 89 samples detected S. enterica in 25% of the 
samples (Crump et al. 2002).  Members of the Animal Protein Producers Industry (APPI) 
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tested samples weekly for Salmonella for at least 52 tests a year (Franco 2005).  On 
average, twenty-five percent of the samples tested positive for Salmonella.  Results from 
197 Salmonella-positive samples during a particular year indicated that the average 
MPN/g was 16.3 with a range of 0.2 to 78.0 MPN/g (Franco 2005).  Of the Salmonella 
serovars found in that study, four were associated with food borne illness (S. 
Typhimurium, S. Enteritidis, S. Agona, and S. Infantis). Unlike samples analyzed by FDA 
studies, which had been transported and subjected to secondary contamination, the 
present study analyzed the rendered animal products collected at the end of the 
processing line.  As compared with above surveys, the low contamination rate for 
Salmonella (8.6%) and absence of E. coli in 150 meal samples analyzed may suggest that 
the rendering industry has made progress toward improving the safety of animal co-
products. In addition, samples positive for Salmonella were mostly poultry meal or 
feather meal.  A possible explanation is that the raw poultry products may contain larger 
numbers of Salmonella entering the rendering plants which would require additional heat 
exposure compared to the other meal types.  Therefore, the initial microbial load of raw 
materials should be considered in order to produce microbiological safe meal products. 
The overall goal set forth by the FDA Center for Veterinary Medicine in 1990 is for both 
animal feed ingredients and the final feed to contain no detectable amount of Salmonella, 
zero tolerance (Meeker 2006). 
Cross-contamination may be one of the major reasons for the presence of 
Salmonella in the finished products. In this study, all Salmonella isolates had D-values in 
the range of 9 minutes at 55°C, 2 minutes at 60°C, and under 45 seconds at 65°C. The 
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temperatures produce in the batch cookers used for meal processing reaches 121-135°C 
and are maintained for 2 to 3 h, which far exceeds the maximum temperature used in this 
study. At 65°C all isolates in this study were reduced by 1 log within 45 seconds 
indicating that the rendering process should be sufficient in killing all Salmonella 
provided that the internal temperature of the by-products reaches or exceeds the cooking 
temperature. D-values for Salmonella were reported as 18-594 min at 50°C in corn flour 
(van Cauwenberged et al., 1981), 55-345 min at 70°C in wheat flour (Archer at al., 1998), 
and 10-115 min at 70°C in meat and bone meal (Liu et al., 1969). Apparently, the D-
values of the Salmonella in this study are lower than those reported for Salmonella in 
above dry materials, suggesting that the Salmonella contamination in rendered animal 
meals is most likely a result of post-processing contamination. The PFGE was used to 
characterize the Salmonella isolates within the processing plant. A comparison between 
each individual set of PFGE types and what type of product that were isolated from, 
where they were collected, and when they were collected revealed that there was not a 
single type present in a particular plant environment over an extended period of time. 
This indicates that the likely source of contamination is the raw animal by-products due 
to the fact it is a consistent incoming new source for contamination. 
Enterococcus spp. is widely distributed in the environment and animals. 
Enterococci also have been consistently isolated from the carcass of beef, poultry, and 
pork meat (Franz et al. 2003).  Knudtson and Hartman (1993) reported that pig carcasses 
from three abattoirs were contaminated with enterococci at 4~8 log CFU per 100 cm2 of 
the carcass surface, with E. faecium and E. faecalis as the dominant species.  Enterococci 
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being found in rendered meals may be less surprising than other bacterial contamination 
due to the fact that enterococci are heat tolerant. A few studies previously reported that 
Enterococcus spp. was detected in rendered animal meals (Cullen et al. 2003, and 
Schwalbe et al. 1999).  A 2003 national survey conducted by the FDA was performed on 
122 samples (MBM 72, Blood 16, Bone 2, Feather 10, Poultry 17, and Fish 5) (Cullen et 
al. 2003).  Of these, 84% of the samples contained Enterococcus spp. which were 
identified as E. faecium (86.5%), E. faecalis (7.5%), E. gallinarum (2%), E. hirae (1.5%), 
and E. avium (0.5%).    The present study revealed a similar contamination rate by 
enterococci (81.3%) with a range from below the detection limit (<1.40 log CFU/g) to 
5.70 log CFU/g.  MIC results revealed that VRE was present in the rendered products but 
with low prevalence (2%). In addition, none of the VRE isolates were E. faecalis or E. 
faecium. The vanA and vanB genes confer high levels of resistance (≥64µg/ml) and are 
the only two resistance genes that have been associated with plasmids. Due to the low 
MIC for vancomycin, the VRE isolates were assumed not to posses the vanA or vanB 
genes, suggesting a low possibility that there is transference of the vancomycin resistance 
genes between other species found in the rendered meal (Gilmore 2002). The absence of 
the vanA and vanB gene was then confirmed by PCR analysis. 
 This study has provided some baseline data on microbiological contamination 
levels in fresh rendered meals.  These results more accurately represent the microbial 
load in rendered products than previous studies since all samples were taken directly 
from the production lines before the rendered meals could be mixed with any other feed 
components in a feed mill.  Although avoiding the contamination of finished animal 
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meals is difficult in post-production shipment and reformulation, using heat tolerant 
enterococci as a marker for bacterial load may help the industry to determine if the meal 
products have been heated adequately or have been contaminated by raw materials or the 
processing environment. Based on the low thermal resistance of Salmonella isolates 
tested in this study, the heat treatment process used by the rendering industry appears to 
be adequate in eliminating bacterial contamination in the product; therefore the 
Salmonella contamination is most likely resulting from post-processing contamination. 
Overall, the low prevalence of Salmonella contamination and absence of E. coli in all 
samples indicate that the rendering industry has microbiologically improved the products. 
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Figure Legend 
Fig.2.1: Total bacterial and enterococci counts for six meal types.  Reported values are 
expressed as the mean ± standard deviation.  The different letters above each bar are used 
to indicate the significant (P < 0.05) differences between the counts of the meal types. 
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Table 2.1. Moisture content and pH level per meal type 
  
      
 Meal Type Moisture % (mean ± std dev) pH (mean ± std dev)   
 Feather (n=30) 5.99 ± 2.48A* 6.20 ± 0.39B   
 Meat (n=14) 2.50 ± 1.49C 6.38 ± 0.58B   
 MBM (n=37) 2.90 ± 1.23C 6.16 ± 0.52B   
 Poultry (n=51) 3.21 ± 1.15BC 6.41 ± 0.28B   
 Blood (n=12) 4.94 ± 2.17AB 7.36 ± 1.08A   
 MBM-P (n=6) 4.04 ± 2.41BC 6.37 ± 0.29B   
 *Means with different superscripts are significantly different (P < 0.05) among meal types. 
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Table 2.2. Total bacterial counts of rendered animal meals produced by 12 companies 
 
       
 Total bacterial counts (log CFU/g) 
Company Feather (n=30) Meat (n=14) MBM (n=37) MBM-P (n=6) Poultry (n=51) Blood (n=12) 
A   4.54 ± 0.71AB* 4.78 ± 0.62A N/A N/A 4.59 ± 0.87AB N/A 
B 3.68 ± 0.26B 4.80 ± 0.62A N/A N/A 4.52 ± 0.65AB N/A 
C N/A** N/A N/A 3.98 ± 0.64 N/A N/A 
D N/A 2.61 ± 0.46B 5.04 ± 0.64A N/A N/A N/A 
E N/A N/A 4.76 ± 0.69A N/A N/A N/A 
F 5.38 ± 0.86A N/A N/A N/A 5.52 ± 0.38A N/A 
G N/A N/A 4.61 ± 0.34A N/A N/A N/A 
H   4.65 ± 0.52AB 3.71 ± 0.90AB 4.11 ± 0.70AB N/A 3.86 ± 0.83B 5.91 ± 0.79 
I N/A N/A 3.98 ± 0.69AB N/A N/A N/A 
J N/A N/A 2.20 ± 0.38B N/A N/A N/A 
K N/A 3.99 ± 0.21AB 5.04 ± 1.09A N/A N/A N/A 
L N/A N/A 4.24 ± 0.94AB N/A N/A N/A 
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*The different letters in each column are used to indicate the significant differences (P<0.05) between the companies for that given meal type.  
**N/A means that there were no samples of that meal type from the corresponding company    
Table 2.3. Enterococci counts of rendered animal meals produced by 12 companies 
 
             
  Enterococci counts (log CFU/g) 
Company Feather (n=30) Meat (n=14) MBM (n=37) MBM-P (n=6) Poultry (n=51) Blood (n=12) 
A 2.94 ± 0.78A* 3.16 ± 0.45A N/A N/A 2.27 ± 1.26AB N/A 
B 2.38 ± 0.38A 3.10 ± 0.45A N/A N/A 2.95 ± 0.76A N/A 
C N/A** N/A N/A 1.15 ± 1.03 N/A N/A 
D N/A 0.57 ± 0.84A 2.18 ± 0.90AB N/A N/A N/A 
E N/A N/A 2.32 ± 1.10AB N/A N/A N/A 
F 2.83 ± 1.61A N/A N/A N/A 3.35 ± 0.07A N/A 
G N/A N/A 2.88 ± 0.20A N/A N/A N/A 
H 2.58 ± 1.06A 1.78 ± 1.51A 0.97 ± 1.41AB N/A 1.16 ± 1.38B 2.97 ± 1.53 
I N/A N/A 1.57 ± 1.38AB N/A N/A N/A 
J N/A N/A BLDB N/A N/A N/A 
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K N/A BLDA*** 3.21 ± 0.80A N/A N/A N/A 
L N/A N/A 2.63 ± 1.33AB N/A N/A N/A 
*
 Means with different superscripts are significantly different (P < 0.05) between the companies for that given meal type.   
**N/A means that there were no samples of that meal type from the corresponding company.   
***BLD, Below the minimum detection limit (100 CFU/g).     
 
Table 2.4. Percentages of samples of each meal type that was positive for Salmonella, enterococci, and coliforms 
 
 % Salmonella (n) % enterococci (n) % coliforms (n)  
Feather (n=30) 6.7(2) 96.7(29) 6.7(2)  
Meat (n=14) 7.1(1) 64.3(9) 0(0)  
MBM (n=37) 8.1(3) 75.7(28) 2.7(1)  
Poultry (n=51) 13.7(7) 78.4(40) 2.0(1)  
Blood (n=12) 0(0) 91.7(11) 0(0)  
MBM-P (n=6) 0(0) 83.3(5) 0(0)  
Total (n=150) 8.7(13) 81.3(122) 2.7(4)  
 1 
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Table 2.5. D-values and z-values of Salmonella Isolates  
  D-value (min) at given temperature  
Isolate Serotype 55°C 60°C 65°C z-value (°C) 
B111419*  Enteritidis 10.12 ± 0.62A 2.47 ± 0.64A 0.50 ± 0.12A 7.66 
23B2 Senftenberg 9.27 ± 0.43A 2.07 ± 0.28A 0.36 ± 0.18A 7.09 
98 Idikan 9.30 ± 1.66A 2.28 ± 0.53A 0.36 ± 0.21A 7.08 
214 Mbandaka 9.76 ± 1.43A 2.19 ± 0.71A 0.43 ± 0.13A 7.37 
222 Banana 9.47 ± 0.82A 2.08 ± 1.03A 0.35 ± 0.17A 6.98 
223B Demerara 9.99 ± 0.42A 2.15 ± 1.02A 0.40 ± 0.14A 7.16 
* Isolate provided by SC DHEC 1 
** Means with different superscripts are significantly different (P < 0.05) 2 
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CHAPTER THREE 
REDUCTION OFSALMONELLA ON ENVIRONMENTAL SURFACES WITH 
BACTERIOPHAGE TREATMENT  
 
Abstract 
 A previous study has suggested that the presence of Salmonella in animal meal is due to 
post processing contamination. The objective of this study was to determine if a bacteriophage 
cocktail could be used to reduce the risk of cross-contamination by reducing Salmonella levels 
on environmental surfaces found within a rendering facility. A cocktail of five bacteriophages 
was isolated and purified for two dominant Salmonella serotypes (Enteritidis and Typhimurium) 
and three other serotypes (Mbandaka, Johannesburg, and Idikan) that were previously isolated 
from finished rendered products. These Salmonella serotypes were treated with the 
bacteriophage cocktail at varying concentrations to determine the optimal multiplicity of 
infection (MOI). The optimized cocktail was then used to treat the attached Salmonella cocktail 
and S. Enteritidis within a single and double species biofilm on templates of steel, plastic, cement 
and rubber at 20°, 30°, and 40°C. The bacteriophage cocktail was found to be most effective at a 
MOI of 10.  Bacteriophage treatment of the surface materials with attached Salmonella resulted 
in a ca. 2 log decrease in the Salmonella count at 40° and 30°C, and ca. 1 log CFU/cm2 decrease 
at 20°C for all surface materials. Bacteriophage treatment of the S. Enteritidis single-species 
biofilm resulted in a ca. 1-2, 2-3, and 1 log CFU/cm2 reduction in Salmonella populations at 20, 
30, and 40°C, respectively. Bacteriophage treatment of the double species biofilm at 20, 30, and 
40°C resulted in reduction of the Salmonella populations by ca. 0.5, 1.5-2.0, and 0.5 log 
CFU/cm2. Overall, the bacteriophage treatment was most effective at 30°C under all test 
conditions. These results demonstrated that a bacteriophage cocktail significantly reduces levels 
 112 
 
of Salmonella contamination on environmental surfaces, and may potentially decrease the 
incidence of cross-contamination in rendering facilities. 
Introduction 
Annually, the U.S. rendering industry produces ca. 11.2 billion pounds of protein and 
10.9 billion pounds of fats. About 85% of these products are then used in the production of 
animal feed ingredients (Meeker and Hamilton, 2006). While rendered by-products have many 
uses, the primary usage is as an additive to animal feed.  The contamination of the feed can serve 
as a vehicle for pathogenic bacteria, such as Salmonella, to enter the food chain (Crump et al., 
2003; Knox et al., 1963). This was demonstrated by a S. Heidelberg outbreak in 1963 that was 
traced back to milk produced from cows infected with the serotype. Microbiological analysis 
revealed that the source of the infection in the cattle was the meat and bone meal used as an 
additive in the feed (Knox et al., 1963).   
The presence of Salmonella has been documented in finished rendered by-products as 
well as in enivornmental swab samples from the rendering facilities (Kinley et al., 2009; Hofacre 
et al., 2001; Loken et al., 1968). Troutt et al. (2001) detected 12 different serotypes of 
Salmonella spp. in raw materials derived from animal production and processing, materials from 
the cooking/expelling process, and in final rendered products. Recently, in an analysis of ca. 200 
rendered animal products collected from 12 processing plants in the U.S., we detected 13 
Salmonella serotypes with an overall contamination rate of 8.7% (Kinley et al., 2009). Four 
serotypes, Johannesburg, Oranienburg, Putten, and Senftenberg, detected matched those reported 
by Troutt et al. (2001). 
It is likely that the presence of Salmonella in rendered animal by-products is due to post-
processing contamination (Kinley, 2009). To prevent cross-contamination by Salmonella in the 
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rendering environment, the most commonly used treatments on surfaces include using chemical 
sanitizers (bleach and trisodium phosphate) or in rendered animal meal by adding chemical or 
biological feed additives such as Sal Curb®, propionic acid, sorbic acid, acetic acid, and benzoic 
acid (Larsen et al., 1993).  
Bacteriophages, viruses of specific bacterial hosts, have been used as a biological control 
method for various applications. Several studies have demonstrated that bacteriophage treatment 
can be very effective against Salmonella contamination. Modi et al. (2001) demonstrated that the 
addition of bacteriophage to a cheddar cheese starter culture significantly reduced the risk of 
contamination in the final product. Whichard et al. (2003) reported that Felix 01 bacteriophage 
can be used to control S. Typhimurium contamination on chicken frankfurters. A study by 
Leverentz et al. (2001) reported that bacteriophages reduced Salmonella contamination on fresh 
cut honey-dew melon by 3.5 logs at 5°C and 10°C, and a 2.5 log reduction at 20°C. Additionally, 
the simultaneous use of two different bacteriophages against three Salmonella serotypes has been 
shown to reduce Salmonella populations in sprout seeds by ca. 0.5 log (Pao, 2004). Currently, 
there is a lack of information on bacteriophage application in rendering environments or in 
finished animal by-products. 
The purpose of this study was to develop a bacteriophage cocktail capable of effectively 
reducing Salmonella contamination on environmental surfaces found within the rendering plant 
environment. 
Materials and Methods 
Bacteriophage isolation. Bacteriophages were isolated from raw chicken offal using 12 
Salmonella serotypes (Senftenberg, Oranienburg, Idikan, Johannesburg, IIIa. 42: z4, z23, 
Banana, Demerara, Putten, Molade, Montevideo, Mbandaka, Livingstone, and Amsterdam) 
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previously isolated from finished rendered by-products as host strains. Each individual culture 
was mixed with the raw material and double strength tryptic soy broth (DS-TSB, Becton-
Dickinson and company, Sparks, MD), and incubated for 24 h at 37°C. The culture was then 
centrifuged and the supernatant was filtered using a 0.2 µm syringe filter (VWR). The 
supernatant was spot plated onto tryptic soy agar (TSA, Becton-Dickinson and Company) with 
an overlay containing the respective Salmonella serotype used to propagate the bacteriophage. 
The resulting plaques were removed using a sterile 1 ml pipette and suspended in sterile SM 
buffer (5.8g l-1 NaCl, 2g l-1 MgSO4*7H20, and 1M pH 2.5 50ml l-1 Tris-HCl). The bacteriophages 
were purified by repeating the process of suspending the agar plugs in sterile SM buffer for 1 h 
and replating on a TSA plate overlayed with the respective Salmonella serotype twice. After 
purification, the resulting plaques were suspended in SM buffer and incubated at 4°C for 24 h. 
Following incubation, the suspension was removed with a sterile pipette and syringe filtered (0.2 
µm). The resulting bacteriophage suspension was stored at 4°C and used to produce stocks. 
Bacteriophage FO was kindly provided by the University of Calgary and a stock solution 
was prepared as described above.  The host strain for this bacteriophage during this study was S. 
Idikan. 
Bacteriophage preparation. The host strain for each bacteriophage was grown in tryptic 
soy broth (TSB) overnight, and one milliliter of the culture was inoculated into 250 ml of fresh 
TSB. The bacteriophage was added to the TSB at a multiplicity of infection (MOI) of 0.1, and 
the suspensions were incubated with agitation (3 rpm) at 37°C for ca. 4-5 h. Chloroform was 
added to the suspensions, and then after incubation at 37°C for 10 min, the suspension was 
vacuum filtered using a disposable water filtration unit (Nalgene, 0.45µm). The filtered solution 
was centrifuged at 70,000 x g for 90 min. The pellet was resuspended in 5 ml of SM buffer, and 
 115 
 
incubated at 37°C for 1 h. The filtered bacteriophage solution yielded a titre of 1010 to 1012 
PFU/ml. 
Transmission electron microscopy: Copper grids (400 mesh, EMS, Hatfield, PA) were 
coated with 0.5% formvar dissolved in dichloroethane (Fischer, Fairlong, NJ).  Dried grids were 
placed on parafilm (American National Can, Menasha, WI) and 5 µl of phage solution (1010 
PFU/ml) was pipetted on the surface for 1 min.  The liquid was drawn off with filter paper and 
the grid was stained for 30 seconds with 5 µl of 0.5% phosphotungstic acid (PTA; EMS, 
Hatfield, PA) or 2% uranyl acetate (UA; EMS, PA).  Grids were air-dried and viewed on a 
Hitachi H-7600 electron microscope (Hitachi, Tokyo, Japan) at 120-keV accelerating voltage. 
Bacteriophage cocktail optimization. Two commonly isolated Salmonella serotypes 
(Typhimurium and Enteritidis) and three previously isolated serotypes from rendered products 
(Idikan, Mbandaka, and Johannesburg) were used for this study. For each of these isolates, at 
least one bacteriophage was selected based on a series of host range testing. Briefly, all 
bacteriophages were spotted onto TSA overlayed with every Salmonella serotype being tested. 
The lytic activity of each bacteriophage was determined by the amount of lysis observed on the 
plate. Before combining the bacteriophage isolates into a cocktail, the MOI needed for complete 
lysis was determined for each bacteriophage individually by plating a series of dilutions of each 
bacteriophage onto a TSA plate overlayed with its individual targeted Salmonella serotype. The 
lowest concentration of bacteriophage that resulted in complete lysis was then used to compose 
the bacteriophage cocktail.   
To determine if the cocktail was effective, each Salmonella serotype was diluted in TSB 
and transferred to a 96-well microplate. SM buffer was added to the control group and each 
bacteriophage was added to the serotype it was selected for at the previously determined 
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concentration. The microplate was incubated at room temperature and O.D. readings were 
determined at 600 nm using a µQuant™ spectrophotometer (Bio-Tek Winooski, VT) at set time 
intervals. This procedure was carried out on each serotype and a mixture of the serotypes using 
the bacteriophage cocktail at MOIs of 1, 10, and 50. 
Attaching Salmonella to environmental surface materials. Stainless steel, concrete, 
high density polyethylene (HDPE) plastic, and rubber were cut into 25 cm2 templates. The 
stainless steel templates were washed with acetone, etched by submerging the templates in 5N 
HCl for 15 min, washed with Micro-90® (International Products Association Burlingotn, NJ) 
detergent, and rinsed with sterile nanopure water (Joseph et al., 2001). The concrete templates 
were cleaned using a scrubbing brush and rinsed with sterile nanopure water. Both HDPE plastic 
and rubber templates were washed with a detergent and rinsed with sterile nanopure water. 
 Each dry template was inoculated with the mixture of 5 Salmonella serotypes by 
spreading the suspension over the entire template surface using a sterile inoculating loop to yield 
an initial concentration of ca. 105 CFU/cm2. The templates were allowed to air-dry for ca. 6 h at 
room temperature inside of a purifier class II biosafety cabinet (Labconco Kansas City, MO). To 
remove unattached cells, templates were washed once with 10 ml sterile phosphate buffered 
saline (PBS). The templates were transferred to petri dishes containing a mixture of TSB and SM 
buffer using sterile forceps.  
The effect of nutrient debris on surfaces with attached bacterial cells was also studied. 
The Salmonella cocktail was mixed into the liquefied raw material (raw chicken offal mixed and 
ground with sterile saline 1:1), spread over the templates, and air-dried to yield an initial 
concentration of 105 CFU/cm2, as described above. 
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Biofilm formation on the environmental surfaces. A green fluorescent protein (gfp) 
labeled S. Enteritidis H4717 was used for biofilm studies. This organism contains a plasmid 
encoded with ampicillin resistance 100µg/ml. To produce a single species biofilm, the templates 
were submerged in 30 ml of 20% TSB with ampicillin (100 µg/ml) that was inoculated with the 
S. Enteritidis at a concentration of 105 CFU/ml and incubated at 30°C for 6 days. The templates 
were removed every other day, washed with sterile PBS, and placed back into fresh 20% TSB. 
To produce the multiple species biofilm, the templates were submerged in 30 ml of 20% TSB, 
which was inoculated with the gfp-labeled S. Enteritidis H4717 and Pseudomonas aeruginosa at 
a concentration of 105 CFU/ml for each culture, and incubated at 30°C for 6 days. The templates 
were handled in the same manner as those with the single species biofilm.  
 Bacteriophage treatment of artificially contaminated environmental surfaces. For 
bacteriophage treatment of templates with attached cells, the templates were suspended in the 
mixture of SM buffer and TSB inside a petri dish. The bacteriophage cocktail was added to the 
solution at a final concentration of 106 PFU/ml. The control templates were treated with SM 
buffer instead of the bacteriophage cocktail. The templates were incubated at 20, 30, and 40°C, 
and removed at pre-determined time intervals. At each sampling time, the surfaces of the 
templates were swabbed thoroughly using a sterile cotton swab, and then transferred into sterile 
saline. The suspension was centrifuged for 10 min at 5,100 rpm to separate bacterial cells from 
remaining bacteriophage particles. The supernatant was decanted and bacterial cells were 
resuspended and serially diluted with sterile saline. All dilutions were spiral-plated onto TSA 
with an Autoplate 4000 (Spiral Biotech Norwood, MA), and incubated at 37°C for 24 h. 
 Biofilm templates were analyzed using the same procedure as described above, with one 
exception. After the addition of the bacteriophage cocktail, the templates were either incubated at 
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37°C for 15 min to produce biofilms with absorbed bacteriophage, or the templates were directly 
incubated at the test temperatures (unabsorbed bacteriophage). Salmonella populations were 
determined as described above. When analyzing the multiple species biofilm containing P. 
aeruginosa, Salmonella was enumerated with xylose lysine tergitol-4 plates (XLT-4, Becton-
Dickinson and company). 
Confocal imaging of the surfaces with single and multi-species biofilms treated with 
bacteriophages. After bacteriophage treatment at 30°C, templates containing biofilm were 
viewed using a confocal scanning laser microscope (LSM 510, Karl Zeiss, Germany) equipped 
with an argon laser (458, 477, 488, and 514 nm) and two HeNe lasers (543 and 633 nm) along 
with untreated templates to visualize the effect the bacteriophage had on the biofilm. The PMT1 
emmision filters were set at band pass (BP) of 505-520 nm and long pass filter (LP) of 580 nm to 
detect the gfp-labeled Salmonella cells. 
Chemical treatment of environmental surfaces artificially contaminated with 
Salmonella. For comparative purposes, two chemical sanitizers were used to treat the 
environmental surfaces containing the attached Salmonella, attached Salmonella with organic 
material, single-species biofilm, and double-species biofilm. The two chemicals were bleach 
solution (Clorox®), containing 200 ppm sodium hypochlorite, and 12% trisodium phosphate 
(TSP). The treatment procedure was performed as described for the bacteriophage treatment, 
except chemical sanitizers were substituted for the bacteriophage cocktail. 
Statistical analysis. All plate count data were converted into log values.  The mean 
Salmonella counts and standard deviations were determined for control and experimental 
samples for each method of treatment at all temperatures. The data were subjected to analysis of 
variance with a test criterion (F statistic) and type I error controlled at P = 0.05.  The Tukey’s 
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multiple comparison procedure of the Statistical Analysis System (SAS 2001, Cary, NC.) was 
used to compare all pairs of means when the test criterion for the analysis of variance was 
significant. 
Results 
 Bacteriophages were isolated from raw chicken offal for every Salmonella serotype used (n=12).. 
The number of bacteriophages isolated for each serotype is shown in Table 1. Two of those 
bacteriophages (JC1 and MbE2) were selected to produce a cocktail based on their lytic activity against 
S. Typhimurium, S. Enteritidis, S. Idikan, S. Mbandaka, and S. Johannesburg. The other three 
bacteriophages included 2 previously isolated from raw sewage (H3353S6p2 and H4717S5p2) and the 
FO bacteriophage. The TEM images of 4 of the bacteriophages (excluding FO)  are presented in Fig. 1. 
The presence of a contractile tail for M226 and H4717S5p2 suggest that they belong to the family 
of Myoviridae. Bacteriophage J161 and H3353S6p2 had flexible non-contractile tails and were of 
the family Siphoviridae. 
The MOI optimization study indicated that increasing the MOI from 1 to 10 enhanced the 
lytic activity of the bacteriophage; however, a MOI of 50 did not increase (P>0.05) the efficacy 
of the bacteriophage cocktail (Fig. 3.2a). MOI optimization also revealed that the cocktail’s lytic 
activity was only sustained for a 12 h period. The addition of a different bacteriophage cocktail 
with a MOI of 10 was shown to extend the lytic activity for an additional 12 h (Fig. 3.2b).  
 An initial trial was conducted to determine the effect of residual bacteriophage particles 
on Salmonella enumeration following bacteriophage treatment. Following treatment on stainless 
steel at 30°C, Salmonella populations were compared when the sample suspension was directly 
plated with when it was centrifuged to remove the remaining bacteriophage. The results (Table 
3.2) showed an insignificant difference (P>0.05) between the two sampling procedures; however, 
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to ensure there was no prolonged effect, samples collected during the current study were 
centrifuged prior to plating for Salmonella enumeration. 
The bacteriophage cocktail reduced levels of the attached Salmonella on all surface 
material at all tested temperatures (Fig. 3.3). Bacteriophage treatment reduced Salmonella levels 
by ca. 1.0, 2.0-2.5, and 1.5-2.0 log CFU/cm2 at 20, 30, and 40°C, respectively, within 6 h for all 
templates. The level of reduction was significant (P<0.05) for all temperatures on all surfaces 
(Table 3.3). The presence of an organic layer had no observed effect on the efficacy of the 
bacteriophage cocktail (Table 3.3). Salmonella reduction within the organic layer when treated 
with the bacteriophage was also significant (P<0.05) at all temperatures and on all surfaces. 
 The bacteriophage cocktail was also capable of reducing the amount of Salmonella 
Enteritidis H4717-gfp within an attached biofilm on all surfaces at the tested temperatures (Table 
3.3). GFP-labeled S. Enteritidis H4717 was reduced by ca. 1.5-2.0, 2.0-4.0, and 1.0-1.5 log 
CFU/cm2 at 20, 30, and 40°C respectively for all templates. As observed with the attached cells, 
the bacteriophage cocktail reduced Salmonella levels (P<0.05) in biofilm at the tested 
temperatures. Allowing absorption into the biofilm prior to incubation had no observable impact 
on the efficacy of the bacteriophage (data not shown). The effect of the bacteriophage cocktail on 
S. Enteritidis H4717-gfp within the biofilm can also be observed in the confocal images (Figure 
3.4). On the treated slide (Fig. 3.4(c)) there is less gfp-labeled Salmonella cells detected by the 
confocal microscope than seen in the control (b) and initial biofilm (a) samples. 
 The bacteriophage treatment of Salmonella embedded in a double species biofilm was not 
as effective when compared to the bacteriophage treatment of the single species biofilm (Fig. 
3.4); however, the bacteriophage still significantly reduced the level of S. Enteritidis H4717-gfp 
(P<0.05) within the biofilm on all surfaces and at all temperatures. S. Enteritidis H4717-gfp was 
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reduced by ca. 0.5, 1.5-2.0, and 0.5 log CFU/cm2 at 20, 30, and 40°C, respectively, for all 
templates (Table 3.3). As observed with other treatments, the bacteriophage cocktail was most 
effective at 30°C.  
 Treatment of the attached cells with the chemical sanitizers TSP and bleach solution  
resulted in Salmonella counts below the detection limit (1 CFU/cm2 ) within 1 and 3 h, 
respectively. In the presence of an organic layer, the attached Salmonella populations were 
reduced below the detection limit within 1 h for TSP. For bleach solution treatment, there was an 
initial decrease in Salmonella counts through 2 h followed by a period of growth through the 
remaining 4 h of treatment. Treatment of Salmonella in single and double species biofilm 
resulted in counts below the detection limit within 3 h for TSP and within 6 h for bleach solution 
(data not shown). 
Discussion 
The presence of Salmonella spp. in finished by-products can be a result of Salmonella 
surviving the heat processing or post-processing contamination. It is documented that the raw 
ingredients used to produce rendered by-products are contaminated with Salmonella and 
therefore serve as a potential source of cross contamination in the rendering facility (Troutt et al., 
2001; Loken et al. 1968). 
If contaminated, the environmental surfaces (steel, concrete, rubber, and HDPE plastic) 
can also contaminate the final products upon contact. Kusumaningrum et al. (2003) reported that 
Salmonella is capable of adhering to stainless steel, and that the presence of food residues 
increased the survival time of the bacteria. For example, when a low inoculum of S. Enteritidis 
was spread on the stainless steel with no food particles there was a 2.2 log reduction within an 
hour as compared with a 1.0 log reduction in the presence of milk residue. Additionally, 
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Kusumaningrum et al. (2003) demonstrated that the S. Enteritidis could be transferred from the 
steel to cucumber slices and chicken filets immediately or 15 minutes after contamination. 
Identical S. Typhimurium isolates were detected on a rubber conveyor belt used to transport 
manure 20 months after initial isolation (Sanvang et al., 2000), suggesting that the strain 
persisted on the conveyor belt over this extended period. Loken et al. (1968) detected Salmonella 
in 19% of 1901 swabs collected from the environmental surface of a rendering facility, which 
further demonstrates the potential for cross contamination between the environment and finished 
products.  
Traditionally the environments in food processing facilities have been treated with 
chemical sanitizers. These sanitizers have been effective but have some disadvantages such as 
high cost, corrosiveness to machinery, inactivated by organic material, inactivated by variations 
in heat and pH, and posing a potential hazard to the environment and the workers (Marriott, 
1994). This warrants the development of a new means of sanitation in the food processing 
industry such as bacteriophage treatment.  
The use of bacteriophages offers multiple advantages: the host specificity is not likely to 
select for bacteriophage resistant bacterial strains, resistance against bacteriophage does not 
affect the efficacy of antibiotics given to humans, and bacteriophage mixtures can be easily 
modified and rapidly developed against resistant bacteria (Kutter and Sulakvelidze, 2005). In 
terms of Salmonella treatment, host specificity can be a hurdle for reducing contamination levels. 
There is not a single bacteriophage capable of lysing all known serovars of Salmonella (Joerger, 
2003). In fact, a particular bacteriophage may not even be capable of lysing all members of a 
particular serovar. To overcome this shortcoming, a “cocktail” of bacteriophages must be 
designed capable of lysing all Salmonella strains of interest (Joerger 2003). The production of an 
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effective bacteriophage cocktail for Salmonella has been previously reported. Chighladze et al. 
reported to have developed a bacteriophage cocktail capable of lysing 232 of 245 Salmonella 
isolates composed of 21 serovars and 78 pulse field gel electrophoresis (PFGE) types (Joerger 
2003). 
Bacteriophage treatment for pathogen inactivation has been considered a very effective 
biological control method. While the majority of research involving Salmonella treatment with 
bacteriophage has focused on live animals and raw meats, it has been demonstrated that 
bacteriophage treatment can be successful at controlling contamination on environmental 
surfaces. Roy et al. (1993) applied a mixture of three bacteriophages (H387, H387-A, and 2671) 
to treat L. monocytogenes on stainless steel resulting in a 3 log reduction of L. monocytogenes 
populations. There have been limited reports on the treatment of Salmonella on environmental 
surfaces by bacteriophages; however, Chigaldze et al. were able to reduce Salmonella to below 
the detectable limit within 48 h of bacteriophage treatment on inanimate surfaces (Joerger, 
2003). In the current study, the bacteriophage cocktail was able to reduce Salmonella by as much 
as 2.5 log
 
at 30°C. MOI optimization suggested that in order for bacteriophages to propagate and 
lyse the host, the bacterial cells should be actively growing. This could be explained by the 
reliance of bacteriophages on host cell machinery for replication (Kutter and Sulakvelidze, 
2005). This could also explain the variation in the efficacy of the bacteriophage treatment based 
on the environmental temperature.  
MOI optimization during this study revealed that the bacteriophage cocktail used was 
capable of reducing Salmonella levels at a low ratio (MOI=10), but the lytic effects of the 
cocktail diminished after ca. 12 h of treatment (Fig. 3.2a). McLaughlin et al. (2007) reported that 
a single bacteriophage was incapable of eliminating Salmonella due to selection of resistant 
 124 
 
strains. The presence of a resistant strain within the Salmonella spp. offers a possible explanation 
for the decreased lytic activity. While a short lytic period is not desirable, in this study, the 
addition of a second cocktail composed of 5 different bacteriophages resulted in suppression of 
Salmonella growth for an additional 12 h (Fig. 3.2b).  
In the natural environment, bacteria may be attached to environmental surfaces as 
components of a large microbial network known as a biofilm. A biofilm can be composed of one 
or various species of bacteria and their excreted products. Salmonella spp. are capable of 
producing biofilm on surfaces such as plastic, steel, and cement (Jones and Bradshaw, 1996; 
Joseph et al., 2002), which are commonly found in a rendering facility. Biofilms are potential 
continuous sources for cross-contamination between contact surfaces and the finished rendered 
by-products.  
 In order for a bacteriophage to lyse bacteria within a biofilm the target bacteria have to 
be susceptible to the bacteriophage being used. Also, the exopolysaccharide (EPS) produced by 
the biofilm must be susceptible to degredation by the polysaccharide depolymerase produced by 
the bacteriophage. The effects of bacteriophage treatment on single species biofilms have been 
well documented.  Using microscopy, Doolittle et al. (1995) discovered that the matrix produced 
by an Escherichia coli biofilm was ineffective in preventing bacteriophage T4 from infecting the 
bacterial cells. Karunasagar (2007) demonstrated that when using a bacteriophage concentration 
of 105 PFU/ml, Vibrio harveyi counts were reduced nearly 1 log CFU/cm2 after 18 h on high 
density polyethylene (HDPE) plastic. Bacteriophage KH1 was able to significantly reduce 
(P<0.05) E. coli O157:H7 counts in biofilms from an initial concentration of 4.0 log CFU per 
coupon to 2.8 log CFU per coupon and 2.7 log CFU per coupon after 24 and 48 h of 
bacteriophage treatment, respectively (Sharma et al., 2005). The results from our study revealed 
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that Salmonella levels can also be reduced in a single species biofilm through bacteriophage 
treatment. Under optimal conditions (30°C), the bacteriophage cocktail was capable of reducing 
S. Enteritidis within the biofilm by ca. 3 log CFU/cm2. While the level of reduction observed in 
this study is in agreement with other studies, the effect observed during the current study 
occurred within 6 h as opposed to the 18-48 h range reported by previous studies. 
  Biofilms composed of multiple bacterial species may contain additional barriers such as 
bacterial cell co-aggregation (Rickard et al., 2003; Sutherland 2004). Storey and Ashbolt (2001) 
attempted to treat biofilm composed of Bacteroides fragilis and E. coli in an urban water 
distribution system with bacteriophages. The bacteriophages were initially taken in by the 
biofilm on stainless steel and polythene surfaces; however, following the initial treatment, 
bacteriophage populations began to decrease rapidly, suggesting that the bacteriophages were 
entering the biofilm matrix but not infecting the host cells. Our current study also demonstrates 
that the presence of multiple species within a biofilm may create additional barriers for the 
bacteriophage treatment, as the addition of P. aeruginosa to the biofilm decreased the amount of 
Salmonella reduction as compared with single-species biofilm.  
  In this study the effectiveness of the bacteriophage cocktail was also compared to that of 
commonly used chemical sanitizers in order to determine if the bacteriohage cocktail would 
make an adequate replacement. Bleach solution (200 ppm sodium hypochlorite) and TSP were 
selected based on a survey of participating rendering facilities (Robertson, 2008). Our results 
indicated that both the bleach solution and TSP were more effective at reducing Salmonella 
contamination than the bacteriophage treatment. Salmonella inactivation by both sanitizers was 
achieved within 1 h for both attachment studies and within 3 h for both the single and double 
species biofilm. The one exception was that the bleach solution was ineffective at treating the 
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attached Salmonella cells in the presence of organic material, which can be explained by the fact 
that chlorine based compounds have a high affinity to bind to organic material. Once bound to 
organic material the compounds are inactivated (Guthrie, 1992). As compared with chemical 
sainitizers, bacteriophages are not corrosive to quipment and are not harmful to the environment 
like many chemical sanitizers do (Kutter and Sulakvelidze, 2005). The bacteriophages are cost 
efficient since they are self replicating and only require actively growing host cells. Furthermore, 
the rendering plant also has a continuous source for new bacteriophages in the incoming raw 
material, as a bacteriophage capable of lysing all Salmonella serotypes of interest was easily 
isolated from the raw material as demonstrated by this study.  
 This study has demonstrated that a bacteriophage cocktail can be used to reduce 
Salmonella on the surfaces found within a rendering facility at various temperatures and in 
various forms of attachment. Up to 3 log CFU/cm2 of Salmonella can be inactivated by the 
bacteriophage cocktail within 6 h of treatment when the temperature was maintained between 20 
and 40°C. By reducing or eliminating the amount of Salmonella contamination found within the 
rendering environment, the bacteriophage treatment may decrease the potential for cross-
contamination leading to a microbiologically safe animal meal. The treatment can be used 
without any concern for potential hazards to the finished animal meal, rendering equipment, 
humans, or the animals consuming the finished feed. While more work is needed with multi-
species biofilm, the data presented in this study suggests that bacteriophage treatment can be 
used by the rendering industry to lower contamination levels of not only Salmonella but any 
pathogens of concern. 
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Figure Legend 
 
Fig. 3.1. Transmission electron microscopic images of individual bacteriophages. J161 (a), M226 
(b), H3353S6p2(c), and H4717S5p2 (d) observed at 100,000X. 
Fig. 3.2. MOI optimization of the bacteriophage cocktail with one application of cocktail (a) and 
two cocktails (b). Control (×), MOI 1 (▲), MOI 10 (■), and MOI 100 (♦). “  “ on (b) signals the 
addition of the 2nd cocktail. 
Fig. 3.3. Bacteriophage treatment of Salmonella attached to concrete (a), plastic (b), rubber (c), 
and steel (d) at 20° (♦), 30° (▲), and 40°C (●). Control and treatment were plotted in solid and 
dashed lines, respectively. 
Fig. 3.4. Confocal images of single and double species biofilm on stainless steel at 0h (a, d), 6h 
of control (b, e), and 6h of bacteriophage treatment (c, f). 
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Table 3.1. Bacteriophages isolated from chicken offal 
    Offal Sample Treatments        Serotypes Affected Bacteriophage ID 
A A1 5*, 6, 7, 12, 16 IA1, JA1, LA1, OA1, TA1 
A2 7, 12, 16 LA2, OA2, TA2 
B B1 1, 6, 7, 10, 11, 12, 16 AB1, JB1, LB1, MolB1, MonB1, OB1, TB1 
B2 1, 3, 6, 7, 10, 11, 12, 16 AB2, DB2, JB2, LB2, MolB2, MonB2,  
C C1 2, 6, 7, 12, 13, 16 BC1, JC1**, LC1, OC1, PC1, TC1 
C2 2, 3, 7, 12, 13, 16 BC2, DC2, LC2, OC2, PC2, TC2 
D D1 1, 3, 5, 6, 7, 9, 12, 13, 16 AD1, DD1, ID1, JD1, LD1, MbD1, OD1, PD1, TD1 
D2 1, 3, 7, 9, 12, 13, 16 AD2, DD2, LD2, MbD2, OD2, PD2, TD2 
E E1 1, 2, 3, 6, 7, 9, 12, 13 ,15, 16 AE1, BE1, DE1, JE1, LE1, MbE1, OE1, PE1, SE1, TE1 
E2 
1, 2, 3, 5, 6, 7, 9, 12, 13, 15, 
16 AE2, BE2, DE2, IE2, JE2, LE2, MbE2, PE2, SE2, TE2 
F F1 2, 3, 6, 7, 12, 16 BF1, DF1, JF1, OF1, TF1 
  F2 2, 3, 6, 7, 12, 16 BF2, DF2, JF2, LF2, OF2, TF2 
*Salmonella serotpye: 1. S. Amsterdam, 2. S. Banana, 3. S. Demerara, 4. S. Enteritidis, 5. S. Idikan, 6. S. Johannesburg, 7. S. Livingstone, 8-9. S. Mbandaka, 
10. S. Molade, 11. S. Montevideo, 12. S. Oranienburg, 13. S. Putten, 14-15. S. Senftenberg 16. S. Typhimurium 
**Bold print indicates the bacteriophage was used during treatment studies 
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Table 3.2. Effect of residual bacteriophage on Salmonella enumeration 
Time (h) Non-centrifuged Centrifuged 
1 2.93*±0.07A** 3.09±0.07A 
2 2.76±0.06A 2.85±0.08A 
3 2.69±0.09A 2.71±0.06A 
4 2.41±0.12A 2.52±0.08A 
5 2.28±0.05A 2.37±0.05A 
6 2.19±0.09A 2.24±0.05A 
*log CFU/cm2 
** The letters represent the levels of significant difference (P<0.05) between the two test groups
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Table 3.3. Salmonella levels following 6 h of bacteriophage treatment (MOI 10) on various surface templates as affected by temperature 
    20°C 30°C 40°C 
Contamination Surface Control Treatment Control Treatment Control Treatment 
Attachment 
in buffer 
 
 
 
Concrete 3.67*±0.15A** 2.50±0.22B 3.97±0.16A 1.97±0.18B 3.92±0.13A 2.35±0.18B 
Plastic 3.68±0.22A 2.34±0.13B 4.19±0.09A 2.11±0.13B 3.84±0.19A 2.06±0.13B 
Rubber 3.47±0.20A 2.29±0.06B 4.04±0.14A 1.56±0.20B 3.90±0.10A 2.03±0.15B 
Steel 3.55±0.09A 2.25±0.13B 4.22±0.11A 2.22±0.20B 3.92±0.19A 2.18±0.14B 
Attachment 
in organic layer 
 
 
Concrete 3.84±0.09A 2.65±0.19B 4.06±0.10A 1.79±0.15B 4.17±0.12A 2.95±0.14B 
Plastic 3.56±0.17A 2.34±0.12B 3.82±0.23A 1.87±0.14B 3.88±0.10A 2.41±0.19B 
Rubber 3.62±0.17A 2.59±0.21B 4.43±0.22A 1.78±0.20B 3.96±0.23A 2.16±0.12B 
Steel 4.03±0.10A 2.62±0.16B 4.28±0.08A 2.21±0.12B 4.03±0.10A 2.39±0.10B 
Single Species 
Biofilm 
 
 
 
Concrete 5.03±0.10A 3.59±0.12B 5.46±0.17A 2.47±0.10B 4.48±0.12A 3.30±0.19B 
Plastic 5.02±0.09A 3.24±0.15B 5.79±0.10A 2.06±0.15B 4.78±0.09A 3.19±0.08B 
Rubber 5.05±0.09A 3.43±0.14B 5.52±0.12A 3.73±0.16B 4.47±0.10A 3.20±0.14B 
Steel 4.97±0.14A 3.01±0.08B 5.63±0.19A 2.82±0.19B 4.57±0.11A 3.36±0.17B 
Double Species 
Biofilm 
Concrete 4.85±0.18A 4.50±0.14B 5.24±0.12A 3.74±0.15B 4.84±0.16A 4.41±0.19B 
Plastic 4.56±0.09A 4.20±0.09B 4.89±0.16A 3.05±0.10B 4.53±0.10A 4.17±0.12B 
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Rubber 4.47±0.11A 4.07±0.12B 4.97±0.14A 3.44±0.15B 4.59±0.16A 4.18±0.08B 
Steel 4.78±0.22A 4.49±0.12B 4.84±0.13A 3.04±0.09B 4.43±0.10A 4.04±0.13B 
*Salmonella counts CFU/cm
2 1 
 2 
**The different letters represent significant differences (P<0.05) between  the control group and treated group after 6 h incubation3 
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a)   b)  
c)  d)  
 
 
 
 
Figure 3.1 
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a)  d)  
b)  e)  
c)  f)  
 
 
 
 
Figure 3.4 
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CHAPTER 4 
BACTERIOPHAGE TREATMENT OF RAW CHICKEN OFFAL, RENDERED ANIMAL 
MEALS, AND MICE CHALLENGED WITH SALMONELLA ENTERITIDIS 
 
Abstract 
 The objectives of this study were to determine if a bacteriophage cocktail could be used 
either to reduce Salmonella in the raw material used by the rendering industry or as a feed 
additive to reduce Salmonella infection in animals. A cocktail of 5 previously isolated 
bacteriophages with a multiplicity of infection (MOI) of 10 and 100 was used to treat sterile and 
non-sterile raw material contaminated with a Salmonella cocktail (ca. 105 CFU/g) at 20°, 30°, 
and 40°C. The bacteriophage treatment reduced Salmonella levels by 2.0, 2.7, and 2.5 log CFU/g 
at 20°, 30°, and 40°C in the sterile poultry offal samples, as compared with a 2.0, 2.2, and 2.2 log 
CFU/g reduction, respectively, in the non-sterile samples. Bacteriophage stability testing 
indicated that the titer of lyophilized bacteriophages mixed in animal meals decreased by 1.5 log 
PFU/g at 30°C, while fresh bacteriophage levels decreased by ca. 0.23 log PFU/g at 4°C over 4 
weeks. The lyophilized bacteriophage did not reduce Salmonella levels in the animal meals 
during storage at 30°C, but Salmonella growth was slowed down during the rehydration step. 
During the 4-week trial, the difference in Salmonella levels after rehydration for 24 h between 
those samples treated with lyophilized bacteriophage and those not treated ranged from 0.8-1.5 
and 1.0-2.0 log CFU/g when using a MOI of 10 and 100, respectively. The addition of fresh 
bacteriophages to the rehydrated meals was able to reduce Salmonella levels by ca. 1.0 log 
CFU/g at 30°C. The bacteriophage was also tested for reducing Salmonella infection of Balb/c 
mice. Mice receiving feed supplemented with the bacteriophage cocktail (MOI of 100) showed 
no signs of infections (shedding in feces or histological analysis), while mice not receiving the 
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bacteriophages shed Salmonella in the feces for a period of 2.5 weeks and histological 
examination revealed signs of inflammation in the liver.  These results indicate that the 
bacteriophage cocktail can be used to significantly reduce Salmonella levels in raw chicken offal, 
which reduces the probability of cross-contamination, and can be used as an effective feed 
additive if added in liquid form shortly before consumption by animals. 
Introduction 
In the U.S., approximately, 100 million hogs, 35 million cattle, and 8 billion chickens are 
slaughtered for consumption annually, resulting in a large quantity of inedible by-products 
(Meeker and Hamilton, 2006). On average, approximately 50% of an animal is inedible 
(Ockerman and Hansen, 1988; Meeker and Hamilton, 2006). Of the potential treatment methods 
(pyre, incineration, landfill, burial, and rendering), the rendering process is the only method that 
adequately eliminates the biological risks without hazardous environmental impact (Meeker and 
Hamilton et al., 2006; U.K. Department of Health, 2001). 
The raw material coming into a rendering facility can be highly contaminated with 
numerous human pathogens. Troutt et al. (2001) detected Clostridium perfringens, Listeria spp., 
Campylobacter spp., and Salmonella spp. in 71.4, 76.2, 29.8, and 84.5% of raw poultry offal 
samples, respectively. An U.S. federal study conducted between January 1998 and December 
2000 reported the following Salmonella contamination rates: 20% in broilers, 8.7% swine, and 
2.7% for cows and bulls (Rose et al., 2002). The Food Safety Inspection Service (FSIS) of the 
USDA reported Salmonella in ca. 16% of broiler carcasses sampled in 2005 (D’Aoust and 
Maurer, 2007). Salmonella contamination levels ranged from 6.5-7.2 log CFU/g from poultry 
feathers and 5.8-6.3 log CFU/g on poultry carcasses (Kotula and Pandya, 1995). Botteldoorn et 
al. (2003) reported an average Salmonella contamination rate of 37% on swine carcasses at 5 
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different slaughter houses. The rates of Salmonella contamination were as high as 70% 
dependent upon the slaughter house and date of sampling.  
While the raw material may contain Salmonella, the rendering system is adequately 
designed to inactivate pathogen contamination from the raw material. The cookers used to treat 
the incoming material are heated by boiler steam so that the internal temperature of the raw 
material reaches 115 to 145°C (Anderson, 2006). However, Hacking et al. (1992) tested finished 
meat and feather meal from Ontario rendering facilities over a four month period and found 
Salmonella contamination rates of 81% and 40%, respectively. In the U.S., a FDA study 
conducted by McChesney et al. (1995) detected Salmonella enterica in 56% of the 101 meal 
samples tested. Our previous study demonstrated that Salmonella isolates collected from finished 
rendered products were heat sensitive with an average D-value of 45 sec at 65° C (Kinley at al., 
2009), suggesting the finished products may have been contaminated with Salmonella post-
processing. This study also revealed that a persistent strain of Salmonella was not found in the 
finished products of a given rendering facility using pulse field gel electrophoresis (PFGE) 
analysis (Kinley et al., 2009). This suggests that the cross-contamination is resulting from a new 
incoming source such as the raw material. 
Regardless of the source, the finished product can serve as a reservoir for Salmonella 
contamination which will then be incorporated into animal feed and into the food chain. 
Epidemiological studies have linked human Salmonella spp. to contaminated animal feed 
(Crump et al. 2002).  For example, a S. Heidelberg outbreak in 1963 led to 77 infections from 
milk consumption, which was linked to bovine mastitis caused by the same Salmonella serotype, 
which was found in the meat and bone meal fed to the cows (Knox et al. 1963).   
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Currently, bacterial feed contamination is treated through organic feed additives such as 
Sal Curb®. Larsen et al. (1993) demonstrated that the addition of Sal Curb® to poultry feed 
reduced Salmonella by ca. 2 log CFU/g. Opitz et al. (1993) further demonstrated that when 
added into poultry feed Sal Curb® can significantly (P<0.05) reduce the rate of S. Enteritidis 
infection in chicks; however, the levels of S. Enteritidis in the feces of infected chicks (1.18 log 
CFU/g) were not significantly less than the control. In addition to Sal Curb®, Opitz et al. (1993) 
tested the potential of probiotics [Primalac®, egg powder, lactose, and Lactobacillus acidophilus 
(Lactbio®)] as anti-Salmonella feed additives. They found that none of the tested additives 
significantly (P<0.05) reduced the rate of S. Enteritidis infection and reduced levels in those 
animals infected, which led them to conclude none of the tested additives should be solely relied 
upon for prevention of S. Enteritidis infection. 
An alternative to these chemical-based additives is bacteriophages. Bacteriophages, 
viruses with specific bacterial hosts, have been used as a biological agent for pathogen control. 
Recent studies have indicated that bacteriophages can be used as a therapeutic agent for 
Salmonella. Berchieri et al. (1991) applied bacteriophages to reduce the level of Salmonella by 1 
log CFU/g within 12 h in the crop, intestine and cecae of chickens. 
The objectives of this study were to determine if treatment with a bacteriophage can 
reduce Salmonella levels within the raw material used by the rendering industry and if a 
bacteriophage cocktail can potentially be used as a feed additive to reduce Salmonella population 
upon rehydration of the feed in vitro and in vivo. 
Materials and Methods 
Bacteriophage cocktail preparation: The bacteriophage cocktail used during this study 
was composed of five bacteriophages previously isolated and purified from raw chicken offal 
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(n=2), inactivated sludge (n=2), as well as the F0 bacteriophage from the University of Calgary’s 
Salmonella Genetic Stock Centre (Kinley et al., unpublished). The bacteriophage stocks were 
prepared and stored in sterile SM buffer (NaCl 5.8 g l-1, MgSO4·7H20 2 g l-1 & Tris-HCl 1 M, pH 
2.5, 50 ml l-1).  
Sample preparation: Incoming raw chicken offal was collected from a SC rendering 
facility. Upon arrival at the lab, the raw material was mixed with sterile saline (1:1), and blended 
in a sterile laboratory blender (Waring model 51BL30) at Hi speed for 5 min. To enumerate 
Salmonella, serial dilutions of sample suspensions were made using sterile saline and spread 
plated onto xylose lysine tergitol-4 (XLT-4, Becton-Dickinson and company). The blended raw 
material, placed inside 50 ml sterile centrifuge tubes, was then frozen at -80°C for subsequent 
bacteriophage treatment. 
Bacteriophage treatment of raw materials: Half of the prepared raw samples were sent 
to the physics department at Auburn University via overnight delivery, where they were 
irradiated at 1.5 MRad at 6,133 R/min. Both sterile and non-sterile raw material was divided into 
8 ml portions in sterile whirl-pak bags in preparation for bacteriophage treatment. Overnight 
cultures of rifampin resistant (100 µg/ml) Salmonella isolates (Typhimurium, Enteritidis, 
Mbandaka, Johannesburg, and Idikan) were added together as a cocktail and then mixed into the 
sterile and non-sterile raw material at a final concentration of 105 CFU/ml. The bacteriophage 
cocktail was then added to each experimental bag at a final concentration of 106 PFU/ml or 107 
PFU/ml. The same amount of SM buffer was added to the control group in place of the 
bacteriophage cocktail. All samples were then incubated at 20, 30, and 40°C for 6 h. Every hour, 
raw material suspensions were removed and centrifuged (5,000 rpm) for 10 min and the 
supernatant was poured off to separate bacteriophages from the sample. The pellets were then 
 144 
 
washed once in sterile saline and then suspended in sterile saline. Serial dilutions were spiral-
plated with an Autoplate 4000 (Spiral Biotech Norwood, MA) onto XLT-4/rif (100 µg/ml) for 
Salmonella enumeration at 37° C for 24 h.  
Bacteriophage treatment of Salmonella in finished rendered animal meals upon 
rehydration: The bacteriophage cocktail and Salmonella were suspended in sterile 10% skim 
milk and tryptic soy broth (TSB), respectively, and lyophilized using a Vir Tis Model 7.0 freeze 
dryer (SP industries NY) for ca. 24 h. Irradiated (1.5 MRad at 6,133 R/min) blood, feather, and 
poultry meals were divided into four treatment groups each. Group 1 had lyophilized Salmonella 
cocktail added at a concentration of 105 CFU/g. Group 2 had both lyophilized bacteriophage and 
Salmonella cocktails added at concentrations of 106 PFU/g or 107 PFU/g and 105 CFU/g, 
respectively. Group 3 had lyophilized bacteriophage cocktail added at a concentration of 106 
PFU/g or 107 PFU/g. Group 4 had no additives. The samples were kept in sterile whirl-pak bags 
at 30°C for a period of 1 month.  
For the rehydration study, samples from groups 1 and 2 were collected weekly and 
suspended into buffered peptone water. Samples from group 3 and 4 were collected weekly and 
suspended into buffered peptone water that was inoculated with the Salmonella cocktail at a 
concentration of 105 CFU/ml. The samples were incubated at 30°C for 24 h with samples taken 
at pre-determined time intervals. The samples were centrifuged and the supernatant was poured 
off to remove bacteriophages from the sample. The pellets were washed as described for the raw 
meat samples and then suspended in sterile saline. Serial dilutions were made with sterile saline 
and spiral plated onto XLT-4. All plates were incubated at 37°C and enumerated after 24 h. 
An additional trial was conducted as described above with lyophilized bacteriophage at a 
concentration of 106 PFU/g. During this additional study, a second bacteriophage cocktail 
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(suspended in SM buffer) was added to the experimental groups at a MOI of 10 at the 12h 
sampling time.  
Stability of lyophilized bacteriophages in dry meals: In addition to testing the lytic 
effectiveness of the lyophilized bacteriophage, the stability of the bacteriophage cocktail in dry 
meals was determined as well. The supernatant removed during Salmonella enumeration was 
added to molten TSA along with the Salmonella cocktail (105 CFU/ml). The molten TSA was 
overlayed onto TSA and incubated for 24 h at 37°C. Following incubation, plaque counts were 
made to determine the amount of bacteriophage reduction over the course of the month-long 
trial.  
The stability of the liquid phage in the dry rodent feed was also determined at 
refrigeration temperatures (4°C). The bacteriophage cocktail (1 ml) was added to dry, sterile 
rodent feed at a concentration of 108 PFU/g. The feed was kept inside sterile-whirl pak bags at 
4°C for 4 weeks. Samples were removed weekly and suspended in sterile saline. The 
bacteriophage titer was determined as described above using the agar overlay method. 
In vivo study with Balb/c mice: Female Balb/c mice (4-6 weeks, Harlan Laboratories) 
were housed in sterile micro-isolater cages with sterile bedding at the Godley Snell Research 
Center (Clemson, SC). The mice (n=10) were divided into two groups equally. All mice were 
given water containing gentamicin (4 mg/l) to reduce background microbial population. The 
experimental group were given a dough diet (Bio-Serv) supplemented with the bacteriophage 
cocktail at a MOI of 100. The control mice were given the dough diet with no additives. After 7 
days of acclimation, feed was removed for 24 h. Following this 24 h period, all mice were 
anesthetized with 2.5% isofluorane mixed with 1.5% oxygen and orally administered 0.20 ml of 
S. Enteritidis H4717 ( 106 CFU/mouse) using gavage needles. After oral challenge, the mice 
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were returned to their respective diets for a period of 4 weeks. Both the weight and behavior of 
each mouse was observed for the duration of the experiment. All procedures were approved by 
Clemson University’s Institutional Animal Care and Use committee. 
Analysis of Salmonella levels in fecal content during mouse trial: Twenty-four hours 
after arrival of the mice, one gram of feces from each cage was collected aseptically and 
homogenized in sterile saline using a stomacher 400 circulator (Seward) for 5 min. Samples were 
enriched in Rappaport-Vassiliadis (RV) broth for 24 h followed by spread-plating onto XLT-4 to 
ensure the mice were free of Salmonella.  
Feces samples were collected and homogenized from each cage at 24 h post-infection as 
described above. Homogenized samples were centrifuged at 5,000x rpm and the supernatant 
removed. The pellet was washed and resuspended in sterile saline. Serial dilutions were made in 
sterile saline and spiral-plated onto XLT-4/ rif. Salmonella levels were determined following 24 
h incubation at 37°C.  Fecal sampling was conducted in the same manner twice weekly during 
the 4 week trial. 
Analysis of Salmonella levels and histological analysis of intestinal and liver tissue 
collected during the mouse trial: At the end of the 4-week trial, all mice were euthanized using 
isofluorane. The liver and intestine were aseptically removed from 2 mice in each group. 
Approximately 50% of each organ was collected and suspended in sterile saline for Salmonella 
enumeration, and the remaining tissues were sent to the Clemson Veterinary Diagnostic Center 
(Columbia, SC) for histological analysis. 
For enumeration, each tissue sample was weighed out, and one gram samples were 
homogenized in sterile saline using a glass tissue grinder. The homogenized samples were then 
 147 
 
used to make serial dilutions in sterile saline. The dilutions were spiral-plated onto XLT-4/rif and 
incubated at 37°C for 24 h. 
For histological analysis, the tissue samples were fixated in 10% formalin, cut, and 
embedded in paraffin. Cross-sections were mounted on glass slides, air dried, and stained with 
hematoxylin and eosin (H&E). Pathological analysis was then performed on all tissue samples by 
one pathologist. 
Statistical analysis.  All Salmonella counts were converted into log values. The mean 
counts and standard deviations were determined for the samples. The data were subjected to 
analysis of variance with a test criterion (F statistic) and type I error controlled at P = 0.05.  The 
Tukey’s multiple comparison procedure of the Statistical Analysis System (SAS 2001, Cary, 
NC) was used to compare all pairs of means when the test criterion for the analysis of variance 
was significant.  
Results 
 Salmonella enumeration from the raw chicken offal revealed a contamination level of ca. 
105 CFU/g (data not shown). Treatment of the raw chicken offal was effective at both a MOI of 
10 and 100, with no significant difference (P>0.05) in the effectiveness of the two (Fig. 4.1). 
After 6 h of incubation the average differences between Salmonella levels in the bacteriophage 
treated (MOI of 10 and 100) and non-treated groups were ca. 2.0, 2.7, and 2.5 log CFU/g in the 
sterile chicken offal at 20°, 30°, and 40°C, respectively (Fig. 4.1a, b, c). The differences between 
Salmonella levels in the bacteriophage treated (MOI of 10 and 100) and non-treated groups in 
non-sterile offal were ca. 2.0, 2.2, and 2.2 log CFU/g at 20°, 30°, and 40°C, respectively (Fig. 
4.1d, e, f). In the control group, Salmonella grew ca. 0.5 log CFU/g more in the sterile offal as 
compared with the non-sterile offal.  
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Experiments were designed to study the suppressive effect of lyophilized bacteriophage 
on the growth of Salmonella during rehydration of the contaminated animal meals (blood, 
feather, and poultry) (Table 4.1). Salmonella counts in the rendered meals decreased by ca. 1 log 
CFU/g during the 4 week study (Fig. 4.2). During the rehydration step, the changes in 
Salmonella counts within blood meal in the presence of lyophilized bacteriophage (MOI of 10 
and 100) are presented in Table 4.1a. In the blood meal, there was ca. a 1.5, 1.5, 1.0, and 0.8 log 
CFU/g difference between the control and treated (MOI of 10)  samples at weeks 1-4, 
respectively, as compared with  ca. a 2.0, 1.5, 1.5, and 1.0 log CFU/g difference between the 
control and treated samples when using a MOI of 100. The effect of the lyophilized 
bacteriophage on Salmonella in both the feather and poultry meal resulted in similar differences 
(Tables 4.1b-c).  
To determine if the lyophilized bacteriophage can prevent the contamination of animal 
meals during the rehydration step, fresh Salmonella was added to the meals containing the 
bacteriophages (treatment group 3). The level of Salmonella reduction was similar to those 
observed when the Salmonella was already present in the meal (Table 4.1). In both studies, there 
was no significant difference (P>0.05) in Salmonella levels between the control and 
bacteriophage-treated samples in all meals after 24 h (data not shown). 
To determine if a fresh, liquid culture of bacteriophage could reduce Salmonella levels in 
rehydrated animal meals, a different bacteriophage cocktail (MOI of 10) suspended in SM buffer 
was added directly to the meals following 12 h of rehydration (treatment group 1). The 
difference in Salmonella growth in the control and treated samples was in the range of 0.7-1.4 
log CFU/g after the remaining 12 h of incubation. The fresh bacteriophage reduced the amount 
of Salmonella by ca. 1 log CFU/g in all meal types (Table 4.2).  
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Analysis of the stability of the lyophilized bacteriophage cocktail within the dry finished 
meals at 30°C, revealed that the concentration decreased by ca. 1.5 log PFU/g over the 4-week 
test period (Fig. 4.3). Stability testing of the fresh bacteriophage inoculated into the animal feed 
used for the mice study at 4°C revealed that the bacteriophage concentration had ca. a 3% 
decrease (0.23 log PFU/g) over the 4-week trial (Fig. 4.4). 
  To determine the feasibility of using bacteriophage as a feed additive for Salmonella 
control, a small animal study was conducted. Our preliminary study suggested that Salmonella 
infection in mice follows a dose dependent pattern. At inoculation levels of 5x108 Salmonella 
CFU/mouse, all mice were killed by the end of a two week trial. By reducing the initial 
inoculation level to 5x106 CFU/mouse, our animal study revealed that no Salmonella was 
detected in the fecal samples from the experimental group throughout the 4-week trial; however, 
Salmonella was detected in the fecal samples from the control group up to 2.5 weeks (Table 4.3). 
The liver and intestinal tract of both the control and experimental mice were free of Salmonella 
4-weeks post-infection as determined by the plate-counting method. The histological analysis 
gave no indications of inflammation associated with Salmonella infection in the liver and 
intestine of the experimental mice; however, it did reveal venous dilation in the liver of the 
control mice. In the liver of one control sample, monocytes were found in the portal areas and 
cholangiohepatitis was observed. The intestine for the control mice showed no signs of 
inflammation. 
Discussion 
 Salmonella is an important foodborne pathogen affecting the microbial safety of rendered 
animal by-products. A study conducted by Watkins et al. (1959) detected Salmonella in 18.5% of 
the finished rendered products tested; whereas in our previous study, Salmonella was detected in 
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8.7% of the finished rendered samples tested (Kinley et al., 2009). The current study 
demonstrated that the level of Salmonella present in finished product decrease at a rate of 1 log 
CFU/g per month, suggesting the pathogen can persist for long periods of time within these 
products. The presence of Salmonella in the finished products can result from either insufficient 
heat processing or post-processing contamination. The previous study by Kinley et al. (2009) 
suggests that contamination may arise from cross-contamination. The Salmonella isolates 
collected during that study had a maximum D-value of 45 sec at 65°C, which is at least 50°C 
lower than the 115-145°C temperatures used during the rendering process (Anderson, 2006).  
 A likely source for cross contamination is the incoming raw material, which may have 
already been contaminated with pathogenic bacteria such as Salmonella. The current study has 
indicated that the average Salmonella count from raw chicken offal is ca. 105 CFU/g. This level 
is in agreement with the 5.8-6.3 log CFU/g of Salmonella on raw broiler carcasses reported by 
Kotula and Pandya (1995). Troutt et al. (2001) reported that 84.5% of the raw products collected 
from U.S. rendering facilities were contaminated by Salmonella.  
Previous studies have revealed that treatment of raw meats is successful for Salmonella 
reduction when using a bacteriophage cocktail. For example, Higgens (2005) demonstrated that a 
72 phage cocktail was capable of reducing S. Enteritidis (SE) by as much as 60% on poultry 
carcasses. Goode et al. (2003) reported that using a bacteriophage cocktail at a MOI of 100 or 
1000 could decrease Salmonella by 2 log CFU/cm2 on chicken skin. Fiorentin et al. (2005) 
demonstrated that SE levels in the rinse water of artificially contaminated chicken skin (106 
CFU/cut) could be significantly reduced (P<0.05) with a bacteriophage cocktail at a MOI of 
1000. In this study, the maximum observed reduction in Salmonella levels in raw chicken offal 
by bacteriophage treatment was 2.7 log CFU/g at 30° and 40°C. The lack of a significant 
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difference between the efficacy of the bacteriophage treatment at a MOI of 10 and 100 may 
suggest the bacteriophage cocktail reaches maximum efficacy at a MOI of 10. There was also no 
notable difference between the treatment of the irradiated offal and the offal that was not 
sterilized, which indicates that a bacteriophage cocktail is host-specific and is less affected by 
background microorganisms. This study has shown that bacteriophage treatment can serve as an 
effective way to lower Salmonella contamination in the raw material, thereby reducing the 
probability for cross-contamination in the rendering facility. 
 Aside from preventing Salmonella contamination in the finished product, the current 
study aimed to determine the potential for bacteriophage to be used as a feed additive when the 
finished product is already contaminated with Salmonella. To accomplish this, we tried to 
determine if the bacteriophage cocktail could remain alive within the finished rendered product. 
The results indicated that the bacteriophage levels decrease by 1.5 log PFU/g within 4 weeks. 
This relatively short shelf life means that for lyophilized bacteriophage to be effective as a feed 
additive, the feed would either need to be used shortly after being mixed together with 
bacteriophage or that the bacteriophage would have to be added at a concentration far exceeding 
the minimal lytic concentration. For example, in this study the bacteriophage cocktail was 
initially added to the meals at a MOI of 10, but the bacteriophage titers had reduced quickly 
during storage, resulting in a MOI of 1 within two weeks.  
In this study, we also determined if bacteriophages within the feed could be reactivated 
upon rehydration to reduce Salmonella levels. The results indicated that the lyophilized 
bacteriophages, at a MOI of 10 and 100, was unsuccessful at eliminating the growth Salmonella 
in the feed during rehydration; however, there was a significant (P<0.05) difference in 
Salmonella levels between samples containing bacteriophage and those without. The 
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bacteriophages did slow the rate of Salmonella growth (average 2 log reduction as compared 
with the control) through 12 h of rehydration. These results suggest that Salmonella can be 
controlled to some extent by bacteriophage treatment when the rendered meal becomes 
rehydrated upon animal consumption. While there are no known studies using lyophilized 
bacteriophages for pathogen control, Kim et al. (2007) added a bacteriophage cocktail to 
reconstituted infant formula and reported that the bacteriophages were able to reduce 
Enterobacter sakazakii (OD600=0.5) levels by 1 log CFU/g after at 24°C using the bacteriophage 
cocktail at a MOI of 1 and 10 for 12 h. In this study, we were able to reduce Salmonella level by 
ca. 1 log CFU/g after a 12 h period in the rehydrated meals using fresh bacteriophage. The 
results suggest that the lyophilized bacteriophage may require a recovery period while fresh 
bacteriophage is already active when it is added to the rehydrated meal. 
 There have been many studies indicating the potential of bacteriophages as therapeutic 
agents. Initial bacteriophage therapeutic trials date back to the work of d’Herelle (1921). He was 
able to use bacteriophage treatment to reduce the occurrence of avian typhosis in chicken flocks 
across France. D’Herelle (1926) also demonstrated that water supplemented with bacteriophage 
prevented Pasteurella multocida infection in water buffalo. More recently, Smith and Huggins 
(1983) demonstrated that a bacteriophage cocktail could be used to reduce the mortality rate due 
to E. coli O9:K30.99 infection from 100 to 17% in calves. Berchieri et al. (2001) showed that a 
bacteriophage cocktail could be used to reduce S. Typhimurium levels in the intestine, crop, and 
cecae by 1 log within 12 h of bacteriophage administration. The study by Berchieri et al (2001) 
and the current study both demonstrate that bacteriophage therapy can be effective at reducing 
Salmonella if given before the pathogenic cells can enter the epithelial cells. In our animal trial, 
the experimental mice were given the bacteriophage supplemented feed a week prior to 
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inoculation. The results of fecal sampling indicated that the bacteriophages were able to prevent 
Salmonella infection immediately after pathogen challenge. Fecal shedding of Salmonella in the 
control mice indicated that Salmonella successfully infected the host; however, the tissue 
analysis indicated that at the end of the 4-week trial, Salmonella was no longer detected in any of 
the mice. Histological analysis did not detect any signs of inflammation due to Salmonella 
infection in the experimental mice; whereas, the control mice had some signs of inflammation 
associated with Salmonella infection in the liver which suggested the mice were initially 
infected. 
 This study has demonstrated that a bacteriophage cocktail can be used to effectively 
reduce Salmonella populations within the raw material used for rendering at temperatures 
ranging from 20-40°C, which reduces the probability of cross-contamination. The presence of 
background microorganisms does not significantly affect the efficacy of the bacteriophage 
treatment. It was also shown that the stability of the bacteriophage as a feed additive is 
maintained when the bacteriophage is added n liquid form and stored at refrigeration 
temperatures. The study also suggests that the presence of lyophilized bacteriophages in 
rehydrated meals does not eliminate Salmonella growth but slows the rate of Salmonella growth 
during the rehydration step. By adding fresh bacteriophages to the rehydrated meals, Salmonella 
populations were reduced by ca. 1 log CFU/g, suggesting that fresh bacteriophage has potential 
as a feed additive. This was further supported by the animal study, where mice given feed 
supplemented with fresh bacteriophage prior to inoculation showed no indications of Salmonella 
infection. Overall results have demonstrated that fresh bacteriophage may be effective at 
reducing Salmonella levels at the farm level when added close to the time of consumption; 
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however, additional animal testing is needed to optimize bacteriophage treatment across various 
species due to differences in the gastrointestinal systems between animals. 
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Figure legends 
Fig. 1. Bacteriophage treatment of Salmonella in sterile raw chicken offal at 20° (a), 30° (b), and 
40°C (c), and non-sterile raw chicken offal at 20° (d), 30° (e), and 40°C (f). Symbols were 
Control (♦), MOI of 10 (■), and MOI of 100 (▲). 
Fig. 2. Stability of Salmonella in finished rendered meal over at 30°C. 
Fig. 3. Stability of lyophilized bacteriophage with MOI of 10 and 100 infinished rendered meal. 
Symbols were MOI of 10 (■) and MOI of 100 (♦). 
Fig. 4. Stability of bacteriophage in animal feed stored at 4°C.
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Table 4.1a. Changes in Salmonella populations in irradiated blood meal as affected by lyophilized bacteriophage   
Lyophilized Salmonella Fresh Salmonella 
MOI 10 MOI 100 MOI 10 MOI 100 
Storage Sampling 
Control Experimental Control Experimental Control Experimental Control Experimental (Week) time (h) 
0 5.27±0.20* 5.12±0.10 6.00±0.20 5.24±0.21 
1 0 4.95±0.23 5.04±0.23 4.86±0.38 4.96±0.14 4.97±0.11 5.10±0.10 5.12±0.04 4.87±0.25 
12 8.62±0.18A** 7.05±0.17B 8.55±0.24A 6.40±0.16B 9.05±0.19A 7.48±0.28B 8.64±0.18A 6.81±0.13B 
2 0 4.72±0.18 4.80±0.26 4.43±0.20 4.62±0.20 5.15±0.06 4.93±0.16 4.91±0.26 5.12±0.08 
12 8.35±0.11A 6.71±0.07B 8.21±0.17A 6.63±0.07B 9.12±0.12A 7.55±0.13B 8.87±0.14A 6.93±0.19B 
3 0 4.10±0.07 4.49±0.17 4.05±0.01 4.18±0.14 5.05±0.19 5.55±0.06 5.32±0.14 5.07±0.08 
12 8.47±0.30A 7.31±0.16B 8.42±0.21A 7.02±0.14B 8.76±0.22A 7.61±0.11B 9.02±0.07A 8.22±0.11B 
4 0 3.94±0.16 4.02±0.44 3.80±0.18 3.93±0.07 5.36±0.15 5.43±0.22 5.17±0.15 5.21±0.22 
  12 8.51±0.17A 7.66±0.38B 8.67±0.25A 7.28±0.35B 8.91±0.20A 8.14±0.15B 8.71±0.04A 8.03±0.09B 
*Salmonella log CFU/g 
**Letters represent different levels of significance between the control and experimental samples among test groups 
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Table 4.1b. Changes in Salmonella populations in irradiated feather meal as affected by lyophlized bacteriophage   
Lyophilized Salmonella Fresh Salmonella 
MOI 10 MOI 100 MOI 10 MOI 100 
Storage Sampling 
Control Experimental Control Experimental Control Experimental Control Experimental (Week) time (h) 
0 5.07±0.20* 4.98±0.21 4.91±0.18 5.16±0.17 
1 0 5.32±0.21 4.93±0.23 4.73±0.06 4.88±0.27 5.39±0.16 4.73±0.26 5.06±0.23 4.80±0.20 
12 8.44±0.24A** 6.62±0.13B 8.31±0.17A 6.27±0.11B 8.87±0.05A 7.11±0.16B 8.91±0.14A 7.04±0.14B 
2 0 4.98±0.17 4.80±0.11 4.51±0.30 4.66±0.07 4.88±0.24 5.49±0.19 5.31±0.18 4.97±0.15 
12 8.71±0.23A 6.88±0.17B 8.20±0.20A 6.12±0.24B 9.14±0.16A 7.37±0.07B 8.73±0.20A 6.90±0.09B 
3 0 4.76±0.16 4.51±0.11 4.17±0.20 4.29±0.30 4.94±0.10 4.96±0.21 4.88±0.16 5.18±0.17 
12 8.55±0.23A 7.22±0.04B 8.27±0.30A 6.89±0.03B 9.03±0.03A 7.19±0.14B 8.80±0.15A 7.96±0.06B 
4 0 4.37±0.35 4.10±0.10 3.97±0.21 4.04±0.08 5.04±0.11 5.35±0.28 5.11±0.33 5.22±0.27 
  12 8.31±0.17A 7.66±0.18B 7.96±0.11A 6.55±0.11B 8.76±0.19A 8.14±0.16B 9.11±0.08A 8.41±0.13B 
*Salmonella log CFU/g 
**Letters represent different levels of significance between the control and experimental samples among test groups 
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Table 4.1c. Changes in Salmonella populations in irradiated poultry meal as affected by lyophilized bacteriophage   
Lyophilized Salmonella Fresh Salmonella 
MOI 10 MOI 100 MOI 10 MOI 100 
Storage Sampling 
Control Experimental Control Experimental Control Experimental Control Experimental (Week) time (h) 
0 5.17±0.14* 5.08±0.14 5.32±0.21 5.01±0.11 
1 0 5.32±0.18 4.98±0.17 5.04±0.10 4.81±0.06 4.98±0.10 5.66±0.17 5.20±0.18 5.02±0.28 
12 7.92±0.20A** 6.44±0.07B 8.47±0.11A 6.52±0.18B 9.10±0.06A 7.63±0.07B 8.78±0.19A 6.92±0.08B 
2 0 4.93±0.11 4.89±0.18 4.70±0.11 4.57±0.18 5.59±0.23 4.89±0.13 5.11±0.04 5.37±0.16 
12 7.77±0.25A 6.09±0.10B 8.31±0.27A 6.08±0.04B 8.94±0.18A 7.21±0.22B 8.93±0.12A 7.10±0.12B 
3 0 4.80±0.18 4.72±0.04 4.33±0.16 4.30±0.33 5.61±0.19 4.76±0.29 4.92±0.24 5.13±0.09 
12 7.94±0.17A 6.87±0.17B 8.30±0.38A 7.06±0.21B 8.87±0.11A 7.78±0.06B 8.64±0.08A 7.74±0.19B 
4 0 4.61±0.07 4.51±0.08 4.06±0.20 4.11±0.08 4.93±0.27 5.41±0.17 5.07±0.10 4.85±0.25 
  12 7.66±0.04A 6.93±0.08B 8.19±0.24A 6.72±0.25B 9.03±0.08A 8.17±0.14B 9.09±0.11A 8.26±0.16B 
*Salmonella log CFU/g 
**Letters represent different levels of significance between the control and experimental samples among test groups 
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Table 4.2a. Changes in Salmonella populations in irradiated blood meal as affected by fresh bacteriophage 
Storage Sampling Salmonella (log CFU/g) 
(Week) time (h) Control Experimental 
0 5.18±0.08 5.02±0.20 
1 12 8.42±0.18 7.07±0.08 
24 9.26±0.24A* 6.13±0.11B 
2 12 8.29±0.04 7.14±0.11 
24 9.07±0.10A 6.22±0.23B 
3 12 8.41±0.14 7.39±0.21 
24 9.19±0.23A 6.26±0.07B 
4 12 8.38±0.08 7.62±0.06 
  24 8.95±0.10A 6.46±0.10B 
**Letters represent different levels of significance between the control and experimental samples  
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Table 4.2b. Changes in Salmonella populations in irradiated feather meal as affected by fresh bacteriophage 
Storage Sampling Salmonella (log CFU/g) 
(week) time (h) Control Experimental 
0 5.17±0.17 5.08±0.13 
1 12 8.28±0.07 6.96±0.11 
24 9.01±0.16A* 5.97±0.13B 
2 12 8.50±0.17 7.24±0.13 
24 9.19±0.07A 6.04±0.11B 
3 12 8.39±0.07 7.28±0.13 
24 9.09±0.08A 6.22±0.24B 
4 12 8.17±0.13 7.41±0.20 
  24 8.86±0.10A 6.35±0.06B 
**Letters represent different levels of significance between the control and experimental samples  
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Table 4.2c. Changes in Salmonella populations in irradiated poultry meal as affected by fresh bacteriophage 
Storage Sampling Salmonella (log CFU/g)   
(Week) time (h) Control Experimental 
0 4.97±0.10 5.06±0.11 
1 12 8.22±0.10 6.84±0.11 
24 9.10±0.11A* 5.86±0.14B 
2 12 8.36±0.04 7.09±0.17 
24 9.27±0.04A 6.17±0.16B 
3 12 8.16±0.11 7.17±0.07 
24 8.99±0.11A 6.24±0.13B 
4 12 8.29±0.17 7.33±0.08 
  24 9.15±0.03A 6.41±0.20B 
**Letters represent different levels of significance between the control and experimental samples 
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Table 4.3. Salmonella enumeration in feces from mice 
  Treated Untreated 
Day Group 1 Group 2 Group 3 Group 4 Group 5 
1 BDL* BDL BDL 3.86±0.13** 4.79±0.13 
4 BDL BDL BDL 3.78±0.25 4.08±0.20 
8 BDL BDL BDL 2.85±0.11 2.78±0.04 
11 BDL BDL BDL 3.45±0.27 3.20±0.08 
15 BDL BDL BDL 2.60±0.06 3.00±0.13 
18 BDL BDL BDL BDL BDL 
22 BDL BDL BDL BDL BDL 
25 BDL BDL BDL BDL BDL 
* Below the detection limit 102 CFU/g 
**Salmonella log CFU/g 
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CONCLUSION 
 
In this study we have demonstrated that finished rendered animal meals are often 
contaminated with pathogenic bacteria such as Salmonella. Through thermal tolerance 
testing we were able to determine the most likely cause of such contamination is post 
processing contamination rather than inefficient heat processing. We were able to isolate 
and optimize a bacteriophage cocktail that was capable of reducing Salmonella found on 
surfaces (stainless steel, rubber, HDPE plastic, and concrete) common to a rendering 
facility’s environment  as well as in the incoming raw material. On average, up to 99.9% 
of Salmonella populations were eliminated by bacteriophage treatment. By doing this, the 
use of a bacteriophage cocktail could potentially reduce the probability of cross-
contamination, leading to no contamination in the finished meals. In addition, our results 
have demonstrated that a bacteriophage has the potential to be used as a feed additive. 
Although the stability of the lyophilized bacteriophage’s in finished meals was decreased 
when stored at 30°C, it was improved when fresh bacteriophage was added to the feed 
and stored at 4°C. In addition to decreased stability, the lyophilized bacteriophage did not 
prevent Salmonella growth but did slow Salmonella’s growth within the animal meals 
through 12 h. The addition of fresh bacteriophage resulted in ca. a 1 log CFU/g reduction 
in Salmonella populations within finished meal, suggesting the bacteriophage’s potential 
as a feed additive is increased when using a fresh bacteriophage suspension. The 
effectiveness of bacteriophage as a feed additive was further confirmed during an animal 
trial. Mice receiving bacteriophage in their feed showed no signs of infection following 
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Salmonella inoculation. In conclusion, we have demonstrated that a bacteriophage 
cocktail can be used to reduce the risk of Salmonella contamination in the processing 
environment, the feed, and upon feed consumption. 
 
